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SUMMARY
Synthetic oligonucleotides representing all possible 
sequences of an N-terminal and an internal region of the A- 
chain of abrin C were used to generate a probe specific for 
abrin-related sequences using the polymerase chain reaction on 
Abrus precatorius genomic DNA. A lambda phage library 
constructed from genomic DNA isolated from leaf tissue of A. 
precatorius was screened and positive hybridising clones were 
characterised by restriction enzyme analysis. The coding 
regions of unique clones were characterised by DNA sequencing. 
One clone encodes a preproprotein closely related to abrin C 
with 83% similarity between the A-chain sequences. Based on the 
similarity with the ricin toxins and Ricinus communis 
agglutinin, the preproprotein consists of an A-chain of 251 
amino acids, preceded by 34 amino acids containing an N- 
terminal signal peptide, followed by a 14 amino acid linker and 
a B-chain of 263 amino acids.
The mature A-chain of the preproabrin has been expressed 
cytoplasmically in Escherichia coli and the soluble recombinant 
protein was produced at levels exceeding 6% of total cell 
protein. The recombinant A-chain has been purified to 
homogeneity and its ability to depurinate 28S rRNA in 
eukaryotic ribosomes has been demonstrated in vitro.
The mature B-chain of the preproabrin has been expressed 
in Xenopus laevis oocytes and was found to be unstable and 
lacking in lectin activity. The non-lectin activity of the 
protein was confirmed by expression and analysis of the 
preproabrin in X. laevis oocytes.
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1.INTRODUCTION
1.1 INTRODUCTION TO TOXIC LECTINS AND RELATED PROTEINS
Many plants serve dual or multiple purposes to man. For 
many thousands of years the seeds of Abrus precatorius and 
Ricinus communis have been known to be highly toxic to man and 
his cattle. The toxicity is now known to be due to the presence 
of toxic lectins called abrin and ricin and these proteins are 
amoung the most poisonous found in nature. The extreme toxicity 
of abrin and ricin has made these proteins a focus of interest 
to scientists for many years. The seeds from these plants, or 
extracts prepared from them, have been used in medicines in 
many parts of the world for centuries. The criminal fraternity 
has also realised the potential of such toxic substances.
Abrin occurs in the seed with the related bivalent lectin 
A. precatorius agglutinin (APA). Similarly the seeds of R. 
communis, which contain the toxin ricin, contain the R. 
communis agglutinin (RCA). The agglutins are essentially non­
toxic.
Abrin and ricin consist of two dissimilar peptide chains, 
an A-chain and a B-chain linked by a single disulphide bond, 
which have different functions. The A-chain catalytically 
inactivates the 60S subunit of ribosomes in susceptible cells 
by cleaving a specific adenine residue from the backbone of 28S 
rRNA (Endo et al., 1987). The B-chain is a lectin and binds to 
terminal galactose residues on the cell surface leading to cell 
entry of the holotoxin (Olsnes and Pihl, 1982). There is strong 
evidence to suggest that a single A-chain molecule within the 
cytosol can kill a cell (Eiklid et al., 1980).
The agglutinins have very limited cytotoxicty. The A-chain 
of RCA has the same action as ricin A-chain in vitro, but the 
activity is reduced by several fold. The B-chain of the 
agglutinins binds to cell surface receptors but there is no 
progression to productive cell entry and intoxication.
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Another type of plant protein, first described from 
Phytolacca americana (Tomlinson et al., 1974), has been found 
to have very similar properties to the A-chains of abrin and 
ricin. These proteins, which have now been found in a wide 
variety of higher plants, lack a cell-binding moeity and are 
therefore non-cytotoxic. However, in vitro they modify 
ribosomes by the same mechanism of action as abrin and ricin 
(Stirpe et al., 1986). Modification of the ribosome by cleavage 
of a single adenine residue from 28S rRNA in vitro is not a 
property exclusive to plant proteins. The Shiga toxin produced 
by Shigella dysenteriae and the Shiga-like toxins of 
Escherichia coli (Calderwood et al., 1987) also modify 
ribosomes in an identical fashion (Endo et al., 1988a).
Proteins which catalytically inactivate ribosomes by 
cleavage of the specific adenine residue from the 
phosphodiester backbone of 28S rRNA are now classified as 
either type I ribosome-inactivating proteins (single-chain 
forms) or as type II ribosome-inactivating proteins 
(heterodimeric forms).
Other bacterial and fungal toxins which include diphtheria 
toxin found in Corynebacterium diphtheriae, Pseudomonas 
aeruginosa exotoxin A (PE), and ot-sarcin from Aspergillus 
gigantea, also inhibit protein synthesis but through differing 
mechanisms of action to the ribosome-inactivating proteins. The 
A-fragment of diphtheria toxin catalyses the ADP-ribosylation 
of elongation factor 2 (EF-2) (van Ness et al., 1980). ADP- 
ribosylated EF-2 cannot translocate the peptidyl-tRNA from the 
A-site to the P-site although it can still bind in the presence 
of GTP. Domain III of PE also catalyses the ADP-ribosylation of 
EF-2 (Hwang et al., 1987). oC-sarcin is an endoribonuclease and 
calalytically inactivates ribosomes by cleavage of a specific 
phosphodiester bond in 28S, 26S or 23S rRNA (Endo and Wool, 
1982) .
The ribosome-inactivating proteins have been shown to have 
anti-viral activity (McGrath et al., 1989) and tumour- 
suppressive properties (Chang et al., 1985) in addition to
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their cytotoxic potential. The extreme cytotoxicity of the 
toxic lectins, and the in vitro activity of the type 1 
ribosome-inactivating proteins has made them a focus of 
research in the development of specific cytotoxic agents, in 
particular as tumour-specific cytotoxins, by linking them to 
antibodies (Frankel, 1988). As a consequence of this there is 
continued interest in determining the details of structure- 
function relationships, cell entry and substrate specificity.
This thesis describes the cloning and subsequent analysis 
of an abrin-related protein. The aim of this section is to 
describe the relevant common knowledge and information known 
about the toxic lectins at the inception of this project and to 
provide the context in which the results are discussed.
I a  BIOgHlTBgBIS AMP ppyiriCATION
Abrin and APA are found amoung the matrix proteins of the 
protein bodies in the endosperm of A. precatorius seeds and 
constitute up to 30% of the dry weight of the seed (Murray and 
Vairinhos, 1982) . Similarly, ricin and RCA are found in the 
endosperm protein bodies of R. communis seeds (Youle and Hwang, 
1976 and Tully and Beevers, 1976). As germination proceeds, 
the protein body membranes fuse, forming the tonoplast (Ashton, 
1976) . The contents of the protein bodies remain intact in this 
vacuole but are later hydrolysed during germination. The toxic 
lectins are therefore kept out of contact with host ribosomes 
in the cytoplasm (Tully and Beevers, 1976).
1.2.1 Precursor polypeptides of the toxic lectin*
Both ricin and RCA are synthesised as preproprotein 
precursors which are translated on membrane bound ribosomes in 
the endosperm cells of maturing seeds (Butterworth and Lord, 
1983) . The preproproteins consist of a leader peptide, the A- 
chain, a linker peptide and the B-chain (Roberts et al., 1985
and Lamb et a l ., 1985) . The nascent prolectins are
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cotranslationally segregated into the lumen of the endoplasmic 
reticulum (ER). From the ER they are transported to the protein 
storage bodies where the linker is cleaved to generate the 
mature lectin (Harley and Lord, 1985).
1.2.2 Co-translational modifications
The leader sequence presumably contains a signal sequence 
which mediates translocation of the nascent polypeptide across 
the ER membrane. The removal of a signal sequence from the 
precursors of ricin and RCA was demonstrated by 
immunoprécipitation of the deglycosylated products of in vitro 
translation of mRNA, isolated from ripening castor bean seeds, 
in the presence or absence of dog pancreatic microsomes 
(Butterworth and Lord, 1983). The nucleotide sequences of cDNA 
clones of ricin and RCA (Lamb et al., 1985 and Roberts et al., 
1985) and of a genomic clone of ricin (Hailing et al., 1985) 
have been determined and the leader peptide is now known to be 
35 amino acids long and is identical in both ricin and RCA. It 
seems unlikely that the entire leader peptide constitutes the 
signal peptide. A 35 amino acid leader is longer than most 
signal peptides (Watson, 1984) and, based on consensus 
sequences, cleavage after the asparagine residue at position -1 
is unlikely. Alternative cleavage sites are proposed after 
residue -10 (Gly) or residue -20 (Ala) , in which case further 
post translational N-terminal processing must occur (Roberts et 
al., 1985).
Another co-translational event is core glycosylation 
(Roberts and Lord, 1981) . N-glycosylation of a nascent 
polypeptide occurs in the ER by en bloc transfer of the 
oligosaccharide [Glc3Man(GlcNAc)2-] from a carrier molecule 
(Snider and Robbins, 1981 and Hanover and Lennarz, 1981). 
Pretreatment of intact castor bean endosperm tissue with 
tunicamycin, inhibited co-translational core glycosylation and 
glycosylation was not necessary for sequestration of the mature 
lectin in the protein bodies (Lord, 1985b).
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It is believed that disulphide bond formation occurs co- 
translationally or shortly after release of the propeptide into 
the ER lumen (Roberts et al., 1987). Ricin and RCA each have a 
single interchain disulphide bond and four intrachain 
disulphide bonds in the B-chain.
1.2.3 Post-translational modlfiçatjoÆJ
During transport from the ER to the protein storage bodies 
there are several post-translational modifications to the 
Ricinus lectins. Cell fractionation of maturing castor bean 
endosperm, pulse-labelled with [3H]-fucose, has shown that the 
lectins are transported through the Golgi apparatus during 
which time the oligosaccharide side chains are modified (Lord, 
1985b). This modification includes the addition of fucose, 
which renders the oligosaccharide moeities partially resistant 
to endo-N-acetylglucosaminidase H (Lord, 1985b) , and the 
addition of xylose (Kimura et al., 1987 and Kimura et al., 
1988b). RCA B-chain contains a fucosylated side chain not 
présent in ricin D B-chain (Lord, 1985a). It is assumed that 
the lectins are transported in Golgi-derived vesicles to the 
protein storage bodies where the vesicles fuse to liberate the 
lectins into the protein storage bodies (Tully and Beevers, 
1976).
Once sequestered within the storage bodies there is 
cleavage of the linker peptide. The linker is identical in both 
ricin and RCA and is 12 amino acids long and ends with an 
asparagine residue (Lamb et al., 1985 and Roberts et al., 
1985). A partially purified soluble extract from castor bean 
endosperm protein bodies cleaves the linker from the lectin 
precursors to generate the mature forms (Harley and Lord, 
1985). Plant proproteins commonly undergo endoproteolytic 
cleavage after an asparagine residue (Lord and Robinson, 1986). 
It may also be in the protein storage bodies that the final 
processing of the N-terminus of the A-chain occurs and an
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endoprotease with specificity for asparagine may be involves 
(Roberts et al., 1987).
Roberts and Lord (1981) noted that the molecular mass of 
the lectins delivered to the protein storage bodies reduces 
slowly to that of the authentic lectin subunits. This 
"trimming" can be prevented in vitro by the addition of 
monosaccharides and is not seen in vivo for non-glycosylated 
lectins, synthesised in the presence of tunicamycin, whiçh 
suggests that this modification involves the removal of sugar 
residues (Roberts et al., 1987).
1.2.4 Purification
A variety of purification schemes have been devised over 
the years for purification of the toxic lectins. In the case of 
type II ribosome-inactivating proteins and the agglutinins, the 
basis of the purification is affinity chromatography on 
Sepharose 4B which contains galactose. The toxic lectins bind 
to the column and contaminating proteins pass through. Ricin is 
eluted from the column with N-acetyl-galactosamine whereas the 
agglutinin requires galactose for elution (Nicholson and 
Blaustein, 1972).
The toxic lectins occur in several different forms. 
Microheterogeneity is seen in seeds of the same source 
(isoforms) and in seeds of different origin. Certain isoforms 
differ only in the degree of modification of the
oligosaccharide side-chains (Kimura et al., 1988a and Islam and 
Funatsu, 1988) .
Lin et al. (1981) isolated four isoforms of abrin termed 
abrin-a,-b,-c, and -d. Abrin-a is similar to abrin C as 
described by Wei et al. (1974), and to abrin as described by 
Olsnes and Pihl (1976). Abrin-a binds strongly to Sepharose 4B, 
is eluted with galactose and is highly toxic. Abrin-b and 
abrin-c are similar to abrin A (Wei et al., 1974 and Olsnes and 
Pihl, 1976) and to the abrin A isolated by Herrmann and Behnke 
(1980) which was found to consist of two isoforms which were
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retarded by Sepharose 4B but eluted in the absence of galactose 
(Herrmann and Behnke, 1981). Abrin-b was noted to be relatively 
unstable when stored at 4°C compared to the other isoabrins 
(Lin et a l ., 1982). Abrin-d has not been described elsewhere. 
Abrin-d binds to Sepharose 4B and is of reduced toxicity 
compared to other isoabrins. The abrin which is generally 
isolated from seed tissue is abrin C (abrin-a) and unless 
specified abrin refers to abrin C.
A similar situation applies to ricin. The ricin isolated 
by most laboratories binds strongly to Sepharose 4B and can be 
eluted with lactose. This isoform is now known as ricin D and 
unless specified ricin refers to ricin D. Mise et al. (1971) 
described a variant called ricin E which does not bind to 
Sepharose 4B although binding to cells was inhibited by 
lactose. The nucleotide sequence of ricin E has been determined 
and differs from ricin D only in the B-chain (Ladin et al. , 
1987).
Modeccin, a toxic lectin from the root tissue of Adenia 
digitata, binds to Sepharose 4B (Stirpe et al., 1978) whereas 
the toxic lectin isolated from the roots of A. digitata by 
Olsnes and Pihl (1982) did not bind to Sepharose 4B but would 
bind to a column containing desialylated fetuin and was eluted 
with lactose. Viscumin, the toxic lectin from the leaves of 
Viscum album, occurs as at least two isoforms (Franz et al., 
1981). Both viscumin isoforms bind to Sepharose 4B but differ 
in that one has specificity for galactose and N- 
acetylgalactosamines whereas the other is specific for N- 
acetylgalactosamines alone.
The single-chain type I ribosome-inactivating proteins do 
not have lectin activity. Several of these proteins have been 
purified to homogeneity but the individual steps involved in 
the purification schemes have differed widely. A general 
procedure has been described for large scale purification of 
type I ribosome-inactivating proteins which involves the use of 
a strong cation exchanger (S-Sepharose) and chromatography on 
CM-Sepharose (Barbieri et al., 1987).
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Table 1 summarises the plant-derived ribosome-inactivating 
proteins which have been described to date. Type I ribosome­
inactivating proteins are far more predominant than the toxic 
lectins.
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1.3 STRUCTURE AND PHYSICAL PROPERTIES OF THE TOXIC LECTINS
1.3.1 primary structure of th+ toxlg l»gUa»
All the type II ribosome-inactivating proteins have 
molecular masses in the range of 60,000 to 65,000 and consist 
of two polypeptide chains linked by a single disulphide bond. 
The A-chain is slightly shorter than the B-chain. The 
agglutinins consist of two heterodimers, each consisting of an 
A-chain and a B-chain linked by a single disulphide bond, with 
the heterodimer held together by weak non-covalent forces 
(Figure 1).
Figure 1 Schematic structure of the toxic lectins and agglutinins
TOXIN AGGLUTININ
The primary sequence of ricin has been determined (Funatsu 
et a l ., 1979) as has the primary sequence of the A-chain of 
abrin C (Funatsu et al., 1988). The A-chains are identical at 
106 residues and the similarity of 42% suggests a common 
evolutionary ancestor. The A-chain of abrin C does not contain 
any glycosylation sites unlike ricin D which has two in the A- 
chain.
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The nucleotide sequences for ricin D, ricin E and RCA have 
been determined (Lamb et al., 1985, Ladin et al., 1987 and 
Roberts et al., 1985). The ricin toxins and RCA are remarkably 
similar in sequence, exhibiting 93% homology at the amino acid 
level in the A-chains. Ricin D and RCA are 83% homologous at 
the amino acid level in the B-chains. The N-terminal leader 
peptide and the linker peptide are identical in all the 
Ricinus toxic lectins.
In total there are only 59 amino acid differences between 
ricin D and RCA. Of these 59 differences, 45 are caused by a 
single base change, 10 involve alteration of two bases within a 
codon and three result from complete codon replacement (Roberts 
et al., 1985). Of the changes, the majority are not expected to 
alter the properties of the proteins significantly. The major 
changes are the presence of two cysteine residues in the A- 
chain of RCA not present in ricin and an additional 
glycosylation site within the B-chain of RCA. The effect of the 
additional cysteines in RCA is not known but they are not 
expected to be able to form either intrachain or interchain 
disulphide bonds (personal communication, Dr J.D. Robertus, 
University of Texas at Austin, Texas, USA). The ricin toxins 
and RCA have two glycosylation sites within the A-chain at 
identical positions and two of the glycosylation sites in the 
B-chain are common to both toxins and RCA. RCA has an 
additional glycosylation site in the B-chain.
Amino acid sequence analysis of the B-chain of ricin D has 
indicated that the B-chain sequence arose from a series of gene 
duplications (Rutenber et al., 1987). The A-chain and B-chain 
of ricin are not similar.
From the sequence data available on type I ribosome­
inactivating proteins, an evolutionary relationship between the 
A-chains of the toxic lectins and the single chain ribosome­
inactivating proteins is postulated (Ready et al., 1984). In 
addition, ricin A-chain and type I ribosome-inactivating 
proteins exhibit some similarity to E. coli RNase H and to 
domains of the reverse transcriptase of Moloney murine
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leukaemia virus, Rous sarcoma virus and human immunodeficiency 
virus (Ready et al., 1988). All these proteins bind to and 
hydrolytically modify nucleic acid. The evolutionary 
relationship is intriguing because the ribosome-inactivating 
plant proteins appear to have undergone as much divergence 
amoung themselves as they have from bacterial and retroviral 
proteins. Ready and co-workers postulate that the divergence 
amoung the proteins has reached an equilibrium where the 
similarity is the minimum needed to maintain function and 
structural integrity. The ancestral gene may have existed prior 
to divergence of the common ancestor of plants and eubacteria, 
or the ribosome-inactivating proteins may have arisen from 
lateral transfer of a bacterial or viral gene into an ancient 
angiosperm. Relevant to the latter case there is no evidence to 
date of ribosome-inactivating proteins in plants below the 
angiosperm grade although they exist in bacteria (Ready et al., 
1988) .
The disulphide bond between the A-chain and B-chain of a 
toxic lectin is not required for toxicity in vitro or in vivo 
(Olsnes and Pihl, 1972). In ricin the disulphide bond plays no 
role in toxicity except to maintain the association between the 
two chains at low concentrations (Lewis and Youle, 1986). 
Olsnes and Pihl (1982) reported that irreversible covalent 
cross-linking of abrin with dimethyl suberimidole resulted in 
non-cytotoxicity. Similar results were obtained with the cross- 
linking of ricin with N,N'-o-phenylenedimaleimdate (Oda and 
Funatsu, 1979) . It has been demonstrated that the disulphide 
bond is more readily reduced in the presence of SDS (Olsnes and 
Pihl, 1982) which might indicate that a conformational change 
which occurs during binding to the cell surface, or during 
transport to the cytosol, would facilitate reduction of the 
interchain disulphide bond.
The amount of carbohydrate present in ricin and abrin vary 
significantly in the published data. The toxic lectins and the 
agglutinins all contain mannose and glucosamine (Olsnes and
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Pihl, 1982) and abrin, ricin and modeccin bind to concanavalin 
A which suggests that the mannose residues are exposed.
The net charge of the toxic lectins has been determined in 
several laboratories. The A-chains of type II ribosome­
inactivating proteins and the type I ribosome-inactivating 
proteins typically have a neutral or basic pi. Abrin C A-chain 
is apparently unusual in having an acidic pi.
The overall charge on the holotoxin was demonstrated to 
have little effect on toxicity in vitro using combinations 
between the A-chain of ricin and the B-chain of abrin, and vice 
versa, to generate molecules with either acidic or neutral 
overall charge respectively (Olsnes et al., 1974a).
1.3.2 3-dimensional structure
Montford et al. (1987) determined the three-dimensional
structure of ricin at 2 . 8 A  by X-ray crystallography. Ricin A- 
chain is a globular protein with extensive secondary structure. 
A prominant cleft at the interface of the A-chain with the B- 
chain is postulated as the active site of the A-chain. The B- 
chain exists as two globular domains which have similar 
topology. Each B-chain domain hydrogen bonds to a molecule of 
galactose which lies in a shallow cleft. The interaction 
between the A-chain and B-chain shows some hydrophobic 
interactions in which proline and phenylalanine play an 
important role.
1.3.3 mninocvtochemiatry and antibody formation
The toxic lectins abrin, ricin and modeccin are 
immunologically distinct (Godal et al., 1981 and Olsnes et al., 
1978). There is some cross reactivity in some sera between 
ricin and abrin which, as determined by radioimmunoassay, is 
limited to approximately 2% compared to binding with homologous 
toxin (Godal et al., 1981). There is no cross reactivity
between sera against the isolated A-chains and B-chains
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(Pappenheixner et al., 1974). Ricin will induce antibodies that 
cross react with RCA and vice versa (Pappenheimer et al., 
1974). Antibodies against abrin however do not cross react with 
APA which suggests that the Abrus lectins differ more than the 
Ricinus lectins (Olsnes and Pihl, 1982).
Godal et al. (1983) used an enzyme-linked immunosorbent 
assay to study antibody formation in mice and humans against 
abrin and ricin. Abrin was found to be strongly 
immunosuppressive and more efficient than cyclophosphamide in 
inhibiting anti-human serum albumin formation in mice. In 
humans treated with therapeutic doses of abrin, the patients 
remained free of anti-abrin antibodies for approximately 10 
weeks compared to about 7 weeks for the production of anti- 
ricin antibodies in patients given eqivalent doses of ricin.
1.3.4 Resistance to Physical treat«#nt
Holotoxins are stable for long periods of time in the 
frozen state and toxicity is altered little by repeated freeze­
thawing cycles. Abrin and ricin are stable for several months 
at 4°C in the presence of 0.1M galactose. Ricin is marginally 
more resistant to heat than abrin, the latter being inactivated 
by heating to 60°C for 1 hour whereas ricin retains some 
activity (Olsnes and Pihl, 1982).
The isolated chains are less stable and require 10% 
glycerol to be present for freezing without loss of activity. 
The isolated B-chains are significantly less stable than the 
isolated A-chains (Wawrzynczak and Thorpe, 1986). The isolated 
chains can be stored at 4°C for several months in phosphate 
buffered saline, with 0.1M galactose in the the case of the B- 
chains, without significant drop in activity although a 10-100 
fold drop in activity of recombinant ricin A-chain stored at 
4°C has been noted (personal communication. Dr M.R. Hartley, 
University of Warwick, UK).
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1,3.5 Chemical modification
In the development of immunotoxins the effect of chemical 
modifications of the toxic lectins continues to be of interest. 
The holotoxins of abrin and ricin are resistant to treatment 
with a wide variety of proteolytic enzymes (Balint, 1974) . The 
denatured holotoxins and the isolated chains are more 
susceptible to proteases (Leignier et al., 1976 and Yoshitake 
et al., 1979) .
Funatsu et al. (1977) found that nagarase released at 
least 18 amino acids from the N-terminus of ricin A-chain but 
did not affect the B-chain. Loss of the N-terminus which 
includes one of the oligosaccharide side-chains did not alter 
toxicity. There have been several reports of peptides from 
limited hydrolysis of ricin A-chain which were as active or 
more active than native ricin A-chain on cell-free systems 
(Olsnes et a l ., 1982) but the peptides have not been well 
characterised.
Ricin and abrin are totally inactivated by treatment with 
oxidising agents (Balint, 1974) and the B-chain of ricin is 
highly susceptible to chloramine-T treatment (Sandvig et al., 
1976). Methylation of abrin and ricin did not significantly 
alter toxicity in vitro, but the ability of the B-chain to bind 
saccharides was abolished. Similar results were obtained with 
acetylation of abrin and ricin (Sandvig et al., 1978b). Houston 
(1983) showed that chemical modification of ricin with 4- 
diazophenyl-B-D-galactopyranaside inactivated the B-chain but 
did not alter toxicity in vitro.
APA retained binding activity after modification of 
lysine, tyrosine, arginine, histidine, glutamate and aspartate 
residues by a variety of methods (Patanjali et al., 1984). 
Modification of tryptophan residues with N-bromosuccinimide led 
to complete loss of carbohydrate binding by APA (Patanjali et 
al., 1987). Modification of the tryptophan residues in ricin 
and abrin with 2-hydroxyl-5-nitrobenzyl bromide did not 
significantly alter toxicity in vitro (Olsnes and Pihl, 1982) .
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1.4 TOXICITY OF THE TOXIC LECTINS
1 1 4 ?1 ABimajs map
The type II ribosome-inactivating proteins are highly 
toxic to mammals, particularly when administered parenterally. 
Animals show different sensitivities to the toxic lectins with 
horses being the most sensitive of those studied to date 
(Balint, 1974). The data from different laboratories on the 
toxicity of the toxic lectins are difficult to compare because 
the purity, doses, administration routes and scoring methods 
differ. Olsnes and Pihl (1982) found that the LD50 dose of 
abrin after intravenous injection in mice was 0.7pg/kg, in 
rabbits was 50ng/kg and in dogs was 1.25ng/kg.
After administration of toxin a lag period is seen during 
which time there are no symptoms. There follows a period during 
which weakness, weight loss, diarrhoea and fever are the 
typical symptoms. The white blood cell count rises transiently 
to up to 5 fold of the norm. Survival time is dose dependent. 
Animals given non-lethal doses of abrin or ricin recover 
completely (Olsnes and Pihl, 1982).
In rats given lethal doses of ricin the liver, spleen and 
pancreas become severely necrotic and the reticulo-endothelial 
cells seem particularly sensitive. Protein synthesis is most 
severely inhibited in the pancreas and spleen. Non-parenchyma1 
cells in the liver take up ricin and abrin more rapidly than 
parenchymal cells and protein synthesis is inhibited in vitro 
to a far greater extent in non-parenchyma1 cells than in 
parenchymal cells (Skilleter et al., 1981).
1.4.2 cultured cells
There is no correlation between toxicity in animals and 
cultured cells. Ricin E is as toxic to mice as ricin D but less 
toxic to cultured cells (Mise et al., 1977). Different cell
lines exhibit a wide degree of sensitivity to the toxic
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found for cultured cell lineslectins. The different IC50 
reflects differences in the number of cell surface receptors, 
efficiency of transport mechanisms, rate of degradation of 
internalised toxin, rate of redistribution of the contents of 
endocytosed vesicles to the cell surface and the inherent 
susceptibility of the ribosomes to the action of the toxin. 
Abrin, ricin and modeccin can kill cells in culture at doses as 
low as lng/ml.
After addition of abrin or ricin to cells there is always 
a lag time of 20-30 minutes even in the presence of an excess 
of toxin (Olsnes and Pihl, 1982). The first demonstrable effect 
is inhibition of protein synthesis, followed by a decrease in 
DNA synthesis and then RNA synthesis (Bennet et al., 1982 and 
Witten et a l ., 1982).
1'9 MECHANISMS OF ACTION OP TgE A-CHAIN
1.5.1 ipactlvatlOB of ribgsopaa
Endo and Tsurugi (1986) noted that the 28S rRNA from ricin 
treated ribosomes migrated slightly slower than that from 
untreated ribosomes and that the modification to the 28S rRNA 
did not involve phosphorolysis. The modification site was found 
to lie within a 553 nucleotide fragment that is normally 
generated by the contaminating nucleases. This fragment was 
sequenced and found to be derived from the 3 '-terminal of 28S 
rRNA. By end-labelling the rRNA from ricin treated ribosomes 
followed by partial digestion with RNases it was shown that the 
bases corresponding to G-4323 and A-4324 of 28S rRNA had been 
modified (Endo et al., 1987).
Partial alkaline hydrolysis indicated that the lability of 
the phosphodiester bonds adjacent to A-4324 was increased (Endo 
et al., 1987). This result implied that the C-l carbon of the 
ribose of the modified residue had been altered to an aldehyde 
by cleavage of the N-glycosidic bond. Treatment of the modified 
rRNA with aniline at acidic pH resulted in scission of the
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phosphodiester bonds adjacent to A-4324 and indicated that A- 
4324 was the base modified by ricin and related toxins (Endo et 
al., 1987). Direct evidence that ricin A-chain inactivates 
ribosomes by cleaving the N-glycosidic bond of A-4324 of 28S 
rRNA in a hydrolytic fashion was obtained by Endo and Tsurugi 
(1987) who demonstrated the release of 1 mole of adenine from 1 
mole of ribosomes by ricin A-chain.
Ricin was also shown to modify naked 28S rRNA but the rate 
and amount of modification was reduced (Endo et al., 1987). The 
ricin to substrate ratio for modification to occur was 
increased by 10,000 fold. Denatured naked 28S rRNA was not 
modified nor was the isolated 553 nucleotide fragment (Endo et 
al., 1987). This suggested that some secondary structure was 
important for action of ricin. Endo et al. (1988a) showed that 
ricin retained activity when tested on a 35-mer that mimics 
the region modified in 28S rRNA. The oligoribonucleotide forms 
a stem loop structure with the base modified by ricin lying on 
the exposed loop. The concentration of ricin required to modify 
the 35-mer was 10,000 times greater than that required to 
modify the 28S rRNA in intact ribosomes which indicates that 
the higher order structure of this loop is different in 
ribosomes than it is in naked rRNA.
The elucidation of the site and mechanism of action of 
ricin and related toxins led to the development of a simple 
assay for detecting the activity of ribosome-inactivating 
proteins: ribosomes are incubated with the ribosome­
inactivating protein, the rRNA is extracted and treated with 
aniline to release a fragment of rRNA from any modified 28S 
rRNA, and the released fragment is visualised by 
electrophoresis and staining with ethidium bromide. Using this 
assay the N-glycosidase activity of all the ribosome­
inactivating proteins known to date has been confirmed using 
rabbit liver ribosomes (Endo et al., 1988b, Endo et a l . , 1988c, 
Endo et al., 1988d, Endo et al., 1988e and Stirpe et al., 
1988).
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Aspergillus giganteus produces a small basic protein 
called oc-sarcin which inactivates ribosomes by hydrolysing the 
phosphodiester bond on the 3' side of G-4325 in rat liver 
ribosomes (Endo and Wool, 1982). The cleavage site lies within 
a purine-rich domain of 14 residues which are highly conserved 
in all organisms, commonly referred to as the c-sarcin domain, 
and forms a stem loop structure (Chan et al., 1983). Table 2 
lists the (x-sarcin domain from a variety of ribosomes. It is 
identical in cytoplasmic rRNAs of mammals, Xenopus laevis, and 
Saccharomyces cerevisiae and is largely conserved in organelle 
rRNAs. ix-sarcin modifies the ribosomes of all organisms that 
have been tested to date, by cleavage of the single 
phosphodiester bond. The finding that cleavage of a single 
phosphodiester bond, or removal of an adenine residue from the 
phosphate backbone, of the «-sarcin domain indicates that this 
domain is crucial for function. Ribosomes do not need intact 
rRNA per se as ribosomes can survive despite treatment with 
nucleases which introduce many nicks (Cahn et al., 1970).
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Table 2 Comparison of the sequence of the cn-sarcin domains 
Residues which differ from the rat liver ribosome sequence are 
shown in bold. The arrow indicates the site of cleavage by cx- 
sarcin and the asterisk indicates the base modified by ricin
RIBOSOMES SEQUENCE REFERENCE
Rat liver 5' -AGUACGAGAGGAAC-3 ' Endo and Wool, 1982
*T
S . cerevisiae AGUACGAGAGGAAC Endo and Wool, 1982
E . coli AGUACGAGAGGACC Edwards & Kossel, 1981
Z . mays 
chloroplast
AGUACGAGAGGACC Edwards & Kossel, 1981
S. cerevisiae 
mitochondria
AGUACGCAAGGACC Sor & Fukuhara, 1983
X. laevis 
oocyte
AGUACGAGAGGAAC Saxena & Ackerman, 1990
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1.5.2 8t«p» inhibited in protein synthesis
The A-chain of the type II ribosome-inactivating proteins 
and the single-chain ribosome-inactivating proteins alter the 
conformation of the ribosome. Terao et al. (1988) used a 
double-labelling technique in which ribosomes were incubated 
with ricin, or i-sarcin, and then treated with [3H]-labelled or 
[14C]-labelled N-ethylmaieimide to investigate conformational 
alterations in the ribosome. Ricin specifically reduced 
labelling of protein L14 in 80S ribosomes and »-sarcin reduced 
labelling of proteins L3 and L4. The proteins L3, L4 and L14 
are all neighbours. Pretreatment of 60S ribosomal subunits with 
ricin facilitated the release of a 5S RNA-L5 protein complex by 
brief heating (Paleologue et al., 1986). L5 is a neighbour of 
L3 and all the proteins L3, L4, L5 and L14 are located at the 
boundary between the 4OS and 60S subunits and interact with 
mRNA (Takahashi and Ogata, 1985) . L3 and L5 are located at the 
P-site and L4 and L5 can be cross linked with EF-2. The 
conformation change in the ribosome may be associated with, or 
the cause of, the inhibition of protein synthesis by ribosome­
inactivating proteins.
The particular steps in protein synthesis which are 
affected by ribosome-inactivating proteins have not been fully 
elucidated. There is some evidence that initiation is 
inhibited. Fernandez-Puentes and Vasques (1977) used 
reconstitution experiments between 40S and 60S ribosomal 
subunits pretreated with ricin to show that the 60S subunit is 
the only component of the translation apparatus affected. 
Skorve et al. (1977) showed that abrin A-chain caused a strong 
reduction in the amount of labelled mRNA in the 80S subunit 
whereas the binding of labelled mRNA or methionine to the 40S 
subunit was unaffected. They concluded that the formation of 
the 80S subunit from the 60S and 4OS subunits was inhibited by 
the action of abrin A-chain.
It is now generally accepted that ribosome-inactivating 
proteins affect the elongation cycle of protein synthesis. EF-2
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protects ribosomes from the action of ricin and this protective 
effect is enhanced by the presence of GTP or non-hydrolysable 
GTP analogues. The protection was reduced in the presence of 
Phe-tRNA, EF-1 or in high magnesium ion concentrations 
(Fernandez-Puentes et al., 1976). The protection against ricin 
by aminoacyl-tRNAs suggests that toxins cannot inactivate 
ribosomes when the acceptor site is occupied. Olsnes and Pihl 
(1982) postulate that in ricin treated ribosomes functional 
groups are located more distantly to each other than usual, and 
in the presence of high magnesium ion concentrations, these 
groups resume the normal position in the more compact ribosome 
structure that is aquired. Protection by EF-2 to the action of 
ricin suggests that the region in the 28S rRNA modified by the 
ribosome-inactivating proteins is identical or close to the EF- 
2 binding site.
Ricin inhibits the binding of limiting concentrations of 
EF-2 to ribosomes (Nilsson and Nygard, 1986 and Nontanaro et 
al., 1975) and affects the activities of the EF-1 and EF-2- 
dependent GTPases (Sperti et al., 1975, Fernandez-Puentes and 
Vasquez, 1977, Benson et al., 1975 and Benson, 1977). The 
peptidyl-transferase component is unaffected by the action of 
ricin (Gessner and Irvin, 1980).
Olsnes et al. (1975a) estimated that ricin and abrin can 
inactivate up to 1500 ribosomes per minute. In a cell free 
system elongation was stopped when only one or a few ribosomes 
per polysome were inactivated (Fodstadt and Olsnes, 1977) . 
Youle and Neville (1979) found that in polysomes pretreated 
with ricin, EF-2 is tightly bound to the polysomes rendering 
the ribosomes resistant to ADP-ribosylation by diphtheria toxin 
and from modification by the addition of ricin A-chain. The 
majority of the ribosomes when released from the polysome, by 
denaturing agents in the presence of anti-ricin antibodies, 
retained protein synthesising activity (Fernandez-Puentes et 
al., 1976).
Until recently little was known of the role of individual 
ribosomal domains or ribosomal components. For many years the
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ribosomal proteins were considered to be the active components 
of the ribosome and the rRNAs provided the scaffolding on which 
the partial reactions of protein synthesis occured. The view 
today is that the rRNAs are responsible for the biochemistry of 
protein synthesis, and the ribosomal proteins facilitate the 
folding and maintenance of the optimal configuration of the 
rRNA.
It?.3 U fc>T«U Q P  9t th» A-chaia
Both in vivo and in vitro, reduction of the disulphide 
bond between the two chains of the holotoxins is an absolute 
requirment for A-chain activity (Olsnes and Pihl, 1982). The 
single-chain toxins are unaffected by reducing agents. Rabbit 
reticulocyte lysate contains sufficient reducing agent to 
rapidly break the interchain disulphide bond and glutathione 
probably accounts for most of this activity (Barbieri et al., 
1982b).
The site within the cell at which the interchain 
disulphide bond is broken remains unknown. Endocytic vesicles 
can have a pH as low as 5.5 which would dramatically slow the 
rate of reduction of disulphide bonds (Heilman et a l ., 1986). 
Compartments within the Golgi apparatus have a higher pH and 
are likely to contain disulphide exchange enzymes (Youle and 
Colombatti, 1986). Reduced ricin and abrin is more toxic to 
cultured cells than the native toxins therefore the reduced 
toxins may not require transport to the compartment where 
reduction of the disulphide bond occurs (Olsnes and Pihl, 1972 
and Lewis and Youle, 1986) . The interchain disulphide bond is 
not required for toxicity but initiation of entry of the A- 
chain into the cytosol is dependent upon the B-chain either 
covalently linked or in an associated form (Lewis and Youle, 
1986). Evidence exists that there is a conformational change in 
the subunits of ricin on reduction of the disulphide bond 
(Olsnes et a l ., 1975b).
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1.6 FUNCTION OF THE B-CHAIN
1.6.1 Binding to sugar» and to complex carbohydrates
Binding of the B-chains of the toxic lectins to a variety 
of sugars has been carried out by several different techniques. 
The association constants of abrin and ricin for lactose have 
been determined from equilibrium dialysis (Olsnes and Pihl, 
1972), temperature jump relaxation studies (Podder et al., 
1978) and microcalorimetric methods (Zentz et al., 1977) and 
was of the order Ka=104 M”1. The affinity for asialofetuin of 
the toxic lectins is several orders of magnitude higher and is 
of the order Ka= 1-5 x 108 M-1 (Sandvig et al., 1978c). 
Typically only one lactose molecule per B-chain was found 
although evidence for two lactose binding sites was obtained 
(Villafranca and Robertus, 1981 and Houston and Dooley, 1982). 
From the X-ray crystallographic data, ricin binds 2 lactose 
molecules per B-chain (Montford et al., 1987) and the mode of 
binding at the two sites is similar.
Hatakeyama et al. (1986) demonstrated that the two lactose 
binding sites of ricin D have different specificities. The low 
affinity site, which lies in the first globular domain of the 
B-chain, binds to galactopyranosides but lacks ability to bind 
N-acetylgalactosamines. The high affinity site lies in the 
second globular domain of the B-chain and can bind to both 
galactopyranosides and N-acetylgalactosamines.
The agglutinins exhibit the binding properties of the low 
affinity site of ricin D in that they lack binding ability to 
N-acetylgalactosamines (Nicholson and Blaustein, 1972) and 
there is evidence that RCA only binds one molecule of lactose 
per B-chain (Podder et al., 1978 and Houston and Dooley, 1982).
Baenzinger and Fiete (1979) studied the specificity of 
binding of ricin and RCA to branched asparagine-linked 
oligosaccharides. They determined that B-l,4-linked galactose 
residues were primarily responsible for binding. The Abrus and 
Ricinus lectins bind to the same kind of oligosaccharides but
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the strength of binding differs (Ishiguro et al., 1964 and
Green et a l ., 1987).
1.6.2 Binding to cell surfaces
Ricin and abrin bind to a large number of cell surface 
glycoproteins and glycolipids which contain terminal galactose 
residues. The number of sites per cell varies between cell 
types and is typically from between 1 0 6 and 10® toxin molecules 
per cell (Sandvig et al., 1976 and Sandvig et al., 1978a). In
the case of ricin it seems likely that only the high affinity 
site strongly binds to cells since modification of the tyrosine 
residue at the high affinity site dramatically reduces cell 
binding (Sandvig et al., 1978b).
Ricin and abrin are also bound by mannose receptors 
through recognition of its mannosylated N-linked
oligosaccharides. The intoxication of macrophages in the 
presence of lactose indicated that cell binding via the mannose 
receptors led to efficient cell killing (Simmons et al., 1986
and Tsuzuki and Wu, 1982). Skilleter et al. (1986) demonstrated 
that uptake by non-parenchyma1 cells is principally through 
mannose recognition. Deglycosylation of the toxin prevents 
entry by this pathway (Foxwell et al., 1984)
To study the binding of the lectins to cell surfaces 
immunocytochemical detection and ligand conjugates have been 
used. The lectin is visualised by probing with ferritin or 
colloidal gold, or by enzymatic means with peroxidase. 
Monovalent and polyvalent conjugates of ricin and peroxidase 
bind evenly to the cell surface at 4°C (van Deurs et al., 
1987a). Washing of cells, after ricin binding, at 4°C followed 
by further incubation at 37°C does not alter the even 
distribution of the ricin conjugates. These results indicate 
that the binding sites are initially evenly distributed over 
the cell surface and internalisation occurs relatively slowly. 
It is possible that some binding sites are not internalised at 
all. Similar experiments with transferrin showed that the
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transferrin receptor is associated with coated pits in the 
absence of any ligand (Sandvig et al., 1987).
Ricin-gold conjugates are evenly distributed on the cell 
surface at 4°C but are rapidly endocytosed at 37°C and the 
conjugate which remains at the cell surface forms patches (van 
Deurs et a l ., 1985). It seems likely that the polyvalent gold- 
ricin conjugates induce receptor redistribution and aggregation 
at 37°C. Cell surface associated ricin or monovalent ricin- 
peroxidase conjugates can be washed off with lactose whereas 
polyvalent or ricin-gold conjugates remain associated with the 
cell indicating the higher binding specificity of the 
polyvalent conjugates (van Deurs et al., 1986 and van Deurs et 
al., 1985).
Some ricin remains at the cell surface even after 
internalisation at 37°C, at least until the cell becomes 
intoxicated. The overall rate of internalisation is slow, some 
binding sites are not internalised and there is rapid recycling 
of some toxin back to the cell surface (Sandvig et al., 1976).
li$,3 h golf lB tr»nalocation
Ricin A-chain has been extensively used in the generation 
of immunotoxins where the A-chain has been linked to a tumour- 
specific antibody. In several instances the immunotoxin had 
limited cytotoxicity and in some cases was non-cytotoxic. 
McIntosh et al.(1983) found that a non-cytotoxic antibody-ricin 
A-chain conjugate could be converted into a potent specific 
cytotoxic agent by the addition of ricin B-chain as a secondary 
agent. The cytotoxicity of the combined reagents was not 
altered by the presence of lactose in the medium which strongly 
argues against the B-chain inducing a signal to internalise the 
conjugates and suggests some association between the ricin A- 
chain and B-chain.
Houston (1983) has shown that ricin A-chain can 
reassociate with B-chain that has already bound to cell 
surfaces. A synergistic effect of ricin B-chain has been
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demonstrated in a different system where ricin A-chain and 
ricin B-chain were separately linked to an anti-IgG antibody 
(Vitetta et al., 1983). In this experiment the specificity of 
the antibody was found to be important in that a B-chain linked 
to an antibody of irrelevant specificity did not synergise the 
effect of the A-chain on Daudi cells (an IgG bearing cell 
line). This suggested that either both immunotoxins were 
binding to the same receptor and being endocytosed into the 
same compartment so that free A-chain associated with B-chain 
is formed in the endosome, or that the A-chain and B-chain 
reach the same compartment via separate endocytic routes. In 
either case the B-chain is enhancing translocation of the A- 
chain into the cytosol, a function distinct from cell surface 
binding.
Fulton et al. (1986) demonstrated the potentiation by B- 
chain using a "piggyback" immunotoxin. In this system an IgG, 
linked to ricin A-chain, against a surface immunoglobulin of 
Daudi cells are bound to the cell surface followed by the 
addition of ricin B-chain linked to an IgG specific for the 
antibody portion of the A-chain immunotoxin
It has been suggested that the galactose binding domains 
are net involved in the potentiating effect of the B-chain. In 
immunotoxins where the B-chain has been blocked by the linkage 
to antibody (Thorpe et al., 1984), or by chemical modification 
(Thorpe et al., 1985), sufficient to prevent galactose binding 
by the B-chain, the B-chain moeity was still capable of 
potentiation. Vitetta (1986) postulates that either the 
galactose-binding domain is distinct from the 'potentiating 
domain' or that the 'potentiating domain' is less sensitive to 
changes in tertiary structure. It may also be a consequence of 
the unblocking of the galactose-binding sites of the B-chain 
during or after internalisation due to a conformational change, 
or in the case of chemically modified B-chain there is not 
complete abolishment of binding (Vitetta, 1986) and the small 
amount of binding may be sufficient for translocating the A- 
chain. It has therefore not been determined if the potentiating
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effect of the B-chain is due entirely to galactose binding 
within the cell or if a second distinct functional domain 
exists.
1.7 INTERKALI 8 AT I ON OF THE TOXINS
1.7.1 Ratf Qi uptake
Kinetic experiments suggest that only one molecule of 
abrin or ricin in the cytosol can kill a cell (Euklid et a l ., 
1980). It is clear that the process through which the lectin, 
or the A-chain, reaches the cytosol is inefficient since 
several thousand molecules of the lectin must be bound to the 
cell surface to ensure intoxication (Tsuzuki and Wu, 1982).
After the addition of toxic lectins to cells there is 
always a lag-time which is strongly temperature dependent 
(Hudson and Neville, 1987). This lag-time cannot be reduced to 
less than about 20 minutes. During this lag-time initially both 
anti-A-chain and anti-B-chain antibodies afford protection 
followed by a period in which only anti-A-chain antibodies are 
effective (Houston, 1982). During the major part of the lag­
time antibodies have no major effect. The initial stage of 
entry therefore involves binding of the B-chain to the cell 
surface followed by penetration of the toxin through the cell 
membrane.
By removing the non-endocytosed toxin from the cell 
surface it is estimated that approximately 15% of total cell 
associated ricin is endocytosed within 10 minutes (Sandvig et 
al., 1978a and Sandvig and Olsnes, 1982a). A lag time is never 
seen when ricin is delivered directly to the cytosol, by fusion 
of erythrocyte ghosts or viral envelopes loaded with ricin A- 
chain with the cell membrane (Sargiacoma et al., 1983 and 
Foxwell et al., 1984). The major part of the lag-time therfore 
involves the transport of the A-chain to the intracellular 
target and the rate limiting step is transport to the cytosol 
(Hudson and Neville, 1987).
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The internalisation of many physiological ligands is far 
more rapid than that of ricin and abrin (Ciechanover et al., 
1983 and Bleil and Bretscher, 1982) . As much as 60% of 
transferrin is internalised within 10 minutes by Vero cells 
(van Deurs et al., 1987b). It seems likely that ricin and 
related toxins bind to a wide variety of cell surface molecules 
of which many may by essentially stationary molecules or are 
internalised only very slowly.
It7,2 Rolf of •nflQcyfcggi?
Evidence has accumulated that the toxins abrin and ricin 
are translocated to the cytosol from intracellular structures. 
The involvement of endocytosis in the penetration of a toxin 
was first demonstrated with diphtheria toxin (Sandvig and 
Olsnes, 1980). Diphtheria toxin requires transport to an acidic 
compartment for translocation and only the intracellular 
vesicles or vacuoles have the required low pH of less than 5.3.
Abrin and ricin do not require low pH and under conditions 
where the acidification of intracellular vesicles is inhibited 
the cells are sensitised to the toxins (Sandvig et al., 1982a 
and Sandvig et al., 1982b). The evidence to support transport 
in endocytotic vesicles comes from studies in which endocytosis 
occurs but translocation is prevented. Cells incubated in the 
absence of calcium ions take up ricin but translocation is 
prevented (Sandvig and Olsnes, 1982a). If the cells are washed 
with lactose and treated with anti-ricin antibodies, then 
incubated overnight in the presence of calcium, the cells are 
intoxicated to the same extent as cells treated with ricin in 
the presence of calcium. These results indicate that 
endocytosed ricin was capable of intoxicating cells without 
returning to the cell surface and that translocation from 
endocytic vesicles is a major entry pathway (Sandvig and 
Olsnes, 1982a).
An as yet unresolved question is how abrin and related 
toxins are endocytosed. There is considerable evidence that
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many molecules are endocytosed via the coated pit pathway which 
include transferrin and viruses (Marsh, 1984 and Pearse and 
Bretscher, 1981). The presence of clathrin as a marker in 
coated pits has allowed the vesicles derived from coated pits 
to be determined. It is clear from several studies that at 
least some ricin is endocytosed via this route (van Deurs et 
a l . , 1985 and Sandvig et al. , 1987), but it remains to be 
determined if this is the productive entry route and does not 
exclude the possibility of alternative mechanisms.
Smooth or uncoated areas on the cell surface are also 
likely to be involved in endocytosis and there is increasing 
evidence that ricin may be endocytosed through a non-clathrin 
coated endocytic pathway. Moya et al. (1985) and Madshus et al. 
(1987) showed that potassium depletion in combination with 
brief hypotonic shock led to the loss of virtually all coated 
pits on the suface of Hep-2 cells. Under these conditions the 
uptake of ricin was virtually unchanged as was the effect of 
human rhinovirus type 2 (HRV-2) , whereas the uptake of 
transferrin was completely inhibited. These results indicated 
that ricin, and HRV-2 which requires translocation to an 
acidified vesicle, are taken up by a non-clathrin endocytic 
pathway.
In support of this evidence, Sandvig et al.(1987) showed 
that acidification of the cytosol of various cell lines by 
different methods inhibited translocation of transferrin but 
only mildly reduced the uptake of ricin. The number and 
distribution of transferrin-receptors was unaltered in the 
acidified cells and it was postulated that acidification 
prevents the formation of vesicles derived from clathrin-coated 
pits thereby preventing endocytosis of transferrin—ligand 
complexes. Tetanus toxin and cholera toxin are apparently 
internalised through smooth pits (Montesano et al. 1982) and 
bind to glycolipids for which ricin and abrin also have binding 
affinity. It seems likely that ricin can bind to surface 
receptors not involved in coated pits and be internalised.
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In summary it is clear that some ricin is endocytosed via 
the clathrin-coated pit pathway and therefore imitates 
physiologically important ligands such as transferrin which 
binds to glycoprotein receptors. There is also evidence to 
support endocytosis of ricin through an alternative pathway but 
lack of a specific marker for cell surface molecules which are 
excluded from coated pits makes characterisation of this 
alternative pathway difficult.
1.7.3 Intracellular traffickiag of vicjn
The endosomal system
Ricin has been detected in endosomes by pre-embedding 
immunoperoxidase cytochemistry (van Deurs et al., 1986) and
postembedding immunogold cytochemistry (van Deurs et al., 1985) 
and both ricin-peroxidase and ricin-gold complexes have been 
traced to endosomes within a few minutes of exposure to the 
cells (van Deurs et al., 1987a). Many ligands and receptors
dissociate under the low pH conditions to allow further sorting 
and cycling of the receptor back to the cell surface. Ricin 
remains attached to its receptor in the endosome and only about 
2C% of the ricin bound at pH 7 was released at pH 5 (van Deurs 
et al., 1987b) . The majority of ricin which is recycled to the 
cell surface remains intact.
The valency of the ligand can affect sorting of molecules 
in the endosomal system. Polyvalent ricin conjugates are 
delivered to lysosomes and the trafficking of transferrin-gold 
conjugates is altered (van Deurs et al., 1986). Monovalent and 
polyvalent ricin-peroxidase conjugates are detected in 
endosomes but only the monovalent conjugate reaches the Golgi 
network (van Deurs et al. , 1985 and van Deurs et al., 1986).
The concept of a distinct population of endosomes with a 
vesicular shuttle to the lysosomes (Helenius et al., 1983) has
now been replaced with the concept of a maturation from early 
endocytic compartments (endosomal) to late endocytic 
compartments (lysosomal). It is also becoming evident that the
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endosomal system may consist of an interconnected system rather 
than discrete vacuolar or tubular structures. Ricin which 
reaches late endocytic vesicles is slowly degraded, either due 
to slow delivery or to resistance to proteolytic enzymes. After 
60 minutes up to 35% of the internalised ricin is found in 
lysosome-like vesicles (van Deurs et ai., 1986).
The trans-gpigj network
The glycosylated 57kDa membrane protein of vesicular 
stomatitis virus (VSV) has been used as a marker of the 
secretory-Golgi pathway of cells exposed to ricin. In cells 
infected with VSV, the G protein is synthesised and within 30 
minutes is transported from the ER, via the Golgi network, to 
the cell surface. A temperature sensitive mutant of VSV, ts 
045, leads to synthesis of the G-protein at the non-permissive 
temperature of 39.5°C but it is retained within the ER. On 
shifting to 20°C, the G protein leaves the ER but accumulates 
in the Golgi in large amounts, particularly in the trans-Golgi 
network and virtually no G protein reaches the cell surface. At 
31°C, the permissive temperature, the G protein is rapidly 
transported via the Golgi-network to the cell surface (van 
Deurs et al., 1987b).
Cells infected with VSV ts 045 were incubated with ricin 
for 60 minutes at 39.5°C after which time ricin was found in 
both early and late endocytic vesicles and in some Golgi- 
associated structures and the G protein remained in the ER. On 
shifting to 20°C the G protein moved into the Golgi-complex but 
further transport of ricin to Golgi-associated structures is 
prevented. Using double-labelling of ultrathin cryosections of 
the infected cells incubated with ricin about 4% of the total 
internalised ricin was found to be colocalised with the G- 
protein in the Golgi-network of which about 75% was in the 
trans-Golgi network (van Deurs et al., 1987b).
Ricin has also been noted in Golgi compartments using 
preembedded immunoperoxidase cytochemistry (van Deurs et al., 
1986) . Conflicting results on the delivery of ricin to the
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Golgi-network have been obtained using ricin-conjugates. 
Monovalent ricin-conjugates are delivered to the Golgi- 
associated compartments whereas polyvalent conjugates are 
rarely seen there. Observations by several workers indicate 
that the sorting of the polyvalent conjugates is altered during 
the stages prior to reaching Golgi-associated compartments.
Translocation to the cytosol
Increasing evidence now points to the trans-Golgi network 
as the compartment from which ricin translocates to the 
cytosol. Toxins which translocate from endocytic compartments 
such as diphtheria toxin A-chain, rapidly inhibit protein 
synthesis and incubation of cells at 18°C has little effect on 
toxicity, whereas toxicity is prevented by increasing the pH in 
the endosomal compartments (Sandvig and Olsnes, 1980 and 
Sandvig and Olsnes, 1981). The long lag-time before inhibition 
of protein synthesis by the toxic lectins, the sensitisation of 
cells to ricin and abrin on increase in pH of endosomes and 
inhibition of the action of ricin at 18°C which prevents 
transport to the Golgi-associated compartments, all indicate 
that translocation occurs from the Golgi-network (Sandvig and 
Clsnes, 1982a and sandvig and Olsnes, 1982b).
Monensin, which sensitises cells to ricin and abrin, 
alters the morphology of the Golgi-complex (Tartakoff, 1983). 
Cyclohexamide, which blocks the peptidyl transferase reaction 
on ribosomes, also sensitises cells to ricin and abrin which 
may indicate that under normal conditions the toxins compete 
for binding sites within the Golgi-network with newly 
synthesised proteins or that an enzymatic processing step is 
required for A-chain translocation (Sandvig et al., 1986).
Strong evidence for translocation from the trans-Golgi 
network comes from the finding that a hybridoma cell secreting 
anti-ricin antibodies is resistant to ricin (Youle and 
Colombatti, 1986). It is postulated that the antibodies 
inactivate the ricin during transport through the Golgi- 
network. Only about 1% of the internalised ricin is
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translocated to the cytosol which is in accordance with only 5% 
reaching the Golgi-network (van Deurs et a l ., 1987b).
1.8 AMT 1-VIRAL PROPERTIES OF RIP080ME-IWACTIVATING PROTEINS
Ribosome-inactivating proteins have long been known to 
have anti-viral properties but the exact mechanism remains 
unclear. Tomlinson et al. (1973) demonstrated that extracts
from the leaves of P. americana inhibited infection of 
Chenopodium quinoa by cucumber mosaic virus and of monkey 
kidney cells and embryonated eggs by influenza virus. Leaves of 
P. Americana are now known to contain the type I ribosome­
inactivating protein called pokeweed antiviral protein (PAP) 
(Obrig et al., 1973 and Irvin et al., 1980). Animal viruses and 
bacteriophages alter the membranes of the host both 
structurally and functionally, leading to a membrane leakiness 
(Carrasco, 1978) . This may therefore allow entry of the type I 
ribosome-inactivating protein to the cytoplasm whereas the 
uninfected cell is usually impermeable. Owens et al. (1973)
postulated that the P. americana extract was acting on the host 
cell machinary and not on the virus per s e .
Foa-Tomasi et al. (1982) studied the anti-viral activity
of PAP on polio virus and herpes simplex virus I infection of 
Hep-2 cells. PAP reduced viral yield, inhibited plaque 
formation and inhibited protein synthesis more in infected 
cells than uninfected cells. Fernandez-Puentes and Carrasco 
(1980) have demonstrated that viral infection permeabilises 
mammalian cells to protein toxins and therefore it seems 
probable that anti-viral activity is a consequence of the 
action of PAP on the host cell machinery in the permeable 
infected cell.
Abrin and ricin reduced local lesions by tobacco mosaic 
virus when applied to the tobacco leaf in an inoculum 
containing the virus and carborundum (Stevens et al. 1981).
Stevens and co-workers reported that reduction of the 
interchain disulphide bond in abrin abolished anti-viral
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activity. Loss of activity is likely to be due to instability 
of the reduced protein.
Currently there is an extensive search for an inhibitor of 
human immunodeficiency virus (HIV) . Recently trichosanthin, a 
type I ribosome-inactivating protein was found to selectively 
inhibit HIV replication in acutely and chronically infected 
macrophages and T-cells (McGrath et al., 1989). Healthy cells
survived treatment but in cells infected with HIV the viral RNA 
was apparently specifically degraded whereas the host RNAs were 
unaffected. This suggests that the anti-viral activity may be a 
distinct property from N-glycosidase action on host ribosomes. 
Hybrids of ricin A-chain and of PE have been shown in vitro to 
be effective immunotoxins against HIV infected cells (Till et 
al., 1988 and Chaudhary et al., 1988).
1.9 ANTI-TUMOUR PROPERTIES OF THE TOXIC LECTINS
Anti-tumour activity of abrin and ricin was noted as early 
as 1951. Since then several laboratories have studied the 
effects of the toxic lectins on animal tumours and neoplastic 
cell lines (Olsnes and Pihl, 1982 and Shionoya et a l ., 1982).
The toxic lectins exert their effect through inhibition of 
protein synthesis which is different to the mechanism of action 
of other chemotherapeutic agents such as vinblastin, 
methotrexate and cyclophosphamide. In several instances abrin 
and ricin were found to be more effective as cancerostatic 
agents than the drug most commonly used to treat the tumour. In 
addition, in combined therapy where ricin or abrin were 
administered in conjunction with a chemotherapeutic agent, a 
synergeneic effect was seen (Walker et al. 1984). Phase I
studies of ricin as a cancerostatic agent have been carried out 
(Fodstad et a l ., 1984).
The mechanism by which these toxic lectins can suppress 
tumour growth may be in part due to the direct cytotoxic 
effects on tumour cells and stimulation of host immunity with 
non-specific suppression of tumour cells. The binding of a few
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molecules of abrin or ricin to a tumour cell may be 
insufficient for inactivation but may cause increased 
destruction of toxin-coated cells by the reticuloendothelial 
system. APA enhances the natural cytotoxicity of peripheral 
blood lymphocytes in vitro and in humans with nasopharangeal 
carcinoma (Won et a l ., 1988). Certain tumour cells have been 
shown to require fewer molecules of toxin to be bound for 
cytotoxicity (Chan et a l ., 1985).
Abrin has been used as the positive control in human 
tumour clonogenic assays for comparison of cytotoxic effects of 
therapeutic agents (Salmon et al., 1983)
M O  IHMPyOTOXXMS
1.10.1 Overview
An immunotoxin is a cytotoxic agent which consists of a 
cell-binding moeity, linked via a chemical cross-link, a 
peptide linker or disulphide bond, to a toxic moeity. The cell­
binding moeity may be an antibody, or antibody fragment, or a 
hormone which has selectivity for a particular cell type. The 
toxic moeity may be a holotoxin, an A-chain or a single-chain 
ribosome-inactivating protein. Immunotoxins therefore combine 
ligand specificity with the exquisite toxicity of the toxin.
Despite the conceptual simplicity of immunotoxins they are 
complex molecules and each component continues to be studied 
and improved. Immunotoxins have been extensively reviewed (see 
Frankel, 1990, Lord et al., 1989, Blakey et al., 1988, Pastan
et al., 1986 and Vitetta and Thorpe, 1989) and only the salient 
points will be mentioned here.
1 .1 0 . 2  Th« ligand portion of ianunotoxjns
Antibodies
Antibodies or fragments thereof have been most frequently 
utilised as the ligand portion of immunotoxins. The specificity
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of monoclonal antibodies can be extremely high although non- 
neoplastic cells of the same lineage may also be a target. 
Whole antibodies are large immunogenic molecules and therefore 
may penetrate solid tumours poorly. Fab' and F(ab')2 fragments 
are less immunogenic, lack Fc receptors and therefore do not 
bind to reticuloendothelial cells, and are smaller. However, 
the antibody fragments are more rapidly cleared from the body 
and the monovalent Fab' fragments bind with reduced avidity 
compared to the bivalent or polyvalent counterparts.
Non-antifrrtY carriers
Non-antibody carriers, such as the interleukins and 
epidermal growth factor, have been used as the ligand in 
immunotoxins. Generally these ligands will also bind to normal 
cells but since many neoplastic cells express large amounts of 
the receptor compared to the normal cell and the normal cells 
that are killed can be replaced from progenitor cells which 
lack the receptor, applications continue to be sought.
1.10.3 Tbs toxin portion of antibodies
The extreme toxicity of the toxic lectins has made them 
the focus of interest in immunotoxin research. The toxin is 
modified by removal of the B-chain, or the blocking of the 
galactose binding sites, and specificity is conferred by the 
addition of a specific ligand. An attractive feature of the 
toxic-lectins is that resting cells are susceptible to the 
action of ribosome-inactivating proteins. The single-chain 
ribosome-inactivating proteins naturally have low toxicity but 
can be rendered specifically cytotoxic by linkage to a ligand 
moeity. Bacterial toxins such as diphtheria toxin and 
Pseudomonas exotoxin A have also been extensively utilised to 
generate immunotoxins.
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*.10.4 F f paratjop of
A variety of linkers have been used to join ligands, with 
a free thiol group, to the A-chains of the toxic lectins, the 
holotoxins or single-chain ribosome-inactivating proteins. In 
the case of the holotoxins the galactose binding sites are 
stearically hindered by the ligand and are selected by failure 
to bind to galactose, or have a chemically reactive group 
covalently attached in the vicinity of the binding sites. For 
review see Cumber et al. (1985).
1.10.5 Cytotoxic properties of iBUBunotoxlna in vitro
Immunotoxins containing the A-chain of ricin or abrin or 
the single-chain ribosome-inactivating proteins can be highly 
specific because the toxin portion does not contribute to cell 
binding. However, these immunotoxins show a wide degree of 
cytotoxic potency. It is now generally accepted that the 
binding affinity of the ligand plays a major role in 
determining efficacy. A ligand with high affinity generally 
gives high potency to the immunotoxin. The receptor for the 
ligand is also important. A receptor that is rapidly 
internalised is preferential. The routing of the conjugate 
after internalisation may be disadvantageous e.g. to lysosomal 
compartments. Immunotoxins constructed with the A-chain of 
diphtheria toxin are consistently less effective than those 
constructed with the A-chain of ricin or abrin. This has led to 
the idea that the toxic lectin A-chains contain a translocation 
domain, lacking in diphtheria toxin A-chain, that is necessary 
for transport to the cytosol.
Virtually without exception, the potency of an immunotoxin 
containing a holotoxin is exceptional but the non-specific 
binding associated with the B-chain makes their use in vivo 
problematical. The blocked forms of these inununotoxins have 
been shown to have potent and specific cytotoxicity in vitro.
Of importance is that these inununotoxins have faster kinetics 
of cell killing which will be of particular relevence in vivo.
1.10.6 cytotoxic properties of Immunotoxins in vjvc
Many of the ribosome-inactivating proteins are 
glycosylated and the B-chains of abrin and ricin are highly 
glycosylated (Kimura et al., 1988). The mannose- and fucose-
containing oligosaccharides are recognised by cells of the 
reticuloendothelial system. Intact ricin has been used to 
selectively deplete Kuppfer cells in rodents (Zenilman et al., 
1988). Therefore immunotoxins containing native glycosylated 
ribosome-inactivating proteins are rapidly cleared from the 
blood and tissues, and liver damage can occur. Deglycosylation 
of the ribosome-inactivating protein, or the A-chain, has been 
shown not to alter enzymatic ability (Blakey et al., 1987 and
Foxwell et al., 1987). Blocking of the galactose binding sites, 
commonly performed using asialofetuin affinity labels which are 
rich in galactose, would therefore only increase liver 
toxicity. In immunotoxins where the B-chain was deglycosylated, 
the potentiating effect of the B-chain was reduced by 5 to 50 
fold.
From studies in tumour models and in rodents the features 
desirable in an immunotoxin have become apparent. Ideally the 
immunotoxin should be highly specific and highly cytotoxic with 
fast kinetics of killing. The immunogenicity should be low, the 
half life in sera and tissues should be high and the linkage 
between the toxic and lectin moeity should be stable. The 
immunotoxin should be unglycosylated and 100% homogeneous.
1.11 AIMS OF THE PROJECT
The toxic lectins are a fascinating group of proteins. 
Their extreme potency has made this group of plant proteins of 
interest to scientists from diverse fields. Ricin in particular 
has been used as a model, or control, in studies of cell
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binding, endocytosis, intracellular transport, protein 
synthesis and kinetic studies of cell death. Latterly, the use 
of ribosome-inactivating proteins in the development of anti­
cancer agents has demanded more extensive study of this group 
of proteins.
The initial aim of this project is to clone an abrin- 
related ribosome-inactivating protein. The only type II 
ribosome-inactivating proteins sequenced to date are the ricin 
toxins and the related RCA. It is of interest to compare the 
primary sequence of other type II ribosome-inactivating 
proteins and agglutinins since only slight differences 
significantly alter cytotoxicity and quaternary structure. The 
abrin toxins are of particular interest as the A-chains are 
acidic at physiological pH, unlike ricin A-chain and the type I 
ribosome-inactivating proteins which have typically basic pi 
values.
It is apparent that the microheterogeneity found between 
the ribosome-inactivating proteins can lead to problems in 
interpreting results using protein isolated from plant tissue. 
The ideal source of a ribosome-inactivating protein is 
therefore of recombinant nature. The production of large 
quantities of homogeneous protein is desirable for the study of 
ribosome-inactivating proteins and in the development of 
therapeutic agents.
The cloning and expression of an abrin A-chain has 
application to the field of immunotoxins. Abrin A-chain 
immunotoxins are more potent than ricin A-chain immunotoxins by 
2-7 fold (Sivam et al. , 1987 and Blakey et al. , 1987b) and 
human melanoma cell lines have been shown to be more sensitive 
to abrin immunotoxins than the equivalent ricin immunotoxin 
(Forrester et al., 1984 and Blakey et al., 1987a). There is 
little cross reactivity between ricin and abrin therefore 
■immunotoxins containing abrin can be used as an alternative or 
in conjunction with ricin immunotoxins. The role of the B-chain 
in determining the efficiency of immunotoxins has become 
evident and the cloning of a type II ribosome-inactivating
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protein is therefore of particular interest to inununotoxin 
research.
The recent finding that trichosanthin could block the 
replication of HIV (McGrath et al., 1989) stimulated interest
in other ribosome-inactivating proteins as anti-HIV agents in 
treatment of AIDS. Abrin A-chain was an attractive candidate as 
it is highly toxic in vitro, does not cross react with 
antibodies against trichosanthin, and the acidic pi of the 
abrin A-chain may be of significance in vivo. Genelabs 
Incorporated (Redwood City, California, USA) had analysed abrin 
A-chain (Inland Laboratories) but the preparation contained 
levels of B-chain sufficient to cause cytotoxicity to 
uninfected T-cells. The A-chain could not be purified 
sufficiently for use in vivo. The initial aim of this project, 
to clone an abrin-related gene, was therefore in accordance 
with a project at Genelabs Inc. to obtain a recombinant abrin 
A-chain for trial as an anti-HIV agent. The cloning and 
sequencing of an abrin-related gene was carried out in the 
laboratories of Genelabs Inc. in colaboration with Dr. M. 
Piatak. The expression and purification of recombinant A-chain 
and the expression of B-chain in vitro was carried out at 
Warwick University.
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2. MATERIALS AND METHODS
2.1 8ÜPPLIERS AND REAGENTS
Aldrich Chemical Co. Ltd.: isoamylalcohol; Tween-20
Amersham International pic, Amersham, Buckinghamshire, UK: E. 
coli polymerase I (Klenow fragment); Hybond C nitrocellulose 
membranes; Hybond N nitrocellulose filters; human placental 
ribonucléase inhibitor; lambda DNA; radiochemicals; restriction 
enzymes; T4 polynucleotide kinase
Anderman and Co. Ltd, London Road, Kingston-upon-Thames, 
Surrey, UK: Schleicher and Schuell NA45 membrane
BDH Chemicals Ltd, Poole, Dorset, UK: acrylamide; chloroform; 
ammonium acetate; ammonium persulphate; caesium chloride; 
calcium chloride; dimethyl formamide; ethanol; formaldehyde; 
glucose; isopropanol; magnesium sulphate; polyethylene glycol; 
potassium acetate; sodium dodecyl sulphate; sucrose; 
trichloroacetic acid; Tris base ; Triton X-100; urea
Beckman RIIC Ltd, High Wycombe, UK: non-aqueous scintillant, 
Quickseal tubes
Biorad Laboratories Ltd, Watford, Hertfordshire, UK: Biogel P- 
6; Biogel P-2; low-range SDS-PAGE molecular weight standards; 
prestained SDS-PAGE standards; SP6 RNA polymerase
Boeringer Mannheim, Lewes, East Sussex, UK: calf intestinal 
alkaline phosphatase; deoxynucleotides; dithiothreitol; random 
primed DNA labelling kit; ribonucleotides
Difco Laboratories, Detroit, Michigan, USA: agar; Bacto- 
tryptone
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Eastman Kodak, Rochester, New York, USA: Kodabrome IIRC paper; 
Panatomic-X photographie film
Fisons Scientific Apparatus, Loughborough, Leicestershire, UK: 
ammonium chloride; ammonium solution; ammonium sulphate; ß- 
mercaptoethanol; di-sodium hydrogen phosphate; glacial acetic 
acid; magnesium chloride; phenol; potassium chloride; sodium 
acetate; sodium chloride; sodium dihydrogen phosphate; sodium 
hydroxide
Fuji Photo Film Co. Ltd, Japan: X-ray film (RX)
Gibco-BRL Ltd, Uxbridge, Middlesex, UK: kilobase DNA ladder; 
restriction enzymes; SP6 RNA polymerase; T4 DNA ligase; T7 DNA 
polymerase
Ilford Ltd, Mobberly, Cheshire, UK: FF contrast developer
Inland Laboratories, Austin, Texas, USA: native abrin A; native 
abrin C; native Abrus precatorius agglutinin, ricin B-chain
Institute of Cancer Research, Sutton, Surrey, UK: affinity 
purified rabbit anti-abrin C A-chain IgG
Imperial Chemical Industries, Alderly Park, UK: recombinant 
ricin A-chain
Johnson Matthey, Materials Technology, Royston, Hampshire, UK: 
silver nitrate
Josman Laboratories, Napa, California, USA: rabbit anti-abrin 
serum
Nucleotide Collective Services, Genelabs Incorporated, Redwood 
City, California, USA: oligonucleotides
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Paterson Products Ltd, Borehamwood, Hertfordshire, UK: Acutol 
FX-14 developer
Perkin Elmer Cetus, Norwalk, Conneticut, USA: GeneAmp™ DNA 
amplification reagent kit; AmpliTaq™
Pharmacia Ltd, London, UK: 5' cap (7me5GpppG5OH); M13 universal 
primer; plasmid pKK233-2; protein A Sepharose; ultrapure 
dioxynucleotides;
Pierce Chemical Company, Rockford, Illinois, USA: 
aminoethylated spherical polyacrylamide beads-immobilised 
lactose
Poloroid Corporation, Cambridge, Massachusetts, USA: polaroid 
667 and 665 film
Premier Brands Ltd, Birmingham, UK: dried fat milk powder
Prolabo, Paris, France: boric acid;
ethylenediaminetetraacetate; glycerol
Promega-Biotech, Madison, Wisconsin, USA: anti-rabbit IgG (H-L) 
alkaline phosphatase conjugate; 5-bromo-4-chloro-3-indolyl 
phosphate; nitroblue tétrazolium; rabbit reticulocyte lysate 
(nuclease treated)
Sigma Chemical Co. Ltd, Poole, Dorset, UK: agarose; amino 
acids; ampicillin; asialofetuin; B-D-thiogalactopyranoside; 
Blue Sepharose CL-6B; bovine serum albumin; bromophenol blue; 
5-bromo-4-chloro-3-indolyl-B-D-galactopyranoside; 
cetyltrimethylammonium chloride; dimethylsuphoxide; ethidium 
bromide; ficoll 4000; gelatin; hydroxyquinilone; isopropanol; 
lysozyme; maltose; mineral oil; 4-mopholinepropane sulphonic 
acid; N,N,N,N'-tetramethylenediamine; NZ Amine A;
phenylmethylsulphonyl fluoride; polyvinylpyrollidone;
ribonuclease A; rubidium chloride; spermidine; tetracycline
Stratagene, La Jolla, California, USA: E. coli host strains 
(JM109, XLI-Blue, NM554, PE2392, LE392); Gigapack II Gold
packaging extract; Lambda DASHII/EcoRI cloning kit; predigested 
Lambda ZKPll/EcoRI cloning kit; vector pBluescript SK+
Unipath Ltd, Basingstoke, Hampshire, UK: yeast extract
United States Biochemical Corp., Cleveland, Ohio, USA: 
Sequenase Kit; T7-GEN in vitro mutagenesis kit
Whatman Labscales Ltd, Maidstone, Kent, UK: 3MM No. 1 filter 
paper; microfibre glass filters
3,3 PEBPAKATION Of 9BNQMIg_pja
2.2.1 Purification and concentration of DNA from aqueous 
solution
B u ffe r in g  phenel
Solid crystals of phenol were melted in a 65°C water bath 
and 8-hydroxyquinoline was added to 1% (mass/v). An equal 
volume of 0.5M Tris-HCl, pH 8.0, was added and the mixture was 
stirred for 10 minutes at room temperature. The two phases 
were allowed to separate and the top aqueous phase was removed. 
Equilibrations with 0.5M Tris-HCl, pH 8.0, were repeated until 
the phenol phase reached pH 8.0. One quarter volume of TE 
buffer (lOmM Tris-HCl, pH 8.0, ImM EDTA, pH 8.0) was added and 
the phenol was stored at 4°C in the dark.
Phenol extraction
An equal volume of phenol:chloroform:isoamyl alcohol 
(25:24:1) was added to the DNA solution. The sample was
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vortexed for 10 s. The phases were separated by spinning for 5 
minutes at 13,000g and the upper aqueous layer was transferred 
to a new tube.
Ethanol precipitation
One tenth volume of 3M sodium acetate, pH 5.2, and 2 
volumes of ethanol were added to the DNA solution. The sample 
was vortexed briefly then placed on dry ice for 1 0  minutes or 
at 20°C overnight. The DNA was pelleted for 10 minutes at 4°C. 
The ethanol supernatant was removed and 1ml of 70% ethanol at 
room temperature was added. The DNA was pelleted and the 
supernatant was aspirated. The pellet was dried in a desiccator 
then dissolved in an appropriate volume of water or in TE 
buffer for storage.
If the DNA solution contained high salt concentrations it 
was diluted to reduce NaCl or sodium acetate concentrations to 
less than 0.5M before addition of ethanol.
Isopropanol precipitation
In general, a one half volume of isopropanol was 
substituted for ethanol in precipitations if the volume of DNA 
solution was larger than 0.7ml.
F W ir iC I t U o p  9t q t BPi tlg  PNA fr 9 B  P la n t  t i s a y e
Overview
Polysaccharide contamination, which inhibits many enzymes 
commonly used in cloning procedures, is the most common problem 
affecting plant DNA purity. Cetyltrimethylammonium bromide 
(CTAB) complexes with polysaccharides and proteins at high salt 
concentrations (>0.5M) and both groups of contaminating 
molecules are efficiently removed in chloroform extraction. At 
less than 0.5M NaCl the nucleic acid complex will precipitate. 
Wide bore pipettes were used, with minimal stirring of the 
plant DNA solutions, to avoid shearing of high molecular mass 
DNA.
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Preparation of genomic DNA from A. p r e c a t o r i u s leaf
tissue
Approximately lOg of frozen leaf tissue was ground to a 
fine powder in a prechilled mortar and pestle. B-
mercaptoethanol was added to 2% (v/mass) followed by an equal 
volume of 2 times extraction buffer (2% (mass/v) CTAB, lOOmM 
Tris-HCl, pH 8.0, 20mM EDTA, 1.4M NaCl) . The slurry was heated 
to 50°C in a 55°C water bath with very gentle stirring. An 
equal volume of chloroform: isoamylalcohol (24:1) was added and 
mixed by gentle rotation. The phases were separated by 
centrifugation at 13,000g for 10 minutes at room temperature. 
The aqueous phase was recovered and chloroform extraction was 
repeated. A one tenth volume of 10% (mass/v) CTAB, 0.7M NaCl 
was added and the extraction was repeated a third time. To 
convert the CTAB-DNA complexes to DNA-Na complexes 2 volumes 
of 1% (mass/v) CTAB, 50mM Tris-HCl, pH 8.0, lOmM EDTA, 1% (v/v) 
B-mercaptoethanol were added and the DNA was allowed to 
precipitate for 30 minutes at room temperature. The DNA was 
spooled onto a glass rod, allowed to drain, then transferred to 
40ml ice-cold 70% ethanol, 0.1M sodium acetate. The DNA was 
pelleted for 3 minutes at 13,000g and the ethanol precipitation 
was repeated. The DNA pellet was washed in 95% ethanol, air 
dried and resuspended in 10ml TE buffer at 55°C in a water 
bath.
2.3 RESOLUTION AND RECOVERY OF DNA FRAGMENTS
2.3.1 Agarose gel eleotrophorasls
Agarose gel electrophoresis was used for separating, 
identifying and purifying 0.1 to 25kb DNA fragments. Typically 
agarose concentrations of 0.8% were used to separate larger DNA 
fragments (>10kb) , 1% to separate 0.5-10kb fragments and 1.2%
to resolve small DNA fragments (0.1-0.5kb).
Electrophoresis was carried out at 10 volts/cm of gel 
except for the resolution of large DNA molecules (>10kb) when 
the applied voltage was low (1 volt/cm of gel).
The desired amount of agarose was added to a volume of 1 X 
TAE buffer (40mM Tris-acetate, pH 8.5, 2mM EDTA) and melted in 
a microwave oven. The gel was cast, placed in a horizontal 
electrophoresis tank and covered with 1 X TAE buffer.
DNA samples were prepared by the addition of the 
appropriate amount of 10X loading buffer (10X TAE, 50% (v/v) 
glycerol, 0.01% (mass/v) bromophenol blue) and loaded. Voltage 
was applied as required and electrophoresis was monitored by 
the migration of the dye front.
DNA was stained by placing the gel in 0.5/ig/ml ethidium 
bromide in water with gentle agitation for 10-30 minutes and 
visualised under a long wave UV light source.
2.3.2 isolation and purificatlon ot PEA graqaan*» tvvm 
aaarosa gels
DNA was resolved by gel electrophoresis. A piece of NA45 
membrane was inserted into the gel ahead of the fragment of 
interest. Electrophoresis was resumed until the DNA had run 
onto the membrane.
The DNA was eluted in 50mM arginine, pH 9.0, 1M NaCl for 
20 minutes at 65°C with occasional shaking. The membrane was 
removed and the DNA solution was extracted 3 times with 
phenol, followed by ethanol precipitation. The DNA pellet was 
taken up in an appropriate volume of water.
2.4 RESTRICTION ENDONUCLEASES
2.4.1 Digestion of DNA with restriction endonucleases
Restriction endonuclease cleavage was accomplished by 
incubation of the enzyme (s) with the DNA in appropriate
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reaction conditions. The amounts of enzyme and DNA, the buffer 
and ionic concentrations, and the temperature and duration of 
the reaction varied depending upon specific application.
All restriction enzymes were obtained from commercial 
sources, and the appropriate supplied 10X reaction buffer was 
employed in all cases. All incubations were at 37°C, except for 
Smal digestion which was carried out at 30°C.
Typically 0.1-4/xg of DNA in water or TE buffer was 
incubated with 2/xl of the appropriate 10X restriction 
endonuclease buffer and lui of enzyme in a 20/il reaction volume 
for a minimum of 1 hour at 37°C. For further enzymatic 
manipulation of the DNA, the reaction was stopped by heating to 
75°C for 15 minutes and the DNA was purified by extraction with 
phenol and ethanol precipitation.
2, ? PROTOCOLS JQ& HOPirYIHg-AHP RADIOLABEkLIPQ WyCLEIC ACIDS
?.5.l Radioisotop»» used fp Manipulate pucl+jc acids
[32P] was used to radioactively label nucleic acids. 
[32P]-labelled NTP and dNTP precursors were purchased 
commercially, at specific activities of >110TBq/mmol for [o<- 
32P]-dCTP, [*-32P]-dATP and [<*-32P]-UTP.
Deoxyadenosine 5'-§9C-35S] triphosphate, at a specific 
activity of >37 TBq/mmol, was used for all the dideoxy 
sequencing procedures.
Measuring radioactivity
A known volume (typically l/il) of a reaction mixture 
containing radioactive precursors was spotted onto a glass 
microfibre filter in duplicate, and allowed to air dry. The 
second filter was placed in 50ml of ice cold 10% 
trichloroacetic acid (TCA) solution and stirred gently for 30 
minutes. The filter was then transferred to 50ml of 5% TCA at 
100°C and boiled for 5 minutes. The filter was washed 3 times
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with ice cold 5% TCA and dried under a heating lamp. The 
filters were placed in separate vials containing 4ml of a non- 
aqueous scintillation fluid and the amount of radioactivity 
present was measured in a liquid scintillation counter. The 
incorporation of radioactivity into the nucleic acid was 
determined from the ratio of total radioactivity (unwashed 
filter) to incorporated radioactivity (acid washed filter).
Removal of unincorporated dNTP precursors 
For DNA greater than lOObp column chromatography on 
Biogel P6 was employed. The resin was swelled by adding excess 
water to Biogel P6, and boiling in a microwave oven for 1 
minute. After cooling to room temperature, excess water was 
removed and replaced with fresh. This was repeated 4 times. The 
swollen resin was stored at 4°C.
A 1ml disposable syringe was plugged with siliconised 
glass wool and filled with the pre-swollen resin. The syringe 
was placed in a polypropylene tube suitable for a bench top 
centrifuge and spun for 3 minutes at 3000 rpm to pack the 
column. The radioactive sample was diluted to 100/il with water 
and loaded onto the column. The column was respun in a clean 
polypropylene tube. A 100/il volume of water was applied, the 
column was spun as before, and the sample was recovered from 
the polypropylene tube.
For oligonucleotides Biogel P2 was used in 0.5X TE buffer 
and the column was washed in 0.5X TE instead of water.
P6 spin columns were also used to remove excess salt from 
DNA samples. The sample was recovered in water and then taken 
down to dryness under vacuum. The DNA was resuspended in a 
small volume of the buffer of choice.
2.5.2 DNA dependent DNA polymerases
Labelling bv oligonucleotide-primed synthesis
Uniform labelling of DNA by "random priming" was the 
method employed for the radiolabelling of DNA to be used as
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sequence-specific probes for screening libraries and genomic 
DNA Southern blots.
The method of "random primed" DNA labelling is based on 
the hybridization of a mixture of all possible hexanucleotides 
to the DNA to be labelled. The complementary strand is 
synthesized from the 3' OH termini of the hybridized 
hexanucleotide primer using Klenow enzyme. Labelled dCTP 
present in the reaction mixture is incorporated leading to a 
uniform degree of labelling along the length of the input DNA. 
The input DNA serves solely as the template and is not degraded 
during the reaction.
A commercially available "Random Primed" DNA Labelling Kit 
was used (Boehringer Mannheim) and the manufacturer's protocol 
was followed.
Briefly, 0.1-2Mg DNA was heated to 95°C for 10 minutes and 
subsequently cooled on ice. To the denatured DNA, 3/il of a 
0.5mM each dATP, dGTP, dTTP mixture, 2nl of a hexanucleotide 
mix in reaction buffer, 5/il [oc-32P]-dCTP and 1/il of Klenow were 
added in a final volume of 20^1. The mixture was incubated for 
30 minutes at 37°C and the reaction stopped by heating to 65°C 
for 1 0  minutes.
Labelling 5' endg of DMA
Refer to T4 polynucleotide kinase (section 2.5.4).
Repairing 3' or 5' overhanging ends
The Klenow fragment of E. coli DNA polymerase I was 
employed to repair 3' or 5' overhanging ends.
To end-fill 5' over-hanging ends 0.1-4M9 of DNA was 
digested in a 20/il reaction volume. One txl of 0.5mM dNTP
(0.5mM of each dNTP) was added followed by l*il of Klenow. The 
reaction mix was incubated at 30°C for 15 minutes, then heat 
inactivated at 75°C for 10 minutes.
To blunt back 3' overhanging ends or to repair DNA with 
both 3' and 5' overhanging ends, the reaction mix was incubated
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at 37°C for 5 minutes, followed by incubation at room 
temperature for 20 min and then 20 minutes on ice.
T7 DNA Polymerase
T7 DNA polymerase is a highly processive enzyme 
incorporating thousands of nucleotides before dissociation from 
the template, and does not perform strand displacement 
synthesis. Cloned T7 DNA polymerase was used for in vitro 
mutagenesis (section 2.12.3).
2.5.3 PNA-P»ptBdent UNA pglyP T »»»»
SP6 RNA polymerase
SP6 RNA polymerase is highly specific for its own promoter 
consisting of a 20bp sequence. Transcription is rapid and 
highly processive.
SP6 RNA polymerase was employed for in vitro transcription 
of cloned DNA inserted into the pSP64-T vector.
2.5.4 Phgspbatiae» »nd.kinaaeg
Calf intestinal.alkaline phosphatase
Calf intestinal alkaline phosphatase (CIAP) was used to 
dephosphorylate the 5' termini of DNA prior to labelling with 
[■jf —32pj —ATP and T4 polynucleotide kinase, and for
dephoshorylation of 5' termini of vector DNA to prevent self 
ligation.
For a 50/il reaction volume, l-20pmol DNA termini were 
incubated in 20mM Tris-HCl, pH 8.0, ImM MgCl2, ImM ZnCl2 and 
0. lu CIAP for 30 minutes at 37°C. The reaction was stopped by 
heating to 75°C for 10 minutes.
T4 palYimglePtide Kinase
T4 polynucleotide kinase (PNK) catalyses the transfer of 
the terminal (*) phosphate of ATP to the 5' hydroxyl termini of
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ends or forDNA and was employed for labelling 5' 
phosphorylating oligonucleotide primers.
For a 30/il reaction volume, l-50pmol dephoshorylated DNA 
5' ends was incubated in 50mM Tris-HCl, pH 7.5, lOmM MgCl2, 5mM 
DTT, 150/iCi [-i -32P]-ATP, 50/ig/inl BSA and 20 units of T4 PNK at 
37°C for 60 minutes. The reaction was stopped by heating to 
75°C for 10 minutes.
For phosphorylating oligonucleotides, l-lO^ig DNA was 
incubated in the above reaction mix with ImM ATP replacing [■/- 
32P]-ATP.
2.5.5 DNA ligase»
T4 DNA ligase catalyses the repair of single stranded 
nicks in duplex DNA and joins duplex DNA fragments with 
cohesive or blunt ends.
For a 15/il reaction volume, 25-100ng of each component DNA 
was incubated in 40mM Tris-HCl, pH 7.5, lOmM MgCl2, lOmM DTT, 
0.5mM ATP, 50Mg/ml BSA and 10 units of T4 DNA ligase for 2-16 
hours at 16°C. The reaction was stopped by heating to 75°C for 
10 minutes.
2.6 CON8TRPCTIOH OF HYBRID PNA HOLBCPLEg
To construct new DNA molecules, the starting DNAs were 
treated with appropriate restriction endonucleases and other 
enzymes if necessary. The individual components were purified 
by agarose gel electrophoresis, combined and treated with DNA 
ligase. The products of the ligation mixture were introduced 
into competent E. coli cells (section 2.10.3) and transformants 
were selected by an appropriate genetic selection. DNA was 
prepared from the colonies or plaques and analysed by 
restriction endonuclease mapping.
?. 7 PQLYMSEj REACTION
2.7.1 Basic principle of PCR
Introduction
The polymerase chain reaction (PCR) is a cyclic procedure 
for in vitro enzymatic amplification of a specific segment of 
DNA. The reaction uses two oligonucleotide primers flanking 
the DNA sequence of interest and hybridising to opposite 
strands. The primers are orientated such that synthesis by Taq 
DNA polymerase extends across the segment of target DNA. Each 
new strand generated can act as a template in subsequent DNA 
synthesis. Each cycle of amplification consists of strand 
dénaturation, primer annealing and enzymatic extension. The 
amount of target DNA doubles with each completed cycle.
PflgjÇ prgtggsl
A typical PCR mixture consisted of lug of template DNA, 
lOOpmoles of each primer (or primer pool), 200/xM each dNTP, 2.5 
units of Amplitaq™ DNA polymerase, lOmM Tris-HCl, pH 8.3, 50mM 
KC1, 1.5mM MgCl2 and 0.01% (mass/v) gelatin in lOOpl total
volume, with 100/xl mineral oil added.
Unless otherwise specified a cycle consisted of 
dénaturation for 1 minute at 94°C, annealing for 2 minutes at 
50°C and extension for 2 minutes at 72°C. PCR was carried out 
for a total of 30 cycles using a Perkin-Elmer thermocycler.
2.7.2 PCR to generate abrin-specific probe
Degenerate primer pools representing all possible coding 
sequences of an N-terminal and an internal domain of abrin C A- 
chain (refer to Figure 10, section 3.2.1) were used in a PCR on 
genomic A. precatorius DNA template to generate an abrin 
specific probe. The optimum temperature for primer annealing 
was determined empirically.
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2.7.3 PCR using linker extended primers
PCR provided an alternative to mutagenesis of target DNA 
for the introduction of restriction endonuclease sites and 
additional codons. Linker extended primers were designed which 
would generate, by PCR on target DNA, the required DNA fragment 
flanked by suitable unique endonuclease restriction sites and 
if necessary the sequence of additional codons. The standard 
design of these linker extended primers were a minimum of 15 
bases at the 3' end of the primer which were complementary to 
the target DNA, a 6-14 base extension encoding the desired 
restriction endonuclease recognition site and additional codons 
if required. The linker extended primers were flanked by two G 
residues at the 5' ends to ensure stabilisation of the DNA 
duplex. A standard PCR reaction was carried out as described.
PSQPgNCIM<?
2.«.1 ov.rvl.w
The dideoxy sequencing method, originally developed by 
Sanger et al. (1977), was used to determine DNA sequence 
information. In practice, the DNA to be sequenced is prepared 
as a single stranded molecule, and a chemically synthesised 
oligonucleotide is annealed to the 3' end of the region to be 
sequenced. The four dNTPs are added (one of which is 
radiolabelled) , and modified T7 DNA polymerase is used to 
synthesise an oligonucleotide complementary to the template by 
the formation of phosphodiester bonds between the 3' hydroxyl 
group of the growing primer and the 5' phosphate of the 
incoming dNTP. The labelling reaction mix is divided into four 
aliquots. The addition to each aliquot of one of the four 
2',3'-dideoxynucleotides (which lack the 3' hydroxyl group) 
leads to the termination of the elongating primer chains at 
each occurence of the included dideoxynucleotide. Each of the
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four elongation reactions contains a population of 
radiolabel led chains, all of which have a fixed 5' end as 
determined by the primer and a variable 3' end terminating at a 
specific base. The strands of the molecules are separated by 
heating and the DNA is electrophoresed on a seguencing gel.
Sequencing Gels
For analysis of DNA seguence close to the primer an 8% 
polyacrylamide gel was used, and electrophoresis was performed 
until the bromophenol blue migrated to within 5cm of the bottom 
of the gel. The standard gel employed contained 6% 
polyacrylamide, and the bromophenol blue was run to the bottom 
of the gel. For reading longer oligonucleotide sequence a 4% 
polyacrylamide gels was used, and the gel was run until the 
xylene cyanol had run off the gel.
For 100ml of gel mix:
Final FAcrylapiflel 11 61 &1
Acrylamide:Bisacrylamide (30:1) 10ml 6.7ml 5ml
Urea 46.7g 46.7g 46.7g
10XTBE buffer 1 0 ml 10ml 10ml
h2o to 1 0 0 ml 100ml 100ml
The gel mix was filtered through a 0.22um filter, then 
degassed. Polymerisation was initiated by the addition of 250/il 
of 10% (mass/v) ammonium persulphate and 25^1 of TEMED. The gel 
was cast between two glass plates with 0.4mm spacers.
Electrophoresis was carried out at 40 Watts in 1XTBE (89mM 
Tris base, 89mM boric acid, 2mM EDTA) buffer. When the dye 
front had reached the desired position, the gel was fixed for 
30 minutes in 10% methanol, 10% acetic acid and dried onto 3MM 
filter paper under vacuum at 55°C for 30 minutes, then exposed 
to X-ray film overnight at room temperature.
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2.8.2 Bequenase™ sequencing method
DNA sequencing was performed using the commercially 
available Sequenase™ kit and following the manufacturer's 
protocol.
Briefly, 0.5 pmoles of primer was incubated with 1/ig of 
DNA in 40mM Tris-HCl, pH 7.5, lOmM MgCl2, 50mM NaCl in a 10/il 
reaction volume for 2 minutes at 65°C and then allowed to cool 
back slowly to below 30°C. To the annealed template-primer 
reaction mix, Ipl 0.1M DTT, 2/il labelling mix (1.5/iM dGTP, 
1.5/iM dCTP, 1.5/iM TTP) , 0.5/il [<x-35S]-dATP (10/iCi//il) and 2/il 
Sequenase™ (diluted 1:8 in TE buffer) were added and the 
reaction mixture was incubated for 5 minutes at room 
temperature. When the labelling reaction was complete, 3.5/il 
was transferred to 2.5/il of each of the termination mixes, 
prewarmed to 37°C, and incubated at 37°C for 5 minutes. To each 
termination reaction, 4/il of 95% (v/v) formamide, 20mM EDTA, 
0.05% (mass/v) bromophenol blue, 0.05% (mass/v) xylene cyanol 
was added. The reaction mixes were heated to 80°C for 2 minutes 
and 3/il was loaded onto a sequencing gel.
For general sequencing, the dGTP termination mixes were 
employed consisting of 8/iM of the selected ddNTP and 80/iM of 
the other three dNTPs. For sequences containing dyad symmetry 
of dC and dG residues which do not fully denature during 
electrophoresis, the dITP termination mixes were used 
consisting of 8/tM of the selected ddNTP, 80/iM each dATP, dCTP, 
dTTP and 160/iM dITP (except for the ddGTP mix which contains 
1.6/tM ddGTP). The inclusion of dITP, which forms weaker 
secondary structure, leads to the denaturation of compressions.
Sequencing plasmid DNA
Plasmid DNA was sequenced directly by including a 
denaturation step to generate single stranded template. The DNA 
to be sequenced was taken up in 8/il of water and 2/il of 2M 
NaOH. The mixture was held at room temperature for 10 minutes, 
3/il of 3M sodium acetate, pH 6.0, and 10/il of water were added.
then the DNA was ethanol precipitated. The DNA pellet was taken 
up in 6nl of water and sequencing was performed as described.
Direct sequencing of PCR products 
A standard PCR reaction was performed and the DNA product 
was purified from an agarose gel. The DNA was lyophilised and 
taken up with the required amount of primer in a total volume 
of 8/il of water. The sample was heated to 95°C for 3 minutes, 
spun briefly to collect condensation, then frozen on dry ice. 
The DNA/primer mix was thawed between the finger tips, 2/xl of 
annealing buffer was added and the sequencing protocol 
continued as described above, except that annealing was for 10 
minutes at 37°C.
2.9 ESCHERICHIA COLI
2.9.1 Media preparation
Minimal media
5 X M9 medium, per litre:
30g Na2HP04 
15g KH2P04 
5g NH4C1 
2.5g NaCl
Autoclaved at 151b/in2 for 20 minutes 
Concentrated media was diluted to IX with sterile water and the 
following sterile supplements added per litre:
lml MgS04.7H20 
1 0 ml 2 0 % glucose
0.lml 0.5% thiamine-HCl, 5% tryptophan, 5% leucine
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Rich media
LB medium, per litre: 
lOg bactotryptone 
5g yeast extract 
5g NaCl
Autoclaved at 151b/in2 for 20 minutes
NZY broth, per litre: 
lOg NZ Amine A 
5g NaCl 
2g MgCl2 .6H20
Autoclaved at 151b/in2 for 20 minutes
Solid media
For minimal media plates, 15g of agar in 800ml was 
autoclaved at 151b/in2 for 20 minutes, then sterile 
concentrated media and carbon source were added. The medium was 
allowed to cool to 50°C and supplements were added. 
Approximately 35ml of medium was poured per plate.
For rich media plates, 15g of agar per litre of media was 
autoclaved at 15 lb/in2 for 20 minutes. The media was allowed 
to cool to 50°C, antibiotic was added if required, and 35ml was 
poured per plate.
Top agar
LB top agar, per litre: 
lOg bactotryptone 
5g yeat extract 
5g NaCl 
7g agar
Autoclaved at 151b/in2 for 20 minutes
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Before use, top agar was melted in a boiling water bath and 
held at 45°C.
2.9.2 Growth in li<mid «»¿la
A single bacterial colony was inoculated into 5-10ml of 
liquid medium. The culture was grown at 37°C for a minimum of 6 
hours to overnight.
Large cultures
Cultures larger than 30ml were inoculated with an 
overnight culture diluted 1 : 1 0 0  in flasks whose volume was at 
least 5 times the volume of the culture. Cultures were grown at 
37°C, unless otherwise stated, with vigorous shaking 
(approximately 300rpm).
Monitoring growth
The growth of cultures of E. coli were monitored by 
recording the optical density (OD) at 600nm.
2.9.3 growth on solid media
isolating single colonies
Plate streaking: an inoculum of bacteria was streaked 
across an agar plate using a sterile toothpick. A fresh 
toothpick was passed once through the first streak. This was 
repeated once more. Plates were incubated at 37°C until 
colonies became visible.
Spreading a plate: liquid culture was spread over a plate 
by pipetting 0.05-lral of culture onto a dry plate and spreading 
over the surface of the plate using a glass spreader which had 
been flamed in ethanol and cooled by touching the agar surface.
Strain storage
For frozen stocks, lml of a freshly saturated culture was
added to a vial containing 7% (v/v) dimethylsulphoxide, and
stocks were stored at -70°C.
3,9.4 Host atr^jB»
JM109
JM109 (recAl, endAl, gurA96, thi, hsdR17, supE44, relAl, 
lambda“ , A(lac-proAB), [F', traD36, proAB, laqIqZAM15]) was
maintained on minimal media plates. JM109 was the host strain 
used for routine transformations, as feeder cells in the 
plating of M13 phage and for the cytoplasmic expression of 
recombinant A-chain.
XLl-Blue
XLl-Blue™ (end Al, hsdR17(rk“, mk+) , supE44, thi-1, 
lambda“ , recAl, gyrA96, relAl, A(lac), [F', proAB, lacIqZAM15, 
TnlO(tetR)] was maintained on LB media plates supplemented with 
15ug/ml tetracycline. XLl-Blue™ was used as the host strain to 
determine the percentage recombinants in the genomic library 
generated in the Lambda ZAPII vector and for growth of the 
recombinant Lambda ZAPII phagemid.
JA221
JA221 (lpp” , hsdR, AtrpE5 leuB6 lacY, recAl, [F', laclq , 
lac+ , pro+ ]) was maintained on minimal media plates. JA221 was 
used for periplasmic expression of recombinant A-chain.
NM554
NM554 (recAl, araD139, A(ara-leu)7696, A(lac)17A, galU, 
galK, hsdR, strA, mcrA, mcrB) was maintained on LB media 
plates. NM554 was used for the generation of genomic libraries.
SDM
SDM (hsdRl7, mcrAB, recAl, a (lac-proAB), [F', traD36, 
proAB+ , laqIqZ A M15]) was maintained on minimal media plates.
SDM was used for transformation of methylated M13 DNA following 
in vitro mutagenesis of cloned inserts.
PE2392 and LE392
PE2392 (hsdR514(rk- , mk+) , supE44, supF58, A(lacIZY), 
ga1K2, galT22, metBl, trpR55, (P2) and LE 392 (hsdR514(rk", 
mk+ ) , supE44, supF58, (lacIZY), galK2, galT22, metBl, trpR55) 
were maintained on LB media and were used to determine the 
percentage recombinants in the genomic libraries generated in 
the Lambda DASHII vector.
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2.10.1 Plasmid vectors
Features of the plasmids employed are described.
BluescriDtll SK+
Bluescriptll SK+ is a 2964bp phagemid derived from pUC19 
(Figure 2) . The vector possesses an fl phage origin, a colEl 
origin, T3 and T7 promoters flanking a polylinker containing 19 
unique restriction sites, and carries ampicillin resistance. 
The vector contains a lacZ promoter for blue/vhite colour 
selection. The fl origin of replication allows single stranded 
DNA rescue via helper phage infection.
Figure 2 Bluescript II SK+ plasmid map
1
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DSP64T
pSP64T is a plasmid derived from pUC13 (Melton et al., 
1984) (Figure 3) . The vector possesses a SP6 RNA polymerase 
transcription initiation site, the SP6 RNA polymerase promoter, 
a polylinker containing 6 unique restriction sites, and carries 
ampicillin resistance. Between the promoter and polylinker is 
the sequence encoding the untranslated regions of Xenopus 
laevis B-globulin cDNA (Patient et al., 1983 and Williams et 
al., 1980) and central to this sequence is a unique Bglll site. 
The SP6 RNA polymerase promoter allows in vitro transcription 
from DNA sequences cloned into the Bglll site, subsequent to 
vector linearisation using an enzyme with a unique recognition 
site within the polylinker.
Figure 3 pSP64-T plasmid map
Pvul 1671
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PKK233-2
The vector pKK233-2 is a 4593bp plasmid derived from 
pBR322 and contains the trc promoter, the lacZ ribosome binding 
site, an ATG initiation codon and a rrnB transcription 
terminator downstream of a multiple cloning site (Figure 4) . 
The plasmid carries ampicillin resistance.
Figure 4 pKK233-2 plasmid map
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2.10.2 Plasmid DNA preparation
M i n i p r e p s  o f  p l a s m i d  P N A
A modification of the method described by Holmes and 
Quigley (1981) was used for the small scale preparation of DNA.
A 10ml overnight culture was pelleted at 3000rpm in a 
bench top centrifuge. The pellet was resuspended in 180^x1 of 
0.1M Tris-HCl, pH 8.0, 50mM EDTA, 20% sucrose and transferred 
to an Eppendorf tube. Then 180/xl of 4mg/ml lysozyme in 0.1M 
Tris-HCl, pH 8.0, 50mM EDTA, 20% (mass/v) sucrose was added. 
After 5 minutes at room temperature, 300jxl 10% Triton X-100 was 
added, the sample was vortexed, then boiled for two minutes and 
placed on ice for two minutes. Chromosomal DNA was pelleted for 
30 minutes in a microfuge and the supernatant containing 
plasmid DNA was recovered to a fresh tube. A 300/xl volume of 
7.5M ammonium acetate was added and the sample placed on ice 
for 20 minutes. The sample was centrifuged for 10 minutes at 
room temperature. The supernatant was recovered, and the DNA 
was precipitated with isopropanol. The DNA was resuspended in 
50/xl TE buffer and 1/xl lOmg/ml DNase-free RNase was added.
Caesium__chlor ide/eUndium__bromide__preparation__ Si
plasmid DNA
Cells from a 400ml culture were pelleted in a Sorvall 
6X250 rotor at 5000rpm for 5 minutes. The pellet was 
resuspended in 14.4ml 0.1M Tris-HCl, pH 8.0, 50mM EDTA, 20% 
sucrose, containing 30mg of lysozyme, and left at room 
temperature for 5 minutes. A 10ml volume of 10% Triton-XlOO was 
added and the flask was boiled over an open flame for 1 minute 
followed by 1 minute at 100°C in a water bath. The flask was 
placed on ice for 2 minutes. The lysed cells were pelleted at 
21,000rpm at 4°C in a Sorvall 6X50 rotor for 20 minutes. The 
supernatant was recovered, 0.5 volumes of 7.5M ammonium acetate 
was added and the sample was placed on ice for 20 minutes. The 
solution was centrifuged at 15,000rpm at 4°C in a Sorvall 8X50 
rotor for 10 minutes. The supernatant was recovered and DNA
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precipitated with isopropanol. The pellet was resuspended in 
4ml TE buffer, followed by the addition of 4.5g of caesium 
chloride and 0.5ml ethidium bromide (5mg/ml). The solution was 
loaded into a Beckman Quickseal tube which was then heat 
sealed. The plasmid DNA was banded by centrifugation at
52,000rpm at 20°C in a Vti65 rotor for 16 hours. Covalently 
closed plasmid DNA was recovered from the gradient using a 
syringe and needle. The ethidium bromide was removed by
extraction four times with isopropanol saturated with TE buffer 
and caesium chloride. The solution was diluted five fold in TE 
buffer and ethanol precipitated. The pellet was taken up in 
0.5ml TE buffer, the absorbance at 260nm was determined and the 
DNA was diluted to lmg/ml with TE buffer.
2.10.3 Introduction of plasaU DKA into cells
Conpetent cello
Competent cells were prepared by the method of Hanahan 
(1980). An overnight culture of E . coli cells was diluted 1:100 
in fresh prewarmed medium and grown at 37°C until the OD600 
reached 0.48 (approximately 107 cells/ml) , then placed on ice 
for 5 minutes. The cells were pelleted at 3000rpm, at 4°C for 5 
minutes in an 8X50 Sorvall rotor. The cells were gently 
resuspended in one third growth volume lOOmM RbCl, 50mM MnCl2, 
30mM potassium acetate, lOmM CaCl2, 15% (mass/v) glycerol, at 
pH 5.8 and left on ice for 15 minutes. The cells were 
repelleted, and resuspended in 1/12.5 growth volume of lOmM 
MOPS, lOmM RbCl, 75mM CaCl2, 15% gycerol, at pH 6.8. The cells 
were left on ice for 15 minutes and then divided into 200/xl 
aliquots in prechilled tubes, and frozen at -70°C.
Iransformation
To introduce DNA into competent cells, a 200^1 aliquot of 
frozen competent cells was thawed on ice, and one fifth volume 
of ligation mixture, or 50ng of plasmid DNA, was added and the 
cells left on ice for 1 hour. The cells were heat shocked at
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42°C for 90s, then placed on ice. To allow for the expression 
of plasmid encoded antibiotic resistance, 8 00fil of LB medium 
was added and the tube placed at 37°C for 20 minutes.
Aliquots of the transformation culture were plated out on 
plates containing the appropriate selective medium and 
incubated for 16 hours at 37°C.
3.11 LAMBDA PHAQE VECTORS
8.11.1 fraafeda Vfgtpra 
Lambda z a p h
The Lambda ZAPII vector has 6 unique cloning sites that 
can accomodate DNA inserts from 0-10kbp in length. The vector 
contains the pBluescript phagemid which allows the insert to be 
rapidly excised in vivo and characterised in a plasmid system 
(Figure 5).
For in vivo excision and recircularisation of a cloned 
insert, the host strain used must carry the F' episome, which 
contain the genes for the expression of the bacterial F' pili, 
and an fl helper phage is required. The proteins from the fl 
phage recognise the initiator DNA sequence within the Lambda 
ZAP vector and nick one of the two DNA strands. New DNA 
synthesis begins and duplicates the DNA downstream of the 
nicking site until the termination signal within the vector is 
reached. The single stranded DNA molecule is circularised by 
the gene II product from the fl phage which recreates a 
functional fl origin. Signals for packaging of the newly 
created phagemid are contained within the fl terminator 
sequence and lead to secretion from the E . coli cells. The E . 
coli host cells are killed by heating to 70°C. The "packaged" 
pBluescript DNA is mixed with fresh host cells and the 
transfected E. coli is plated out on solid media to produce 
colonies.
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Figure 5 L a m b d a  Z APII v e c t o r  m a p  a n d  excision
”  J  2 5 Ï 1 â ' t 7
U  DNA INSERT T7
- 92 -
Lambda DASHII
The Lambda DASHII vector is a standard lambda vector and 
can accomodate DNA inserts from 9-23kbp (Figure 6).
Figure 6 Lambda DASHII vector map
2.11.2 Piet jpg of phage LftPbd«
An overnight culture of E . coli in LB media, supplemented 
with 0.2% (mass/v) maltose and lOmM MgS04 , was pelleted at 
lOOOg for 10 minutes then resuspended in lOmM MgS04 at 
OD600=0.5. A phage lysate was diluted accordingly in suspension 
medium (5.8g NaCl, 2g MgS04 .7H20, 50ml 1M Tris-Cl, pH 7.5, 0.1% 
(v/v) gelatin) and 0 .1 ml of diluted phage was added to 0.2ml of 
host cells. Phage and host cells were incubated at 37°C for 15 
minutes to allow for phage absorption. Top agar (3ml) at 45°C 
was added and mixed gently, then plated out onto a 80mm X 15mm 
NZY plate. The plates were incubated for 12 hours at 37°C. For 
150mm X 15mm plates, 0.6ml of host cells (OD600=0.5 in lOmM 
MgS04) and 6.5ml top agar was used per plate.
cos
- 93 -
2.11.3 Growth of phage lambda
Liquid lvsate
A single plaque was picked into 0.4ml 20mM Tris-HCl, pH 
8.0, 20mM MgCl2 and incubated at 4°C for 2 hours to allow the 
phage to elute. To 0.1ml of a saturated culture of host E. 
coli, 0.1ml of eluted phage and 0.1ml lOmM MgCl2 , lOmM CaCl2 
was added and the mixture incubated at 37°C for 15 minutes to 
allow phage absorption. The solution was added to 50ml of NZY 
medium and shaken at 300rpm for 6 hours at 37°C or until lysis 
had occured. Cell debris was removed by centrifugeition at 5000g 
for 10 minutes at 4°C. The supernatant was decanted and stored 
in aliquots at 4°C in the presence of 0.3% (v/v) chloroform.
Plate lvsate
Approximately 50,000 lambda phage were plated out onto 
150mm X 15mm NZY agar plates and incubated at 37°C until 
plaques were clearly visible and approximately 90% of the lawn 
was lysed. A 10ml volume of suspension medium was pipetted onto 
the lawn and the plate was left at 4°C with gentle rocking 
overnight. The liquid was decanted, the plate was rinsed with 
an additional 2ml of suspension medium and pooled, and 
chloroform to 0.5% (v/v) was added and mixed. Cell debris was 
removed by centrifugation at 5000g for 10 minutes at 4°C. The 
supernatant was decanted and stored in aliquots at 4°C in the 
presence of 0.3% (v/v) chloroform.
2.12 FILAMENTOUS PHAGE M13
Overview
The filamentous phage M13 was used for site-specific 
mutagenesis of cloned DNA inserts at internal sites. The 
commercially available USB T7 G E N ™  In Vitro Mutagenesis Kit 
was used. This method employs an in vitro selection procedure 
in which the mutant strand is selectively methylated by 5-
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methyl-dCTP incorporation during second strand synthesis. The 
non methylated parent strand is subsequently removed by 
treatment with Sau3Al, which nicks only the unmethylated DNA, 
and exonuclease III which digests the nicked parental strand. 
The inclusion of Hhal in the reaction removes uncopied single 
stranded DNA. The method is highly efficient (mutation 
frequencies >75%) and rapid.
2.12.1 introduction of M13 into cells
Competent cells of an appropriate host strain were 
prepared. To a 200ul aliquot of competent cells, lOOng of M13 
DNA was added and then held on ice for 45 minutes. The cells 
were heat shocked at 42°C for 90s and then quenched on ice. 
Cells were plated out onto prewarmed LB plates in 3ml of top 
agar, containing 40/il of 20mg/ml X-gal in dimethylformamide and 
10/il of 20mg/ml IPTG, held at 42°C. Plates were incubated at 
37°C for 16 hours.
2.12.2 Preparation of »inql» »tr«nd+d W13 P W
A single plaque was picked into 2ml of a 1/100 dilution of 
an overnight culture of E. coli host cells in LB and shaken 
vigorously at 300rpm for 6 hours at 37°C. The lysate was 
transferred to an Eppendorf tube and cells were pelleted for 5 
minutes at 4°C in a microfuge. The supernatant was taken off 
with a pipette to a fresh tube and one tenth volume of 20% PEG 
6000, 2.5M NaCl was added and the phage were allowed to 
precipitate for 30 minutes at 4°C. The pelleted cells were 
saved for the preparation of M13 RF DNA. The phage was pelleted 
for 10 minutes at 4°C, and the supernatant was removed with a 
drawn out Pasteur pipette. The phage was resuspended in 150ul 
of TE buffer and extracted with an equal volume of phenol. The 
phases were separated by centrifugation for 4 minutes, and the 
sample was re-extracted with an equal volume of chloroform. 
Traces of chloroform were removed by 3 sequential ether
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extractions. The DNA was recovered by ethanol precipitation, 
and the pellet was resuspended in 20^1 TE buffer.
IP V it r o  WMtaq ane s ig
M13 single stranded template containing target DNA was 
prepared and diluted to 1 pmole/jil. In a lO/il total volume, 5 
pmoles of single stranded target DNA was incubated with 2 
pmoles of phosphorylated mutagenic primer in 40mM Tris-HCl, pH 
7.5, 20mM MgCl2, 50mM NaCl for 5 minutes at 65°C, and then 
cooled slowly back to room temperature.
To the annealed template/primer mix, 2/il of lOOmM Tris- 
HCl, pH 7.5, 20mM DTT, 5mM dATP, 5mM dGTP, 5mM dTTP, lOmM ATP, 
5mM 5-methyl-dCTP was added, the volume was made up to 18/il 
with water and 2.5 units of T7 DNA polymerase and 5 units of T4 
DNA ligase were added. The mix was incubated at 37°C for 60 
minutes, then heat inactivated for 10 minutes at 70°C.
To the hemimethylated DNA 5 units of Sau3A and 10 units of 
Hhal were added and the mix was incubated for 45 minutes at 37° 
C. Fifty units of exonuclease III was then added and the mix 
incubated for a further 4 5 minutes at 37°C. The reaction was 
stopped by heating to 70°C for 10 minutes.
The DNA was transformed into competent SDM E . coll cells 
and then plated out with E. coli JM109. Plaques were picked, 
single stranded DNA was prepared and analysed by DNA 
sequencing.
2a.l2t4 P r» p ftritl9 B  a t  <3 pub I t  >tran<3»<3 Ml? PKft
The cells from a 1.5ml phage lysate were pelleted and the 
supernatant removed. The cells were resuspended in 100/il TE 
buffer and left at room temperature for 5 minutes. Two volumes 
of 2M NaOH, 1% (mass/v) SDS were added and the tube placed on 
ice for 5 minutes. A half volume of 3M potassium acetate, pH 
4.8, was added and held on ice for a further 5 minutes. Cell 
debris was removed by centrifugation at 4°C in a microfuge.
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and the supernatant was transferred to a fresh tube. The DNA 
was recovered by ethanol precipitation and the pellet was 
resuspended in 20/xl TE buffer and lul of lOmg/ml DNase-free 
RNase. The DNA was analysed by restriction endonuclease 
mapping.
iiil PREPARATION OF INSERT.DNA FROM GENOMIC DMA
;.13.1 preparation of PH* tor ligation
In a 50/il reaction volume, lO^ tg of genomic A. precatorius 
DNA was digested with EcoRI.
Lambda Z h F l l J E gqR I
The DNA was concentrated by ethanol precipitation and 
resuspended in TE buffer at lmg/ml.
Lambda Q h S h ll/E G Q B J
The DNA was treated with CIAP, concentrated by ethanol 
precipitation and resuspended in TE buffer at lmg/ml.
2 , 14 PEODPCTIQM Qf QWQHIQ PN& LIIBABI58
Lambda ZAPII
Test ligations were performed to determine the optimum 
concentration of insert. In a ligation reaction volume of 5^1» 
lnq of Lambda ZAPII/EcoRI prepared arms were incubated with 
50ng, lOOng, 150ng, 200ng or 250ng of insert DNA at room
temperature for 1 hour then overnight at 4°C. A control 
ligation was performed using 0.4/xg of the supplied test insert.
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Lambda PASHII
For a ligation reaction volume of 5ul, lug of Lambda 
DASHII/EcoRI prepared arms was incubated with lOOng, 200ng, 
300ng, 400ng or 500ng of insert DNA (CIAP treated) at room
temperature for 1 hour followed by overnight at 4°C. A control 
ligation was performed using 0.4/ig of the supplied test insert.
2.14.2 Packaging
The Gigapack™II Gold Packaging Extract (Stratagene) was 
employed for generation of recombinant lambda phage.
Sonic extract was thawed on ice. The freeze/thaw extracts 
were warmed between the fingers until they just began to thaw, 
1 /xl of the ligation mix was added and the tube placed on ice. 
Immediately, 15/il of sonic extract was added, mixed gently, 
then briefly spun. The packaging mix was incubated at room 
temperature for 2 hours. A 500/il volume of SM buffer was added 
followed by 20/xl of chloroform. The contents were spun briefly. 
The supernatant was titred.
1x11*1 Bafcmlnlag r t p r w n m i p a
To determine that sequences of interest, i.e. abrin- 
related DNA sequences, were contained within the packaged 
library, Ifil of each packaged extract was diluted 1:100 in TE 
buffer. A standard PCR was carried out using lul of the diluted 
extract as template and lOOpmoles of the primer pools employed 
to generate an abr in-specific probe. The products of PCR were 
analysed by agarose electrophoresis for the presence of an 
amplified DNA sequence.
2.14.4 Determining efficiency of ligation and packaging 
Lambda ZAPII
To test the quality of the packaged ligation products, 1/il 
of 500/il packaged reaction was plated with 200/il of XLI-Blue
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cells (OD60o=0*5) onto NZY agar plates in 3ml top agar, 
containing 12.5mM IPTG and 3mg/ml X-gal (in DMF). The plates 
were incubated at 37°C for 6 hours. Background (blue) plaques 
were less than 1X105 pfu/jxg of arms and positive plaques 
(white) were greater than 50 fold above background. The optimum 
test ligation was selected and the remaining sample was 
packaged.
Lambd? PASHII
To test the quality of the packaged ligation products, lul 
of each 500ul packaged reaction was serially diluted. The 
diluted packaged material was plated with 200jxl each of 
OD600=0-5 LE392 and P2392 cells in 3ml of top agar onto NZY 
agar plates. The percentage recombinants were determined from 
loss of sensitivity to P2 inhibition. The optimum test ligation 
was selected based on the highest titre on NM554 cells, and the 
remaining sample of the selected ligation was packaged.
PCM B MIHQ or EgCQHPIWAMT DMA LIBRARIES
2,15,1 put jpg ilfrrarit? ai>4 tripggfg tg wgabran»»
The packaged genomic DNA libraries were plated out onto 
150mm X 15mm NZY plates using the host strain NM554 at 
approximately 50,000 plaques per plate and were incubated 
overnight. The plates were chilled for 2 hours at 4°C. A 
nitrocellulose filter was placed onto each plate for 1 minute 
and were orientated by piercing through to the agar with a 
needle. A second transfer was performed for 4 minutes with a 
duplicate filter. The filters were floated on the surface of 
0.5M NaOH, 1.5M NaCl for 2 minutes to denature followed by 
neutralisation for 2 minutes on 1.5M NaCl, 0.5M Tris-HCl, pH 
8.0. The filters were then washed in 2X SSC (15mM NaCl, 15mM 
sodium citrate) for 5 minutes. The filters were blotted onto 
3MM paper and air-dried. The filters were baked at 80°C for 2
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hours in a vacuum oven prior to hybridisation with 
radiolabelled probe.
2.15.2 Hvbridiaatioa with radjoactivt probe
The nitrocellulose filters were incubated for 1 hour in 6X 
SSC, 0.5% (mass/v) SDS, lOmM EDTA, 5X Denhardts solution and 
lOOug/ml denatured salmon sperm DNA at 65°C. Abrin-related 
probe was radiolabelled by "random priming" and unincorporated 
dNTPs were removed. The probe was boiled for 5 minutes then 
placed on ice. The filters were removed from the
prehybridisation solution then incubated in 1ml/filter of 6X 
SSC, 0.5% (mass/v) SDS, 5X Denhardts solution, 0.01M EDTA, 
lOO^g/ml denatured salmon sperm DNA, 1x10s cpm/ml of 
radiolabelled probe at 65°C for 14 hours. The filters were 
removed, excess buffer allowed to drain, and washed in an 
excess volume of 2x SSC, 0.1% (mass/v) SDS at 65°C for 15 
minutes. The wash was repeated. The filters were washed in lx 
SSC, 0.1% (mass/v) SDS for 15 minutes at 65°C, followed by a 
final wash in 0.1X SSC, 0.1% (mass/v) SDS for 15 minutes at 
65°C. Excess buffer was allowed to drain, then the filters were 
placed between plastic wrap, marked with IBI Glo-Juice to 
orientate and exposed to X-ray film overnight at -80°C.
2.15.3 Purification of hvbridiaation-positiv plaqu«»
Hybridisation-positive regions were cored from the master 
plate using the wide end of a Pasteur pipette and a small 
secondary library was plated out. Plaques from the secondary 
plates were transferred to nitrocellulose filters and screened 
using the radiolabelled abrin-related probe. An isolated plaque 
was picked, replated and screened. This process was repeated 
until the desired hybridisation-positive plaque was pure. A 
pure plaque was used to prepare a phage lysate. The phage 
stocks of each positive clone was stored at 4°C.
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2.15.4 In vivo »xcigion protocol
Recombinant pBluescript plasmid was recovered from 
positive recombinant Lambda ZAPII clones by in vivo excision. 
Briefly, in a 50ml conical tube, 200nl of OD600=1 XLl-Blue 
cells were incubated with 200jil of phage stock (1 x 1 0 s pfu) and 
ljil of R408 helper phage for 15 minutes at 37°C. A 5ml volume 
of LB medium was added and the mixture was incubated at 37°C 
for 3 hours with shaking at 300rpm. The sample was heated at 
70°C for 20 minutes then pelleted at 4000g for 5 minutes and 
the supernatant was decanted. To plate the rescued phagemid 
lOfil of the phagemid supernatant was incubated with 200/il 
o d 600=1 XLl-Blue cells at 37°C for 15 minutes, then aliquots 
were plated out onto LB plates containing lOO/ig/ml ampicillin 
and incubated overnight at 42°C to remove any helper phage and 
allow colony formation. A single colony was streaked onto a 
fresh LB plate supplemented with lOO^g/ml ampicillin.
Recombinant pBluescript plasmid DHA was prepared and 
analysed by endonuclease restriction mapping. The inserts were 
fully characterised by DNA sequencing. Oligonucleotide primers 
were synthesised as required to extend the DNA sequence 
analysis.
2,19 m H i i l f l i  QT BgCQHPIUAyT FRPTMW IB Ei—QQLl
The steps involved in the construction of the expression 
vectors and the recombinant vector maps are presented in the 
results section (section 3.8).
2,19,1 <?Yt 9 P l« » P lg  ♦X PrfgflbB
E. coli host strain JM109 was transformed with the 
recombinant expression vector and a frozen stock was prepared 
from a positive transformant. A 1 litre volume of minimal media 
supplemented with lOO/ig/nl ampicillin was inoculated with 1ml
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of an overnight culture of JM109/expression plasmid in minimal 
media supplemented with 100/jg/ml ampicillin. The culture was 
grown to OD600=0.8 at 37°C with shaking at 300rpm. The culture 
was shifted to 30°C and induced by the addition of IPTG to ImM. 
The culture was grown for a further 3 hours, the OD600 was 
recorded and the cells were pelleted at 7000rpm in a Sorval 
8x500 rotor at 4°C for 10 minutes.
The cell pellets were resuspended at 20 OD60o units/ml in 
lOOmM Tris-HCl, pH 8.0, 5mM EDTA at 4°C. The suspension was 
sonicated at an amplitude of 1 8  microns for 1 minute intervals 
with cooling on ice until the sonicate became translucent. Cell 
debris was removed by centrifugation at 8 0 0 0 g for 10 minutes at 
4°C and the supernatant was recovered and stored at 4°C.
2.14.2 Periplasmic expression
A 1 litre culture of minimal media supplemented with 
lOO/xg/ml of ampicillin was inoculated with 1ml of an overnight 
culture of JA221 harbouring recombinant expression vector. The 
culture was incubated at 37°C with shaking at 300rpm until the 
°D6oo reached 0.8. The culture medium was supplemented with 2% 
caseamino acids, then induced with ImM IPTG. The culture was 
grown for another 3 hours, then the cells were pelleted at 
7000rpm in a Sorvall 6X500 rotor at 4°C for 10 minutes.
Periplasmic proteins were isolated by osmotic shock. The 
pelleted cells were resuspended in IX growth volume of lOmM 
Tris-HCl, pH 7.1, 30mM NaCl, then repelleted. The wash was 
repeated and the cells were resuspended in one third growth 
volume of 33mM Tris-HCl, pH7.1, 0.4mM EDTA, 20% (mass/v) 
sucrose and left at room temperature for 30 minutes. The cells 
were repelleted as before, then rapidly and vigorously 
resuspended in one growth volume of ice cold O.lmM MgCl2 . The 
solution was left on ice for 30 minutes. The shocked cell 
fraction was pelleted out and the supernatant containing 
periplasmic proteins was recovered and stored at 4°C. For small 
volumes (500/il) , the sample was concentrated by lyophilisation.
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and resuspended in polyacrylamide gel electrophoresis loading 
buffer prior to analysis. Protein from larger volumes was 
concentrated by ammonium sulphate precipitation.
2.17 ELECTROPHORETIC SEPARATION Of PROTEINg
The discontinuous buffer system of Laemmli (1970) was 
employed for protein analysis. Stock acrylamide containing 30% 
(mass/v) acrylamide and 0.8% (mass/v) bis-acrylamide was used. 
Resolving gels with a final concentration of 12% or 15% stock 
acrylamide were employed.
R egp lv in q  q e l mix
121 151
Stock acrylamide 16ml 2 0 ml
3M Tris-HCl, pH8.8 5b 1 5ml
10% (mass/v) SDS 0.4ml 0.4ml
h 2o  to 40ml 40ml
Polymerisation was initiated by the addition of 200/xl of 
10% (mass/v) ammonium persulphate and 20/il of TEMED.
Water-saturated isobutanol was layered on top of the 
resolving gel during polymerisation. Once the gel was set, the 
isobutanol was removed by washing with distilled water, and 
replaced with the polymerising stacking gel mix.
stacking gel mix
Stock acrylamide 1.3ml 
0.5M Tris-HCl, pH6.8 2.5ml 
10% (mass/v) SDS 0.1ml 
H20 to 1 0ml
Polymerisation was initiated by the addition of 50ul of 
10% ammonium persulphate (mass/v) and 5^1 of TEMED. A gel comb 
was inserted and the gel allowed to set. Once set, the comb was 
removed and the gel assembled into a vertical electrophoresis 
tank, with 25mM Tris-HCl, pH 8.8, l92mM glycine, 0.1% (mass/v) 
SDS in the top and bottom resevoirs.
For reducing SDS-PAGE, samples for analysis were combined 
with the appropriate volume of 10X loading buffer (50mM Tris- 
HCl, pH 6.8, 1% (mass/v) SDS, 10% (v/v) glycerol, 0.05% (v/v) 
B-mercaptoethanol, 1% (mass/v) methionine, 0.05% (mass/v) 
bromophenol blue) and boiled for 5 minutes then guenched on 
ice. For non-reducing SDS-PAGE the B-mercaptoethanol was 
omitted from the loading buffer.
Samples were then loaded and electrophoresed at 40mA until 
the dye front reached the bottom of the gel.
The molecular weight markers routinely used were pre­
stained protein standards or low range protein standards 
(Biorad) with molecular weights and for autoradiography the 
[14C]-methylated molecular weight standards were used 
(Amersham).
Low Range(Da) Prg-gtained(Dfl)
Rabbit muscle phoshorylase b 
Bovine serum albumin 
Hen egg white ovalbumin 
Bovine carbonic anhydrase 
Soyabean trypsin inhibitor 
Hen egg white lysozyme
97.400
6 6 , 2 0 0
45.000
31.000 
21,500
14.400
110,000
84.000
47.000
33.000
24.000
16.000
[14C]-methylated myosin 
[14C]-methylated phosphorylase-b 
[14C]-methylated bovine serum albumin 
[14C]-methylated ovalbumin 
[14C)-methylated carbonic anhydrase 
[14C]-methylated lysozyme
Daltons
200,000
97,400
69.000
46.000
30.000 
14,300
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2,18 DETECTION OF PROTBIN8
2. 1$ , l  Detection Qj  pr o f  in» in qflg
Coomassie blug staining
The gel apparatus was dismantled and the gel was stained 
in an excess volume of 10% glacial acetic acid, 40% methanol, 
0.25% (mass/v) Coomassie Brilliant Blue for 1-3 hours at room 
temperature. The gel was transferred to 40% methanol, 10% 
acetic acid and gently agitated until protein bands were 
clearly visible.
Silver staining
The gel apparatus was dismantled. Gels were incubated in 
50% (v/v) methanol for a minimum of 3 hours, then transferred 
to freshly prepared solution A (21ml of 0.36% (mass/v) NaOH and 
1.4ml of 14.8M ammonium solution were combined and added 
dropwise with stirring to 0.8g of silver nitrate in 4ml of 
water, then the volume was made up to 100ml with water) for 15 
minutes. The gels were washed with copious volumes of deionised 
water then transferred to solution B (2.5ml 1% (mass/v) citric 
acid and 0.25ml 38% (v/v) formaldehyde in 500ml of water) for 
15 minutes or until protein bands were clearly visible. The 
gels were then fixed in 10% (v/v) glacial acetic acid, 40%
(v/v) methanol for 1 hour.
Autoradiography
The gel was fixed in 30% (v/v) methanol, 10% (v/v) glacial 
acetic acid for 1 hour at room temperature. The gel was 
transferred to an excess volume of Amplify™ for 15 minutes at 
room temperature. The gel was dried under vacuum at 65°C onto 
Whatman 3MM paper then exposed to X-ray film for 4 hours to 
overnight at room temperature.
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2.18.2 Detection of proteine on nitrocellulose
W^stern_bl<?fc
Proteins were transferred to nitrocellulose by a 
modification of the method of Towbin et al. (1979). Gels were 
equilibrated in transfer buffer (25mM Tris-HCl, pH 8.3, 192mM 
glycine, 20% (v/v) methanol) for 15 minutes with gentle 
shaking. The gel was layered with an equal sized piece of 
nitrocellulose, then placed between 2 pieces of 3MM paper and 
the felt pads of the Biorad transblot apparatus. The apparatus 
was assembled and filled with transfer buffer. A 50 mA current 
was applied for 3 hours.
The apparatus was dismantled and the nitrocellulose was 
incubated in 50ml of TBST (50mM Tris-HCl, pH 7.5, 0.9% (mass/v) 
NaCl, 0.1% (v/v) Tween-20 containing 5% (mass/v) fat-free dried 
milk powder for 1 hour to block non-specific antibody binding 
sites. The nitrocellulose was transferred to 10ml block 
solution containing a 1:2000 dilution of rabbit anti-abrin C A- 
chain antibody and incubated at 37°C for 1-3 hours with gentle 
shaking. The filter was washed three times in 50ml TBST for 15 
minutes.
Alkaline phosphatase development system 
The ProtoBlot Alkaline Phosphatase System (Promega) was 
routinely used for Western blot analysis.
The washed filters were incubated in 15ml TBST containing 
2/xl anti-(rabbit IgG)-alkaline-phosphatase conjugate for 1 hour 
at room temperature. The filters were washed three times for 15 
minutes in 50ml TBST, then blotted damp dry on a piece of 3MM 
paper. The damp filters were transferred to 10ml colour 
development substrate solution prepared by the addition of 66/il 
of 50mg/ml nitroblue tétrazolium (in DMF) and 33/il of 50mg/ml 
5-bromo-4-chloro-3-indolyl phosphate (in DMF) to lOOmM Tris- 
HCl, pH9.5, lOOmM NaCl, 5mM MgCl2 - When the colour had 
developed to the desired intensity, the reaction was stopped by
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replacing the substrate solution with 20mM Tris-HCl, pH 8.0, 
5mM EDTA. The filter was then air dried.
r125I1-protein A development system 
After incubation with the primary antibody and washing, 
the filters were incubated in 10ml TBST containing lul [125I]- 
protein A (kindly provided by Dr P. Richardson, University of 
Warwick) overnight at room temperature, with gentle shaking.
The filter was then washed 5 times for 5 minutes in 50ml 
TBST, then placed between plastic film. The filter was marked 
with IBI Glo-Juice, then exposed to X-ray film for 1 week.
2.19 PURIFICATION 0F 80L0BLE RECOMBIHART A-CHAIN
2.19.1 Solubility
Solubility of recombinant proteins was determined by 
centrifugation at I08,000g for 1 hour at 4°C. The supernatant 
containing soluble proteins was recovered, and the pellet was 
washed with lOOmM Tris-HCl, pH 8.5, 5mM EDTA, then resuspended 
in an equal volume to the supernatant of lOOmM Tris-HCl, pH 
8.5.
9 -1 »? tmaoniurn sulphate precipitation
Concentration of recombinant abrin A-chain was performed 
using (NH4)2S04 precipitation. Solid (NH4)2S04 was added to the 
soluble fraction from cell sonicates (or periplasmic fractions) 
to 30% (mass/v) slowly at 4°C with stirring. The precipitated 
proteins were recovered by centrifugation at 15,000g for 15 
minutes at 4°C, then resuspended in one tenth precipitation 
volume of lOOmM Tris-HCl, pH 8.5, 5mM EDTA. The sample was 
filtered through a 0 .2 2 /im filter.
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The recombinant abrin A-chain was purified using an LKB 
DEAE-5PW UltraPac column (21.5X150mm) with a Beckman model 344 
HPLC system. The column was equilibrated with the starting 
buffer (lOmM NaCl, 5mM sodium phosphate buffer, pH 7.5), and a 
5ml volume of sample was applied. The column was washed with 
the starting buffer at 3ml/minute until the OD280 reached the 
baseline level. The bound proteins were eluted with a gradient 
from lOmM to 500mM NaCl over 2 hours at 3ml/minute and eluate 
was collected in 3ml fractions. The fractions were analysed by 
SDS-PAGE and Western blotting. Fractions containing A-chain 
were pooled and dialysed against lOmM NaCl, 5mM sodium 
phosphate buffer, pH 7.5.
3.^9,4 Plv»t gn>h«rp»f CL-$P gfaromtqgrirhY
Recombinant A-chain was purified to homogeneity by 
chromatography on Blue Sepharose CL-6B. A 30Xlcm column was 
packed with Blue Sepharose CL-6B resin, pre-swollen overnight 
in an excess of lOOmM NaCl, 5mM sodium phosphate buffer, pH7.5, 
at a flow rate of 0.275ml/minute. The column was equilibrated 
with starting buffer (lOOmM NaCl, 5mM sodium phosphate buffer, 
pH 7.5) and the baseline for OD28o was established, at a flow 
rate of 0.15ml/minute.
The A-chain sample was applied, and the column was washed 
at 0.15ml/minute with starting buffer until all non-bound 
materials had eluted, and the OD280 baseline was reached. A 
gradient to 500mM NaCl, 5mM sodium phosphate buffer, pH 7.5, 
was applied over 6 hours at 0.15ml/minute and 0.5ml fractions 
were collected. The fractions were analysed for A-chain by SDS- 
PAGE and Western blotting. The fractions containing A-chain 
were pooled and dialysed against PBS.
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2.2 0 A88AY FOR IN V I T R O ACTIVITY OF RIPB
3.20.1 Sait-washing fiboaomeg
To remove bound elongation factors and aminoacyl-tRNAs, 
ribosomes were washed in 0.5M KC1 (Blobel, 1971). Ribosomes 
were incubated at a final concentration of 2mg/ml in 50mM Tris- 
HC1, pH 7.5, 0.5M KC1, 5mM MgCl2 for 1 hour on ice. The 
ribosomes were pelleted at 108,000g, at 2°C for 40 minutes. The 
supernatant was removed and the ribosomes were washed twice in 
1 X TEP buffer (3.6mM Tris, 3mM NaH2P04, 0.2mM EDTA). The 
washed ribosomes were resuspended at lnq/nl in 1 X TEP buffer.
in vitro m u
Incubation with RIP and anil in? treatment
Aliquots containing appropriate dilutions of abrin A-chain 
(or PAP or ricin A-chain as a control) in PBS were incubated 
with 1 0 /ig of salt washed ribosomes in a 30/il reaction volume 
for 2 minutes at 30°C. The reaction was stopped by the addition 
of 60/il of water and 10^1 of 10% (mass/v) SDS. The sample was 
extracted with phenol three times and the RNA was recovered by 
ethanol precipitation. The pellet was washed twice with 70% 
ethanol, dried under vacuum and then resuspended in water at 
lnq/nl. A 2/xl volume was incubated with 20jil of aniline/acetic 
acid, pH 4.5 at 60°C for 2 minutes, then placed on ice. The 
rRNA was recovered by ethanol precipitation, and the washed 
pellet was resuspended in 20/il 60% (v/v) formamide, pH 6.8, 0.1 
X TEP buffer.
Gel analysis <?f BMA
A gel containing 1% agarose in 50% (v/v) formamide, 0.1 X 
TEP buffer was cast and assembled in a horizontal gel 
apparatus. The reservoir tanks were filled with 0.1 X TEP 
buffer to the upper level of the gel. The samples were heated 
to 65°C for 5 minutes, then quenched on ice. One fifth volume
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of 50% (v/v) glycerol, 0.01% (mass/v) bromophenol blue was 
added and the samples were loaded. Electrophoresis was 
performed at 20mA until the dye front reached two thirds the 
length of the gel. The RNA was visualised by staining the gel 
in 1 litre of water containing O.Olmg/ml ethidium bromide with 
gentle agitation for 30 minutes. The gel was destained in 
deionised water for 3 hours with several changes of water and 
then photographed.
3-.21 IE VITRO TRAMgCRIPTIQH AWP TRAEgLftTIPH
3 »31 .l-Jn. vitr<?
The construction of the vector for transcription in vitro 
is described in the results section (3.11.1).
The recombinant transcription vector was linearised using 
EcoRI. The DNA was recovered by ethanol precipitation and
resuspended in water at lmg/ml. The linear DNA templates (2pq) 
were transcribed in 40mM HEPES, pH 7.5, 6mM magnesium acetate, 
2mM spermidine, 100/xg/ml BSA, lOmM DTT, 0.5mM each UTP, ATP, 
CTP, 0.0 5mM GTP, 0.5 pCi [32P]-UTP, 50 units RNAsin, 0.5mM
7me5GpppG50H with 20 units SP6 polymerase at 37°C. After 30 
minutes dGTP was added to 3mM and the reaction mix was 
incubated for a further 30 minutes. An aliquot was removed and 
the percentage incorporation of radiolabel was determined. The 
RNA was extracted with phenol and recovered by ethanol 
precipitation. The pellet was taken up in water at lOO^g/ml.
2 .2 1 . 2  Rabbit reticulocyte lvsat» in vitr<? tliMlitifi»
system
The RNA template was heated to 67°C for 10 minutes then 
placed on ice prior to translation. A 2pl volume of RNA was 
incubated in 35pl nuclease treated reticulocyte lysate 
(Promega) , 50 units RNAsin, Ipl lmM L-aminoacid mixture minus
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methionine and 4/il [35S]-methionine (60/iCi) in a 50^1 reaction 
volume at 30°C for 1 hour. The reaction was stopped by the 
addition of 10X SDS-PAGE loading buffer. The products of 
translation were analysed by SDS-PAGE and autoradiography.
f.jf TRANSLATION IN X. IhEVIS OQQYTB6
2.22.1 Oocyte injection and fepgpgepien U P S
A 30nl volume of in vitro transcribed mRNA at lnq/nl was 
injected per oocyte and 25 oocytes were injected per mRNA 
species. Each set of 25 oocytes were incubated at 14°C in 200^1 
Barth's saline supplemented with lOmg/ml penicillin and lOmg/ml 
streptomycin plus 50MCi [35S]-methionine overnight.
The media was removed using a Pasteur pipette and the 
oocytes were washed twice in 200^1 of Barth's saline. The 
washed oocytes were placed in 1ml oocyte homogenisation buffer 
(OHB) which consisted of 20mM Tris-HCl, pH 7.6, 0.1M NaCl, 1% 
(v/v) Triton X-100 and ImM PMSF and were homogenised in a 
ground glass homogeniser. The sample was transferred to a 
microfuge tube and pelleted for 5 minutes to separate out the 
lipid, aqueous and particulate fractions. The aqueous fraction 
was recovered to a fresh tube.
Determinination of Solubility
To determine the solubility of the B-chain a 40/il volume 
of the aqueous phase (equivalent to one oocyte) was pelleted at 
100,000g at 4°C for 1 hour. The supernatant was recovered to a 
fresh tube and the pellet was resuspended in 200/il of OHB and 
the centrifugation was repeated. The supernatant was recovered 
and pooled and the pellet was resuspended in 500jil OHB. The 
samples were immunoprecipitated (see below) and analysed by 
SDS-PAGE and autoradiography.
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i m m u n o p r é c i p i t a t i o n
Prior to immunoprécipitation all sample volumes were made 
up to 500ul with OHB. To each 500/xl sample, an equal volume of 
immunoprécipitation buffer (IPB) consisting of 0.1M Tris-HCl, 
pH 7.6, 0.1M KC1, 5mM MgCl2 , 1% (v/v) Triton X-100, 0.5% 
(mass/v) SDS, 10% (mass/v) deoxycholate free acid, (adjusted to 
pH 8.2 with 5M NaOH) , was added. The sample was mixed gently 
then 5-10/il of the required anti-sera or antibody, and 40/il of 
protein A-Sepharose were added. The samples were rotated gently 
for 2 hours at room temperature. The Sepharose beads were 
pelleted for 10 seconds in a microfuge and the supernatant was 
discarded. The beads were washed 4 times in IPB and then 
suspended in 4 0/il of SDS-PAGE loading buffer. The samples were 
boiled for 2 minutes, quenched on ice then pelleted briefly. 
The supernatant was analysed by SDS-PAGE and autoradiography.
3.22.2 Assay for l.ctln «Ctlyltï
Immobilised lactose column
A lcm by 10cm column was packed with 0.5ml lactose 
immobilised on aminoethylated polyacrylamide beads. The column 
was equilibrated with 5ml OHB. A 2 00/il volume of aqueous 
homogenate was made up to 1ml with OHB and passed down the 
column. The eluted sample was then repassed down the column 
twice. The column was washed with 3ml OHB and 1ml fractions 
were collected. Any bound protein was eluted with 3ml OHB 
containing 50mM lactose and 1ml fractions were collected. The 
procedure was carried out at 4°C. A 500/il volume of each 
fraction was immunoprecipitated and analysed by SDS-PAGE and 
autoradiography.
Asialofetuin Plate assay
To the wells of a 96 well microtitre plate, 300/il of 
lmg/ml asialofetuin in 0.1M NaHC03, pH 9.2, was added and the 
plate was stored at 4°C for at least 6 hours to allow the 
asialofetuin to bind. The asialofetuin was removed and each
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ImrounQprggipitflt ion
Prior to immunoprécipitation all sample volumes were made 
up to 500ul with OHB. To each 500/il sample, an equal volume of 
immunoprécipitation buffer (IPB) consisting of 0.1M Tris-HCl, 
pH 7.6, 0.1M KC1, 5mM MgCl2, 1% (v/v) Triton X-100, 0.5%
(mass/v) SDS, 10% (mass/v) deoxycholate free acid, (adjusted to 
pH 8.2 with 5M NaOH) , was added. The sample was mixed gently 
then 5-10/il of the required anti-sera or antibody, and 40/xl of 
protein A-Sepharose were added. The samples were rotated gently 
for 2 hours at room temperature. The Sepharose beads were 
pelleted for 10 seconds in a microfuge and the supernatant was 
discarded. The beads were washed 4 times in IPB and then 
suspended in 40/il of SDS-PAGE loading buffer. The samples were 
boiled for 2 minutes, quenched on ice then pelleted briefly. 
The supernatant was analysed by SDS-PAGE and autoradiography.
3,32.2 A?aly fçg ltçtih içUYltY
Inmpfrilised lagtpsg gplumn
A lcm by 10cm column was packed with 0.5ml lactose 
immobilised on aminoethylated polyacrylamide beads. The column 
was equilibrated with 5ml OHB. A 200/il volume of aqueous 
homogenate was made up to 1ml with OHB and passed down the 
column. The eluted sample was then repassed down the column 
twice. The column was washed with 3ml OHB and 1ml fractions 
were collected. Any bound protein was eluted with 3ml OHB 
containing 50mM lactose and 1ml fractions were collected. The 
procedure was carried out at 4°C. A 500/il volume of each 
fraction was immunoprecipitated and analysed by SDS-PAGE and 
autoradiography.
Asialofetuin Plate assay
To the wells of a 96 well microtitre plate, 300/il of 
lmg/ml asialofetuin in 0.1M NaHC03, pH 9.2, was added and the 
plate was stored at 4°C for at least 6 hours to allow the 
asialofetuin to bind. The asialofetuin was removed and each
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well was filled with blocking solution consisting of PBS, 0.05% 
(mass/v) BSA and 0.05% (v/v) Tween-20. The plate was stored at 
4°C overnight. Just prior to the assay the blocking solution 
was removed.
A 2 00/il volume of oocyte homogenate was added to each well 
and incubated at room temperature for 2 hours. The sample was 
removed and the wells were washed three times with PBS. A 1 in 
50 dilution of sheep anti-ricin B-chain antibody, which had 
previously been shown to cross react with the abrin B-chain, in 
blocking solution was made and 250/xl was then added to each 
well. The plate was incubated at room temperature for 2 hours. 
The antibody was removed, the wells were washed three times 
with PBS then 250/il of a 1 in 250 dilution of [ 125I]-Protein G 
(kindly provided by Dr R. Wales, University of Warwick) in 
blocking solution was added. The plate was incubated for 2 
hours at room temperature. The wells were washed four times 
with PBS before counting in a Gamma counter.
To obtain a standard curve for the assay, purified ricin 
B-chain (at 5mg/ml) was diluted accordingly and used as a 
positive control in place of the oocyte homogenate. Each 
control and test sample was assayed in triplicate.
2.22.3 Reassociation of B-ch»in with r+goafrinan* A-gh»ln
At least 2nq i.e. a 50 fold excess, of either recombinant 
abrin A-chain or recombinant ricin A-chain were added to 200m 1 
of homogenate and the volume was made up to 500/il with OHB. The 
samples were rotated for at least 4 hours at 4°C. To determine 
any reassociation with A-chain the samples were divided and 
immunoprecipitated with anti-ricin A-chain antibodies. The 
immunoprecipitated protein was analysed by reducing and non­
reducing SDS-PAGE and autoradiography.
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3.RESULTS AMD DISCUSSION
?•! PREPARATION AMP ANALYSIS Of flQQHIg PMft
3.1.1 Preparation of qenoaic A. precatorius DNA
Leaves from A. precatorius were harvested in southern 
Florida onto solid C02 for shipment and were stored at -70°C. 
Approximately 3.5mg of high molecular mass DNA was obtained 
from lOg of frozen A. precatorius leaf tissue. This yield was 
considerably lower than the yield of DNA obtained from frozen 
M . charantia tissue using the same method. Several factors 
could have influenced the yield of DNA including the DNA 
content, the number of cells/g tissue, water content and the 
growth state of the leaves. A. precatorius leaves are small and 
of low water content which made the grinding difficult and 
inefficient. The method of DNA extraction used, modified from a 
procedure described by Taylor and Powell (1983), removed the 
majority of contaminants such as polysaccharides, polyphenols 
and pigments which can co-purify with the DNA and interfere 
with cloning efficiency for plant DNA. Generally the efficiency 
of cloning of plant DNA is reduced by one- to three-fold lower 
than that of bacterial and animal DNA
All the type II ribosome-inactivating proteins that have 
been sequenced to date lack introns (Hailing et al., 1985) and 
the plant lectin genes sequenced to date lack introns. The 
soybean lectin gene (Vodkin, 1983) and Phaseolus vulgaris 
lectin genes (Hoffman, 1984 and Hoffman and Donaldson, 1985) 
all lack introns. In addition certain other plant genes lack 
introns which include all the genes which have been sequenced 
for the maize storage protein (zein), (Pederson et al. , 1982 
and Hu et al., 1982). It was therefore highly probable that 
abrin-related genes would also lack introns.
The genomic DNA cloning approach overcame the problem of 
obtaining mRNA from developing seeds. The temporal expression 
of ricin in the developing seed has been studied (Tregear,
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therefore suggest that abrin-related mRNAs would also be 
relatively abundant during late seed maturation. However, 
obtaining developing seeds would have been difficult and 
genomic DNA can be isolated from the more convenient leaf 
tissue.
3.1.2 Digestion pf.qenomjc DHft
Figure 7 shows genomic A. precatorius DNA digested to 
completion with a variety of restriction enzymes. The 
restriction enzymes chosen were selected for the presence of 
their recognition sites in the cloning site of the lambda phage 
vectors Lambda ZAPII and Lambda DASHII. Lane 12 shows uncut 
DNA which is approximately 50kb in size. Sizing of the uncut 
DNA, on a sucrose gradient for example, to remove the smaller 
DNA fragments was omitted to avoid further handling of the high 
molecular mass DNA. The planned method, of generating a probe 
by PCR and of generating lambda phage libraries using a 
complete digest of the genomic DNA, circumvented the need to 
remove the smaller fragments.
Digestion of the genomic DNA with each of the restriction 
endonucleases used led to loss of the very high molecular mass 
DNA showing that the method employed for isolation of genomic 
DNA yielded DNA which was pure enough for digestion by the 
majority of restriction endonucleases. Digestion with Notl 
(lane 5), which recognises an octanucleotide sequence, 
generated significantly less of a smear. There are bands of DNA 
visible against the background smear which is indicative of 
repetitive DNA.
Figure 7 Restriction endonuclease analysis of genomic A. 
precatorius DNA Approximately 10ng of A. precatorius DNA was 
digested with various restriction endonucleases. Lanes 1-11, 
BamHI, EcoRI, HindiII, Ncol, NotI, PstI, SacI, Sail, Spel, Xbal 
and Xhol respectively; lane 12, uncut DNA; lane 13, 
lamïxia/Hindi 11 DNA markers
1 2 3 4 5 6 7 8  910111213
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3.2 GENERATION OF AM ABRIN-8PECIFIC PROBE
3.2.1 Primer design for polymerase chain reaction
The complete amino acid sequence of abrin C A-chain was 
used to design primers for PCR on genomic DNA. The protein 
sequence data were converted into degenerate nucleic acid 
coding sequence by reverse translation using the universal 
genetic code. Figure 8 and 9 show the complete sequence of 
abrin C A-chain converted into mRNA and cDNA respectively. An 
N-terminal region and an internal region, each approximately 12 
amino acids long, were selected for primer design.
Previous experiments carried out using shorter primers (25 
mers) on M. charantia genomic DNA, in PCR, were unsuccesful due 
to a high background of product generated from non-specific 
priming. Longer primers were therefore designed (30-35 mers) to 
reduce non-specific binding. Figure 10 shows the design of the 
primers that were synthesised. To reduce the overall complexity 
of each primer pool, deoxyinosines were included at certain 
positions where all four nucleotides were possible. Inosine is 
occasionally found in the first position of tRNA anticodons 
(Crick, 1966) and is known to form base pairs with A, C and U. 
Ohtsukan et al. (1985) have shown that deoxyinosine residues in 
an oligonucleotide sequence do not seriously disturb DNA duplex 
formation nor destabilise the duplex. Deoxyinosine 
substitutions were distal to the 3' end to ensure specific 
binding and each primer ended with a GC pair to stabilise the 
3' end for primer extension during PCR. The inclusion of 
deoxyinosines reduced the number of primers in pool ABR-N from 
3,145,728 to 3,078 and in primer pool ABR-INT from 104,704 to 
781. The codon usage in plants does not show a significant bias 
(for review see Brown, 1990) therefore the number of isomers 
could not be reduced further by omitting particular codons.
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Figure 8 Reverse translation of the primary sequence of abrin C 
A-chain into mRNA The primary sequence is numbered according to 
the published sequence (Funatsu et al., 1988). The mRNA 
sequence is shown below where N represents A, C, G or U, R 
represents A or G, Y represents U or C and H represents A, C or 
U. The domain selected for primer design is shown underlined
Figure 9 Reverse translation of the primary sequence of abrin C 
A-chain into complementary DNA The primary sequence is numbered 
according to the published sequence (Funatsu et al., 1988). The 
complementary DNA sequence is shown below where N represents A, 
C, G or T, R represents A or G, Y represents T or C and H 
represents T, C or A. The region selected for primer design is 
shown underlined
eiu *»pArgPro11. tywPh.*«rTil«uGlyAlaThrSar GinTCI TO TO
*«r Tyrl»acmPh.11aGluAl.Lau*rgcmArgL«Arg Gly
TCJt GAWTCT TCTGAWTCT
■ la 11aProValLau ProThrThr LauTAD“T* TADcowCAWCAWGCW CW
Gin GluArgAanArg Tyr11.ThrvalGluLauSarAanSar Aap
TCT TCT GAWTO TO
Thr GluSar11.GluValGly11aAapval- »laTyr val
TO
Val AlaTyrArgAlaClyThrGinSarT»r77LauArgAap AlaTO CAWTCT
SarAl.SarAapTyrLau"7ThrGlyThrA.PGin liaTOTO TO GAW
Sar 1«ProPhaTyr ClyThrTyr«JrA»P\Tt'cmArgTrp AlaTO CAW GAW
■la GinSarArgGinGin11aProLauClyLauGinAl.Lau Thr.lk -1»TOTCT CAW CAW
■la 01»I laSarPh.Ml*ArgSarGlyCly ‘SA«Clu CluTO TCTTO
ArgThrLau11aval if*»}•01"17-valAlaClu AlaTCT CAW
Ala ArgPhaArgTyr11»SarAanArgvalArgv.l sarIla Gin
tct TCT TO TCT TCT TO
Thr Gl» TCW CW £ E CTYProGWCTWCGW -T& IS-Si-Si
ttHft43- •»LauArgGCWClyCW GTGluCTSarValGin AapLAWTCT TO
Thr phaProAanGinValThrLauThrAan11.ArgAanGlu Pro
GAW TCT
v.l 11.ValAapSarLauSarHI. ProThrValAl.V.lLau Al.TOGAWTO GAW
Lau HatAAV TAC USValAO£2 Pro
119
Figure 10 Degenerate oligonucleotide primer design The N- 
terminus and internal regions of abrin C A-chain selected for 
primer design are numbered according to the published sequence 
(Funatsu et al., 1988) and the primer pools that were 
synthesised are shown below. The orientation of the primers is 
indicated with primer pool ABR-INT representing complementary 
DNA. Nucleotides included at each position are listed 
vertically and positions chosen for deoxyinosine substitutions 
(I) are shown
Primer pool ABR-N
11 23Gly Ala Thr Ser Gin 8 er Tyr Lys Gin Phe Ile Glu Ala 
5 /- QGG GCG ACI III CAA III TAT AAA CAA TTT ATT GAA GC -3' 
A A  G C G G C C G
T T AC C
Primer pool ABR-INT
190 200
Ala Met Ile Ser Leu Glu Asn Asn Trp Asp Asn
3'- CGG TAC TAA III IAI CTT TTA TTA ACC CTA TT -5'A A T A G G G
T GC
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)-i'i polymerase cfrain f««ctloB
The primer pools ABR-N and ABR-INT were used in PCR on 
genomic A. precatorius DNA template. Figure 11A shows analysis 
of the PCR products by agarose gel electrophoresis using 
different temperatures for annealing and denaturation. Lane 5 
shows the major product of 570bp using the standard conditions 
for PCR of denaturation at 92°C, annealing at 50°C and 
extension at 72°C. A 570bp fragment was the expected size based 
on placement of the primers on the derived coding sequence of 
abrin C A-chain. The major effect on the amount of PCR product 
was temperature of annealing: at 40°C (lane 4) and at 58°C 
(lane 8) a 570bp product was not detected on agarose gels 
stained with ethidium bromide, whereas a 570bp product was 
clearly visible at annealing temperatures of 42°C (lane 3) and 
48°C (lane 2). The amount of 570bp product was not improved by 
increasing the denaturing temperature from 94°C to 98°C for the 
first 5 cycles (lane 7) indicating that the genomic DNA was 
fully denatured at the lower temperature of 92°C, for 1 minute.
When the primers were labelled prior to PCR with *-[32P] 
the 570bp fragment was radiolabelled as determined by 
autoradiography of the PCR products on agarose gel shown in 
Figure 11B. The smear of radiolabelled product larger than 
570bp is due to the long form PCR products derived from primer 
extension on the original genomic DNA template. It is also a 
possibility that the primers may be annealing to separate and 
distinct genes on the genomic DNA template, generating a PCR 
product extending from the 5' end of an upstream abrin-related 
gene, across any intervening sequence, to the internal domain 
of a second downstream abrin-related gene. Two faint bands of 
approximately 1.35kbp and l.Okbp which appear as more of a 
smear are too small to be due to annealing to distinct separate 
genes.
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Figure 11 Analysis of the products of PCR using primers ABR-N 
and ABR-INT on genomic DNA template A standard PCR was carried 
out as described (section 2.7.1) and 5% of the end-reaction 
volume was analysed by agarose gel electrophoresis. The effect 
of the temperature of annealing and of denaturation was 
determined empirically (A): lane 1, no primers or template in 
PCR; lanes 3-5, annealing at 42°C, 40°C and 50°C respectively; 
lanes 6 and 10, *?X174/HaeII (1.4kb, l.lkb, 0.8kb, 0.6kb, 0.3kb, 
0.28kb, 0.23kb, 0.2kb and 0.12kb); lane 7, denaturation at 
94°C; lanes 8 and 9, annealing at 58°C and 50°C respectively. A 
standard PCR was carried out using tf-32P-radiolabelled primers 
and the products were analysed on agarose gel and visualised by 
autoradiography (B) : lane 1, <5>X174/Haell DNA markers; lane 2, 
radiolabelled PCR products. The arrow indicates the 570bp 
product
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3-3.3 Analysis of 570bp tr.qmant
The 570bp fragment was sequenced directly as described 
(section 2.8.2). The derived amino acid sequence from the 
determined nucleic acid sequence was closely related to abrin C 
A-chain confirming that the 570bp fragment was abrin-related. 
To produce large amounts of the fragment for radiolabelling for 
use as a probe, the 570bp fragment was subcloned: PCR was 
repeated using the linker extended primers ABR-NX and ABR-INTX 
shown in Figure 12, the fragment was isolated and subcloned 
into the Bluescript vector. The original primer pool design was 
used but each primer was extended at the 5' end with a linker 
which would generate the recognition sites for Xhol at the 5' 
end and SacI I at the 3' end of the PCR product. These two 
restriction endonucleases were selected since they cut genomic 
A. precatorius DNA less frequently than the other restriction 
endonucleases analysed. The primer sequence derived from abrin 
C A-chain was shortened to 6 amino acids to circumvent the use 
of deoxyinosine substitutions and ensure specific priming. The 
primers ABR-NX and ABR-INTX were used in a standard PCR 
reaction on genomic DNA template, the 570bp fragment was 
recovered from agarose gel, digested sequentially with Xhol and 
SacII then subcloned into pBluescript SK+. This allowed the 
insert to be fully sequenced and the sequence obtained is shown 
in Figure 13. The sequence obtained was identical to and 
extended the sequence determined from direct sequencing of the 
570bp PCR product. The abrin-related probe was removed from the 
vector by digestion and was recovered from agarose gel prior to 
radiolabelling by random priming.
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Figure 12 Linker-extended degenerate oligonucleotides, ABR-NX 
and ABR-INTX The coding sequence of abrin C A-chain is numbered 
according to the published sequence (Funatsu et al., 1988) and 
the primer pools that were synthesised are shown below. The 
orientation of the primers is indicated with primer pool ABR- 
INTX representing complementary DNA. Nucleotides included at 
each position are listed vertically. The linker regions, to 
generate restriction endonuclease recognition sites, are 
underlined
Primer pool ABR-NX
17 23
Tyr Lys Qln Phe Ile Glu Aie 
5 /- GG CTC GAG TAT AAA CAA TTT ATT G AA GC -3'
Xhol C G G C C G
A
Primer pool ABR-INTX
194 200
Leu Glu Asn Asn Trp Asp Asn 
3'- AT CTT TTA TTA ACC CTA TTQ GCG CCQ G -5'
C C G G G SacII
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Figure 13 Nucleotide sequence of the 570bp abrin-related probe 
The nucleic acid sequence is numbered starting with the first 
nucleotide deduced within the 570bp fragment. One long 
continuous open reading frame was obtained on translation and 
this is shown below. The homologous region from abrin C A-chain 
is shown in italics. Amino acid changes between the abrin- 
related probe and abrin C are highlighted
1 CTT CGA CAG AGA CTA ACA GGT GGG CTG ATA CAT GGC ATA CCT 42
Leu Arg Gin Arg Lau Thr Gly Gly Lau Zla Bis aly lie Pro
Leu Arg Glu Arg Lau Arg Gly Gly Lau H e sis Asp H e Pro
43 GTG CTT CCA GAT CCA ACA ACA TTG CAA GAA AGA AAT CGA TAT 84
Val Lau Pro Asp Pro Thr Thr Leu Gin Glu Arg Aan Arg Tyr
Val Leu Pro Asp Pro Thr Thr Leu Gin Glu Arg Asn Arg Tyr
85 ATT TCA GTC GAA CTC TCA AAC TCG GAT ACG GAA TCT ATC GAA 126
11« Car Val Glu Lau Ser Aan ser Aap Thr Glu Ser lie Glu
lie Thr Val GlU Lau Ser Aan ser Aap Thr Glu Ser H e Glu
127 GCA GGT ATC GAT GTG AGT AAT GCA TAT GTT GTA GCA TAC CGA 168
Ala ciy I la Aap val Ser Aan Ala Tyr val Val Ala Tyr Arg
val Gly lie Asp Val Thr Asn Ala Tyr val Val Ala Tyr Arg
169 GCA GGA AAT CGG TCT TAT TTC CTC CGT GAT GCC CCA ACA GCT 210
Ala Gly Abo Arg Ser Tyr Phe Lau Arg Aap Ala Pro m ¡H!
Ala Gly Thr Gin Sar Tyr Phe Lau Arg Asp Ala Pro Ser Ser
211 GCA TCT AGG TAC CTT TTC ACT GGC ACG CAG CAG TAC CTC GCT 252
Ala Sar Tyr Lau Pha Thr Gly Thr Gin tyr f u  XI.
Ala Sar Asp tyr Leu Phe Thr Gly Thr Asp Gin His Ser Leu
253 TCG TTT AAT GGT AGT TAT ATT GAT CTA GAG AGA TTG GCT CGT 294
ear Phe Aan Gly Sar Tyr lie Aap Leu Glu Arg teu Ala Axg
Pro Phe Tyr Gly Thr Tyr Gly Asp Leu Glu Arg Trp Ala His
295 CAG ACA AGA CAG CAA ATA ccc CTG GGG TTA CAG GCC TTG AGA 336
Gin The Arg Gin Gin lie Pro Leu Gly Lau Gin Ala Leu Arg
Cln Ser Arg Gin Gin H e Pro Lau Gly Leu Gin Ala Leu Thr
337 CAT GCA ATA TCG TTT TTC TCG AGA GGT GGA CTG ATG ATC GAA 378
His Ala H e Ser Phe Phe Sar Arg Gly Cly beu MET lie Glu
Him Gly lie Ser Phe Phe Arg Sar Gly Gly Asn Asp Asn Glu
379 GAA ATA GCG CGT ACC CTG ATC GTG ATA ATC CAA ATG GCT TCA 420
GlU lie Ala Arg Thr Leu lie Val lie lie Gin MET Ala Ser
Glu Lye Ala Arg Thr Leu lie Val H e H e Gin Met Val Ala
421 GAA GCA GCT CGA TAC AGG TTC ATA TCA TAC CGG GTT GGT GTC 462
Glu Ala Ala Arg Tyr Arg Phe Ila Sar Tyr Arg Val oly val
Glu Ala Ala Arg Phe Arg Tyr lie Ser Asn Arg Val Arg val
463 AGO ATC CGA ACT GGT ACG GCG TTT CAA CCT GAT GCT GCA ATG 504
Sar lie Arg Thr Gly Thr Ala Phe Gin Pro Aap Ala Ala MET
Ser lie Gin Thr Gly Thr Ala Phe Gin Pro Asp Ala Ala Met
Several distinct isoforms of abrin have been described and 
therefore the 570bp fragment may have been derived from several 
of the abrin genes. If this had been the case the sequence 
obtained from direct sequencing of the PCR product would 
expected to have been mixed. Only a single sequence was 
detected, therefore, although subcloning would select only one 
DNA molecule from the many within each pool from PCR, this 
cloned fragment would be representative of the most abundant 
amplified DNA. This was confirmed by the sequencing of the 
cloned fragment which was 100% identical with the sequence 
obtained from the entire pool of 570bp fragments.
3.3 8QPTBBRM BLOT ANALYSIS
A Southern blot of genomic A. precatorius DNA digested 
with a variety of restriction endonucleases and probed with the 
abrin-related 570bp fragment is shown in Figure 14. Lane 12 
confirms that a proportion of uncut DNA is of high molecular 
mass. It is apparent that digestion with Notl (lane 5) , PstI 
(lane 6), Sail (lane 8) and Xhol (lane 11) generated positive 
hybridising bands of relatively high molecular mass and would 
be unsuitable for use for library generation in standard lambda 
phage libraries. Digestion with Sail (lane 7) gave a smear of 
positive hybridising DNA but no distinct bands were visible. Of 
the remainder, digestion with EcoRI (lane 2) gave a good range 
of positive hybridising bands from 0.5kbp to lOkbp and EcoRI 
can be used to linearise both lambda ZAPII and lambda DASHII.
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Figure 14 Southern blot analysis of A. precatorius genomic DNA 
Genomic DNA (lOpq) was digested with a variety of restriction 
endonucleases, electrophoretically separated on 0.8% 
agarose/TAE gel and transferred to nitrocellulose. 
Radiolabelled abrin-related 570bp fragment was used as probe. 
Lanes 1-11, DNA digested with BamHI, EcoRI, Hindlll, Ncol, 
Notl, PstI, SacI, Sail, Spel, Xbal and Xhol respectively; lane 
12, uncut DNA
1 2 3 4 5 6 7 8 9 101 112
0 .6-
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The results of the Southern blot indicate that the genome 
size of A. precatorius is compatible with standard lambda 
phage library banks: as a crude estimate for a genome size of 3 
x 1010bp, with approximately 1 x 1 0 5 genes each on average lkb 
in size, a single copy gene will be represented by lOpg out of 
10/xg genomic DNA which is detectable by Southern blot. The 
presence of several positive hybridising bands in several 
tracks indicates that there are at least five abrin-related 
genes which was expected from the number of isoforms of abrin 
described previously (Lin et al., 1981).
3.4 GENERATION OF LAMBDA LIBRARY BANES
3.4.1 A»plified/Oigapack gold packaged libraries
Initially all library banks were generated using Gigapack 
Gold (Stratagene) packaging extracts and the host strain XLI- 
Blue. The packaged library was subjected to a single round of 
amplification, before plating out, to generate a high titre 
library for screening. Several million plaques were screened 
from both a lambda ZAPII and a lambda DASHII library and no 
positive-hybridising plaques were obtained after secondary 
screening.
The Southern blot indicated that there were several abrin- 
related genes, and that the genome size was compatible with 
standard lambda phage libraries so lack of any positive- 
hybridising plaques was unexpected. Although the efficiency of 
cloning of plant DNA is generally lower than for animal or 
bacterial DNA due to contamination of the DNA, in particular 
with polysaccharides, the plant DNA here was sufficiently pure 
to allow digestion by a wide variety of restriction 
endonucleases.
A possible cause may have been the round of amplification 
used since not all recombinant phage will amplify to the same 
titre and this may have led to under-representation of
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sequences of interest. However, in addition to this, 
methylation-dependent restriction systems may be relevant. 
Plant DNA is often highly methylated: up to 50% of all 
cytosines may be methylated including 80% of CG and C^/^G 
sequences (van Etten et al., 1988 and Blumental, 1989). The 
modified cytosine restriction (Mcr) system (Vanyushii and 
Kernos, 1988) may therefore be of particular importance: on 
introduction to mcr+ E.coli the more heavily methylated DNA 
will be preferentially restricted.
3.4.2 pacfctqinq with Mcr" »xtgacti
A new commercially available packaging extract became 
available called Gigapack II Gold which was prepared from acr~ 
E. coli. To determine if Mcr restriction and amplification were 
leading to loss of representation of sequences of interest 
within the libraries, PCR was used to confirm the presence of 
abrin-related sequences. PCR was carried out using primer pools 
ABR-N and ABR-INT on Ifil of a 1 to 100 dilution in water of 
either a Gigapack Gold packaged and amplified library, or a 
Gigapack II Gold packaged library without amplification, in a 
standard reaction. Figure 15 shows analysis of the PCR products 
on agarose gel and a 570bp band is visible only when the 
template was from Gigapack II Gold packaged DNA and prior to 
amplification (lane 3). A Southern blot of this gel probed with 
the radiolabel led 570bp fragment indicated that a very faint 
band was present in the Gigapack Gold packaged and amplified 
library (lane 2) however since the titre of this library was 
several fold higher than the Gigapack II Gold packaged library 
it was clear that the modified cytosine restriction system 
and/or the amplification step was leading to a significant 
under-representation of abrin-related sequences.
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Figure 15 Analysis of packaged libraries for sequences of 
interest by PCR A Ipl aliquot of a 1 in 100 dilution of 
packaged library extract was used as template in PCR using 
primers ABR-N and ABR-INT. 5% of the end-reaction mix was 
analysed by agarose gel electrophoresis. Lane 1, $X174/tfaeJJ 
DNA markers; lane 2, Gigapack Gold packaged and amplified 
library extract; lane 3, Gigapack Gold II packaged, unamplified 
library extract
1 2 3
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Libraries were generated using the Gigapack II Gold 
packaging extract and were plated out for filter lifts without 
an amplification step. Table 3 below, shows the titres, 
efficiency of plating and percentage recombinants determined 
for test ligations of genomic DNA into lambda ZAPII and lambda 
DASHII vectors.
Table 3 Titres, efficiency of plating and percentage 
recombinants for test ligation of genomic A.precatorius 
DNA/EcoRI into Lambda ZAPII/EcoRI and Lambda DASHII/EcoRI 
vectors The optimum titres for recombinant lambda ZAPII and 
lambda DASHII libraries, without amplification, were obtained 
from ligations containing 250ng and 500ng respectively of 
genomic A. precatorius DNA. Percentage recombinants in lambda 
ZAPII libraries were determined by blue/white colour selection 
in the presence of X-gal and IPTG. Percentage recombinants in 
lambda DASHII libraries were determined by sensitivity to the 
P2 lysogen (see section 2.9.4 for host strains)
Efficiency of plating 
(par pg lambda arms)
I.smbda 2 > P T T
3.6 X 106
Lambda PA8BII
2.8 X 106
Titra 
(par ml)
4.2 x 106 4.8 x 105
% recombinants 99.8 99.1
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3.5 SCREENING OF RBCOMBIMAMT LIBRARIES
3.5.1 Lambda ZAPII libraries
After final stringent wash conditions in 0.1XSSC at 65°C 
for 20 minutes, a total of 10 positive-hybridising plaques were 
obtained from the lambda ZAPII library of which four gave a 
strong signal. The other six plaques gave weak signals under 
the conditions used and these six plaques were picked, a liquid 
lysate was prepared for each of them and the lysates were 
stored for later analysis. The four strongly-hybridising 
plaques were converted to double stranded recombinant 
Bluescript phagemid as described (section 2.15.4).
3 .5 .2  I,m 4xU  PA9B I I  l l f r g i r la »
After final stringent wash conditions in 0.1XSSC at 65°C 
for 20 minutes a total of three positive-hybridising plaques 
were obtained. The degree of hybridisation was weak relative to 
the strongly-hybridising plaques from the lambda ZAP II library 
bank. The plaques were cored, a liquid lysate was prepared from 
each and stored for later analysis.
3 .5 .3  _nummary__Of__q+Ref a t i og tfid__» g r t t h i s q  9t--- g»B 9« tg
libraries
PCR was successfully used to prove sequences of interest 
were represented within the libraries. By this method it was 
shown that abrin-related sequences were represented in standard 
lambda phage libraries only when packaging was carried out in 
extracts derived from mcr~ host strains and the packaged DNA 
was plated out without amplification.
A total of 13 positive-hybridising plaques were obtained 
of which four were analysed further. The remaining 9 weakly- 
hybridising plaques were stored as phage lysates for later 
analysis. Unfortunately, these stored lysates were destroyed
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October 1989 beforeduring the San Francisco earthquake of 
further analysis. Figure 16 shows the cold room where 
lysates were stored, after the earthquake hit.
the
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3^< ANALYSIS OF RECOMBINANT PHAGEMID8
3.6.1 Analysis by restriction mapping
Large scale plasmid DNA was prepared for each positive 
clone and analysed initially by restriction mapping. Figure 17 
shows the restriction maps determined for the four clones pQK2, 
pQK3, pQK7 and pQK9. The three clones pQK2, pQK3 and pQK7 had 
identical restriction maps. The similarity expected between the 
isoforms of abrin-related genes would also be reflected in the 
similarity between restriction maps. To determine identity, the 
5' and 3' ends of the inserts within these three clones were 
sequenced using the T3 and T7 priming sites within the vector. 
The sequence of several hundred base pairs at both the 5' and 
3' ends showed the three clones were identical over the regions 
sequenced. Open reading frames were not found in these flanking 
regions, therefore, the 100% identity between this non-coding 
DNA showed that the three clones pQK2, pQK3, and pQK7 were 
identical and allowed selection of pQK3 as a representative for 
complete sequencing.
3.6.2 Nucleic acid sequencing strategy
The sequencing strategy used is shown in Figure 18. The 
restriction mapping of the clones pQK3 and pQK9 showed that 
sequencing overlapping subcloned fragments of the insert would 
be lengthy due to the limited number of convenient unique 
restriction endonuclease sites. To avoid this the inserts were 
sequenced inwards from the T7 and T3 priming sites of the 
vector and thereafter primers were generated as required. Both 
strands of the plasmid DNA was sequenced and all sequencing 
reactions were repeated with the dITP termination mixes to 
ensure any compressions were fully denatured.
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Figure 17 Partial restriction maps of the inserts of clones 
pQK2, pQK3, pQK7 and pQK9 The partial restriction maps of the 
inserts of (A) pQK2, pQK3 and pQK7 and (B) pQK9 are shown. The 
restriction endonuclease sites determined and their distance in 
kilobases from the 5' EcoRI cloning site in the vector is 
indicated
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Figure 18 DNA sequencing strategy on pQK3 and pQK9 A schematic 
diagram of the EcoRI insert in (A) pQK3 and (B) pQK9 is shown. 
The arrows indicate the approximate length of sequence reads 
from the ends of the primers used. The sequenced regions 
encoding open reading frames are boxed. pQK3 contains a 
frameshift and this is indicated. The position of relevant 
restriction sites are noted. A distance scale is given relative 
to the T3 and T7 priming sites in the vector
Eco R I Hat II Xba I Nco I Eco R I
T T T f T
AT6 TAA TAA
T3
T7
B)
EcoR 1 Hat II Nco 1
T
4 — / / _______
T T
‘ 7/ ATG TAA
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3.ft. 3 8»qutnct analysis of PQIC3
Analysis of the sequence of the insert of pQK3 by 
translation into amino acid sequence (Figure 19) showed that a 
putative long open reading frame encoding a polypeptide of 563 
amino acids was disrupted by an insertion of AC after amino 
acid 67. The frameshift caused by this two base insertion leads 
to a stop codon after amino acid 104. This two base insertion 
was the only frameshift within the putative long open reading 
frame and was only revealed by sequencing using the dl 
termination mixes. It is possible that this two base insertion 
was generated during the cloning procedure. However mutations 
that lead to reduction or elimination of seed polypeptides have 
been found in several different plant species, including gene 
inactivation due to translational frameshift (Goldberg, 1989) 
and several ricin pseudogenes have been described (Tregear, 
1990).
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Figure 19 Nucleotide sequence of the insert of pQK3 The coding 
strand sequence of pQK3 is numbered (bold type) for reference. 
The deduced amino acid sequence of the open reading frame is 
shown in bold type above the corresponding nucleotide sequence 
and is numbered for reference. The frameshift is shown with the 
amino acids deduced within this frame numbered in brackets
CAATTCAATCTAGCATAAACTTTTTGCATAATCATCAAACTTATAAATTCTTAATATTTTACAACTTCCTAAGCCAAACATCACATATAC 90 
AACAATGCATCCTAAACTATTTATCCTTCGTATGGAAAATATCAATTCGTGCTTAAATTCCTCTTAATAAAAATGCCTTTCTTCCCATAT 180 
CAACAAAGACAATTTTAAAATTCTCCACTATTTACTTTTAAATACTTTATTAGAGGATTGAATTTACACCAAACAGATAGAATTATAATA 270 
TCACrrCTATCCTTCTCACATAIATTAATTCTTACTCTCATTATTTATTATTTTCTTCTATTAATCTCTTATTTTCACTCCAAATCACCT 360 
CATCAATACTCCTCTACAATTACAGACCCATTTCATTTGAAATTCTTTCTTAGAACAAGTTTTTAAGCATGACCTCACTTCTTAAGTACA 450 
ACCGTTGAACATATAATGCAGTTGCAGAATGTTACAGGCCATAAAAACTTGCAGGTTTTCAAGATAATAACTAACTAGCAGTTATACTAA 540 
ACTTTCCATATTTATCCAAACTCAATATTTTTTACCTCCTAGATATTAAATTACTCTAATTTTAATTTTAAAACATTTTAAATTCTCTCA 630 
AAATTTAAACTGTCCATCCAAACACAGTAATACTAGCAATAATCCATATTCCTAGACCACAAATCAAACTACCAATAAACTCTCCTTATA 720 
AACATTAGTTTTTTTATATAAACGTACAATCCAGATCCCTATAAACATTTGCCCTCGTAACATCATAAAAGATTCCCCTTCTITCGGTGC 810 
TGACATTTCITTTGAAACGGCGATCTCTCTCTCTCTCTCTCTArATATATATATATATATATATATATATATATATATATCATGCTACCC 900 
TTTCAGCTGAGCAAGACCAACCCCTGCCTCCCTAAACCGTCATCTrTATATATCATGCCCTCCCAACCATTCTTGCCAAAATTGTTAGCC 990 
ACAGGTAAATTATGCACTCTGTCCAAATCAGACTAATCCTCCAAAAATAGGCTTTATTTTTATTCTCACCTCCTACCAATGCTCCAAGAT 1080 
CCCTATGCCTATAAAAGCCACAGTCACTCCACAACTTTC AACCC ACACC AAAC ATTCCACACCATCCTTTATTTTACTCCAACTCCGATC 1170 
AACAAGCTTCCCTCTACGCTTACCTTCAGCTTTAAAATTTGAATTACTTCTTTCAGTTTTCATTACATCTTTTCCTAAAATTTGGTGCAA 1260 
H D K T L K L L I L C L A W T C S P S A L R C A A 25 
CtGCATCCACTCTCAAATCGACAAAACTTTGAAGCTACTGATTTTATCTCTTCCATCCACTTGTTCATTCTCTCCACTCAGATGTGCCCC 1350 
I T y T P T A T H Q D Q P I K r T T B C A T S Q S T K Q r i 5 5  
AAGAACCTATACTCCCCTAGCAACAAATCAGGACCAGCCCATTAAATTTACTACTCAACCTGCCACTTCACAAACCTACAAACACTTCAT 1440 
« , L . Q . L . « e L I E „T . L C , « , « Q « ,» e. « N. ,» M  
:atacctgtgcttcgagatccaacaacagtggaagaaacaaatcca 1530TCAAGCGCTTAGACAGAGACTAACAGCTCCCCTGATACACACGACATA
! tc8aTATCTCCCACCATACCGA<
c8aACTcXaTCCTATTTCCTTCCTCATCCCCCAGCAtStCCAt3tA?CTACcVtTTCCCTCCCA?Cc2gCCGTACt8aCTTCCTTTTGAT(Ì7i£ 
G8TASrrATc8TGATctAGAGAGATGCCCTCATc2GA?AAGAGAGCAAATAA3TCTAG8cTTAc2ccécTTGA?ACATGCCAÌATCG A'iitó
cÌfACGAA^ TGGCCCCA^ TAACCATGAACAAAAAGCTCCTAjcCTCATCGTGATAATCcÌAATGCCTT^ AGAAGCACCTCGATACAGGT 5c‘i85i 
AÌATéAAACCGGGTTGSTCTCAScATCCCAAjTGGTAjcGCCTTTcXACCACATCCTGCCATGTTAASTTTGCACAACAATTCCCATAAT^ i^  
cÌìct8ac8ac8tgttcXac2at8actcc2agatacttttccaaataatctcattttat8aa8tattaatcccc 2acctcttcttgtagat( 
t3cttgt8acacccaa? acttccacttctaccattaatcctttttgtctccaatccgccaaatccaaaccgat8acctctcctaataaga ( ! ? i i
t8aA ^ w L u « t2ac2gGTGCTCaScTACCATTATGAGc£aa2tGTGCGCATTCCTg8tCCACATCGGCTGtScTTCCATGTTCCT<25U  
aaccaactctataacaatccccatcccatcataatgtI ta!wtgcaaagacaagcttgaccagaacc2cc TGTCCACCTTGAAACTTCAC( lllh 
aagaccataacgtccaaggSgaagggtttaaccaccaaaccttatgcttcacccgattcgatcgtca TAT ATC ATtStACCtÌÌGCCAGAA^  
c8ACACcècACTTATTGCCAAAÌATCCGACAATG8AA?TATTATCAATA?AAACTSTGécTTCGCCTTCACTGCAAAAGCTAGACACAAT ‘H5A 
c8cTATCAACTCATCCTGc2AA2cAACGAATATCTAATGc8Ac2cc8cTGGCGTACGc8cAATAACA?AACCCCTTTCGTAACTTCAATC<2 tU  
g8tgggtatt8ggatctctgcatgc2agctc2gggaaataatgtgtggctggctgactgtcataaaaataaggagcagc2cc2atggcca( 
CTTTACA?AC A TCCCTC T AT ACCTTC AGTCC 2 A A A T AC aaacaactStttaa?  TTATAAAGACCACAAAcXAGSATSTCCCAÌTCTCClfc ?^  ^
ATCg8ttSca8caATcSaTGCCCTa8tc2aAGATGCTTGTTTAAAAATCACg8tACCATTTATAATt}ìaTATCACGACATGGTCATCCAT ' m  
CTCAAACCCTSTCATc8AACTCTTAAAGACAÌAATACTTCATCCCTACCATc8TAAACCTAACc2AA{ATCGCTTACTTTCTfTTAATCC( ^ ? Ì  
CTTCATCtCTGAGCAGACAAATCCT ATCTGICTGTGTGTAATCTTT AAATAACTG ATCC TATCCATCGATCTGCAAAAACACTC ATGACC 3060 
TTCATCCTGCCTTCTAATCTTTCTAATGTGCTTAAATAATAAATTTATATTTTACCAACACCCTACCCCATCAACTGATCAATAAACACA 3150 
AACCAGATTGCTTCAACTCAAAATATATTTTAGAACCTAACTGCATAAAATCAAAACAATTCCAAACCTAAATCATAATTACACCCCGCC 3240 
CATTTAATTCCAAAGCTACATCTTCATTCCTCCAATTAACAAATTATCTAGCAATTGGATATACAATATAATAAACTCAATATAACATCA 3330 
ATATACCTAGTTCCTTCCCTTCAAACATACAAAATTAAATCATCATAACAACCTTCATCACAACAAAAGTTCAATTAAAACTTACCAAAA 3420 
AAACAGCCCAAATTTCATGGCTTACCACTTAAGACTTACATAAACATTTTCCTTCACATCCTCGGCTACCTTCTACCATCAACCTAATCA 3510 
GACACTITAGTTTTGATTCAATAATTCTTAAGAAAAACTTCTTACAATACTCAAACACCCCAATATATTCATACAATCTTACATAATTCA 3600 
ATTC 3604
3.t.4 Sequence analysis of cot)
Analysis of the sequence of the insert of pQK9 by 
translation into amino acid sequence shows the insert contains 
a single long open reading frame encoding 563 amino acids and 
is shown in Figure 20. The amino acid sequence determined for 
the abrin-related probe is identical over its length with the 
sequence shown here.
The similarity between ricin and abrin suggested that the 
structure of the polypeptide encoded within pQK9 would be 
similar to preproricin. Based on a comparison with abrin C A- 
chain and ricin D the polypeptide encodes an abrin-related 
preproprotein consisting of a leader of 34 amino acids, an A- 
chain of 251 amino acids, a linker of 14 amino acids and a B- 
chain of 263 amino acids
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1 Pat I 100
ACATTTGTCGCGTACATCATAAAAGATTCCTGCAGTACAATAATTTGCCTTCTTTCGGTGACACTTCCTTTGAGCTGGCTCTTACGTGACGTCAGCAAGA
GTGACCTAATTATAATTACTATCATCATAAATTATGCACTCIGTCCAAATGAGGCIAATCCTCCAAAAACGGG1TGATTTTTATTATGAGGTGCTACCAA
Kpn I 300
TGGTCCAAGATCCCTCTGCCTATAAAGTGATCCCACCACTTCCAAGCCACACCAAACATTGCACAGCATCCTTTATTTIACTGCAAGTGGGATCAACAAG
GTTCGCTCTACGGTTAGGTTCAGGTTTAAAATTTGAATTACTTCITTCAGTTIICATTACATCTITIGCTAAAATTTGGTGCAATTGCATGCAGTTTTAA
401
1226 A-chain......| l«~
TIG ATG CTT ITT GTC TGC AAT CCG CCA AAT GCA AAC CAA TCA CCA CTA TTA ATA AGA TCA ATT GTC GAA GAA TCA 
Leu HET Leu Phe V»l Cys Asn Pro Pro Asn Ala Asn Gin Ser Pro Leu Leu lie Arg Ser lie Val Glu Glu Ser
266
....«-chain Fsp l
AAG ATT TGC AGC TCT CGT TAT G 
Lye lie Cyt Ser Ser Arg Tyr G
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Figure 2 0 Gene sequence of the preproprotein The coding 
sequence of pQK9 is numbered above for reference, with relevant 
restriction sites noted. Potential control sequences are 
underlined. The deduced amino acid sequence is shown beneath 
the corresponding nucleotide sequence and is numbered below. 
The N-terminal residue of the mature A-chain is numbered 1 and 
residues 5' to residue 1 are numbered negatively. The 14 amino 
acid linker separating the C-terminus of the A-chain and the N- 
terminus of the B-chain is indicated
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3.7 .ANALYSIS OF,THE ABRIN-RBLATBD PREPROPROTBIN
3.7.1 Untranslated regions
The 5' flanking region of the preproprotein gene is 86% 
A+T. This is commonly found in other plant genes (Hailing et 
al., 1985). Upstream to the start codon are two potential 
promoter elements (5'-TATAA/TA-3') . In animals and plants the 
consensus TATA box is found approximately 25bp upstream of the 
cap site and is believed to act as a recognition site for RNA 
polymerase II.
In animals a consensus sequence GG(C/T)CAATCT found 80- 
lOObp upstream to the cap site is known to be important to 
transcription. Many plant genes however lack a CAAT box or the 
sequence is less well conserved. In some plant genes a 
different box is found with consensus CATC. In other genes, 
including zein, the consensus (C/T)A2_5 (G/T)NGA2_4 (C/T)(C/T) 
described as the AGGA box is found in this region although the 
significance of this sequence is not yet determined. The 
sequence shown here does not contain a recognisable CAAT, CATC 
or AGGA box.
A sequence 5'-CATGCAGT-3' is found at position -5. 
Alternating purines and pyrimidines in the 5* flanking regions 
of genes expressed in cotyledon tissue are termed RY repeats 
and are found within 300bp of the cap site in seed lectin genes 
(Hoffman and Donaldson, 1985). These RY repeats have been 
implicated in the regulation of seed lectin genes and it is 
postulated that by promoting Z-DNA formation near the cap site 
the accessibility of RNA polymerase II to the transcription 
start site is improved (Kilpatrick et al., 1984). Of 21 legume 
seed genes 20 contained at least 7bp of identity with the 
consensus RY repeat CATGCATG (Dickenson, 1988). In the soybean 
lectin gene the sequence 5'-CATGCATG-3' is found at position -5 
(Goldberg et a l . , 1989).
Downstream to the stop codon are two potential poly-A 
signal sequences (5'-AATAAG/T-3'). All the ricin toxin and RCA
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genes sequenced also contain two potential poly-A signal 
sequences downstream to the termination codon. In the sequence 
obtained from cDNA clones of ricin and RCA (Lamb et al., 1985 
and Roberts et al., 1985) the polyadenylation signals are at 55 
and 118 nucleotides downstream from the stop codon. In the 
preproprotein the polyadenylation signals are at 48 and 127 
nucleotides downstream of the stop codon.
3.7.g signal g a m m a *  a&U jml*
The leader sequence of the preproprotein consisting of 34 
amino acids, was analysed using the analogue described by 
Parker et a l . (1986) using a window of 7 and the result is 
shown in Figure 21A. A signal sequence is predicted to extend 
from Met-34 to Ser-16 with cleavage after the Ser-16. The N- 
terminus is basic, followed by a hydrophobic core extending 
from Leu at -31 to Thr at -20.
A method described by von Heijne (1985) was used to 
predict the signal sequence cleavage site and this is shown in 
Figure 2IB. This also predicts the signal will be cleaved after 
the serine residue at position -16. Cleavage after serine at 
position -16 satisfies the current model for signal sequences 
(von Heijne, 1989): the N-terminus has a net positive charge 
and is less than 6 residues long, the hydrophobic core is more 
than 5 residues but less than 20 residues long, the carboxy 
terminus has a small non-polar residue at position -3 (serine) 
and at position -1 (serine) and proline is absent from residues 
-3 to +1.
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Figure 21 Analysis of the preproprotein leader for a signal 
sequence Analysis of the leader sequence for the site of 
cleavage of a signal sequence was determined by the method 
described by (A) Parker et al., 1986 which determines charged 
(positive value) and hydrophobic domains (negative value), and 
by (B) von Heijne, 1986 which gives a high positive value for 
potential cleavage sites
B)
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In a comparison of 136 eukaryotic signal sequences where 
the cleavage site has been characterised, cleavage occured 
after serine, cysteine or threonine in 24% (Watson, 1984) and 
alanine is the most common residue found in the +i position 
after signal cleavage (von Heijne, 1984) which is the case 
here. If the site postulated for signal sequence cleavage is 
correct the protein must undergo further N-terminal processing 
to generate the mature form of the protein. This post- 
translational processing may by carried out by a specific 
protease which must recognise some feature of the cleavage 
domain. There is no similarity between the leader of ricin and 
the leader described here and there is no apparent consensus 
between the leaders of other ribosome-inactivating proteins 
which have been sequenced except for the start methionine and 
the Asn residue at position -1. The strong conservation of an 
asparagine residue at the carboxy-terminus of the leader 
sequences might indicate the specificity of the enzyme involved 
in the post-translational modification to generate the mature 
N-terminus of the abrin-related gene.
Qt A-ffftllB IM B lM i
overview
The A-chain of the abr in-related gene is 2 51 amino acids 
long assuming the N-terminus is glutamine as determined for 
abrin C and the C-terminus is asparagine from comparison with 
abrin C A-chain and the ricin toxins. The abrin-related A-chain 
contains a potential glycosylation site at Asnl96, unlike abrin 
C A-chain which is unglycosylated. The A-chain sequence is 49% 
G+C and there is slight bias for A or T at the wobble position.
Arginine versus lysine bias
There is a bias towards arginine versus lysine with a 
ratio of 19:3. London and Luongo (1989) noted that many toxins 
exhibited an arginine versus lysine bias. Ricin A-chain has 
considerable bias to arginine and the A-chain sequence reported
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here shows similar character with 19 arginine and only 3 lysine 
residues. Changes between arginine and lysine are relatively 
conservative. However, since arginine codons are GC rich and 
lysine codons are AT rich there may be some selection to 
maintain a high GC% composition. This is not borne out 
statistically however therefore maintenance of percentage GC 
composition alone cannot explain the bias. Arginines may be 
preferential for the conformation of the protein or may improve 
resistance to proteolysis.
The proposed active site residues 
The structure of the proposed active cleft in ricin is 
known (Montford et al., 1987). The hydroxyl of Tyr80 makes a
2.5 A hydrogen bond to the oxygen of Glyl21 whilst the other 
invariant residues form a supporting network structure. The 
side chain of Argl80 lies parallel to the plane of the indole 
ring of Trp211. The guanidium protrudes beyond the Trp ring 
where NH1 forms a strong hydrogen bond to the oxygen of Asn78. 
n H2 aPPears donate two bonds, one to an active site water 
molecule and a second to 0E2 of Glul77. The other oxygen of 
Glul77 forms two hydrogen bonds, one to water and the other to 
the hydroxyl of Tyrl23 (Robertus, 1991). The residues Asn78, 
Argl34, Glnl73, Glu208 and Asn209 in ricin are conserved active 
site amino acids and may play less specific roles in the 
catalytic mechanism or in maintaining the active site 
structure. Glu208 hydrogen bonds to Glnl73, forms an ion pair 
with Argl34, and contacts the side chain of Glul77. Glul73 
bonds to a trapped water molecule and anchors Glu208. Asn78 and 
Asn 209 sit on the molecular surface at the edge of the cleft 
(Robertus, 1991). Figure 22 illustrates the proposed active 
cleft of ricin.
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Figure 22 The active site cleft of ricin A-chain The model 
includes invariant and conserved groups in the active site 
cleft (taken from Robertus, 1991)
-147-
Several of the amino acids with side chains in the cleft, 
are invariant in the ribosome-inactivating proteins. In ricin 
these invariant residues are Tyr80, Tyrl23, Glul77, Argl80 and 
Trp211 and these same residues are conserved within the 
sequence of the A-chain reported here. Of the other invariant 
residues found in the ribosome-inactivating proteins, which are 
Tyr21, Arg29, Leul44 and, Alal78 in ricin, all are conserved in 
the A-chain sequence reported here. The conserved active site 
residues, equivalent to Asn78, Argl34, Glu208 and Asn209 in 
ricin, are also found in this A-chain sequence.
In addition, amino acids are conserved at certain 
positions in E. coli RNase H, Rous sarcoma virus reverse 
transcriptase and ricin D A-chain which include the residues 
equivalent to Alal65, Leu214 and Pro229 in ricin. RNA binding 
is the common function shared by these proteins and these amino 
acids may be important for the enzymatic function of RNA- 
binding proteins (Ready et al., 1988). Again these residues are 
conserved in the A-chain sequence reported here although they 
are not invariant within all ribosome-inactivating proteins.
Site directed mutagenesis has been used by several workers 
to determine the effect on catalytic activity. Generally 
mutations in ricin A-chain have had relatively limited effects 
on biological activity compared to key residue mutations in 
other enzymes (Robertus, 1991). In ricin, a mutation of Trp211 
to Phe led to a nine fold drop in activity (Bradley and 
Mcquire, 1990). Mutation of the Argl80 to His reduced activity 
by 1000 fold (Frankel et al., 1990), alteration to Gin reduced 
activity by 200 fold (Robertus, 1991) whereas alteration to Lys 
has minimal effect (Frankel et al., 1990). These results 
indicate that a positive charge is required at position 180 and 
not a guanidinium group per se.
Glul77 has been mutated to Ala with only a 20 fold loss in 
activity and to Asp with a 80 fold drop in activity. Hovde et 
al. (1988) found that in E. coli Shiga-like toxin I, a mutation 
of Glul67, equivalent to Glul77 in ricin, to Asp reduced 
activity by 1000 fold. A double mutation in ricin A-chain
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where Glul77 is altered to Ala, and Glu208 is altered to Asp, 
reduced activity by 1000 fold. Mutation of Glu208 alone does 
not alter activity significantly therefore it has been 
suggested that Glu208 can substitute for Glul77 when the 
carboxylate of Glul77 is removed (Robertus,1991)
Frankel et a l . (1989) selected for mutations in ricin A- 
chain by loss of lethality when expressed in yeast. Eight of 
the nine mutants they isolated had single amino acid changes in 
the proposed active site. These mutations were Glul77 to Asp, 
Glul77 to Lys, Trp211 to Arg, Gly212 to Glu, Gly212 to Trp, 
Ser215 to Pro and Ile252 to Arg.
The current model for the W-glycosidation reaction assumes 
protonation of the leaving adenine group with stabilisation of 
the oxycarbonium ion which would develop during the 
transitional state of the ribose. The hypothesis is supported 
from model experiments using kinetic isotope effects to 
investigate hydrolysis of the adenine base of AMP by a 
nucleoside (Mentch et al., 1987 and Giranda et al., 1988). 
During the transition state the leaving adenine is protonated, 
the ribose ring has carbonium character, there is partial 
bonding between the base and the ribose and nucleophilic attack 
at the Cl of ribose by a participating water molecule. Based on 
this evidence and the results of mutagenisis of ricin A-chain a 
mechanism for the enzymatic reaction of ricin A-chain has been 
made (Robertus, 1991) and is summarised in Figure 23.
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Figure 23 A schematic diagram of the proposed ricin A-chain 
mechanism The adenine ring is shown of the substrate is shown 
in the syn conformation, with partial breakage. Oxycarbonium 
ion development is shown on the ribose, and this stabilises by 
ion pairing with Glul77. Argl80 is shown binding the phosphate 
backbone of the RNA. The attacking water molecule is positioned 
close to the scissile glycoside linkage. A: H represents an 
unspecified residue which hydrogen bonds to the leaving adenine
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The ribosome is recognised and bound by several contacts 
of which none are of major significance alone. The susceptible 
adenine ring is distorted into the high energy syn 
configuration by the many favorable interactions. The 
juxtaposition of Glul77 to the developing oxycarbonium ion on 
the ribose enhances bond breakage. Protonation of the leaving 
adenine is from several donors such as Tyr80 and Tyrl23. Argl80 
forms an ion pair with a substrate phosphate, thereby 
stabilising substrate binding and contributing to the energy 
needed to distort the susceptible adenine conformation.
Recently Evensen et al. (1991) used PCR to isolate two 
complete abrin-related A-chain sequences. These two sequences 
had 84% identity with each other and comparison with the A- 
chain sequence reported here shows a similar degree of 
similarity.
Cysteine residues
In ricin the A-chain and B-chain are linked by a single 
disulphide bond between residue 259 of the A-chain and residue 
4 of the B-chain. In the abr in-related A-chain there is a 
single cysteine residue which corresponds to Cys 259 in ricin 
A-chain.
Summary
The A-chain sequence of the abrin-related preproprotein 
has all the features characteristic of ribosome-inactivating 
proteins. At positions which have been shown to be important 
for calalytic activity of ricin A-chain there is 100% identity 
between the A-chain sequence reported here and ricin A-chain.
Recently a molecular model for abrin C A-chain has been 
described (Collins et al., 1990) which was generated by fitting 
the primary sequence of abrin C A-chain to the backbone 
structure for ricin A-chain. The overall structure of the abrin 
model was very similar to that of ricin despite the 17 
additional residues in ricin A-chain. The deletions are easily 
accommodated in the abrin molecule. The two major deletions.
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centred on ricin residues 105 and 151, lie on the surface of 
the molecule, the five single-deletions and the single 
insertion do not significantly perturb the peptide and the 
internal packing of the molecule is not disrupted. The close 
similarity between the primary structure of abrin C A-chain 
with the A-chain reported here, and the similarity between the 
structure of abrin C A-chain and ricin A-chain suggests that 
analogies drawn between ricin and the abrin-related
preproprotein will be valid.
3.7.4 AB#iy»i> of th+ link«
The linker in the cloned abrin-related gene is 14 amino 
acids long. The linker in type II ribosome-inactivating 
proteins is believed to maintain the protein in an inactive 
form until it is sequestered within the protein storage bodies 
(Lord, 1985) . The linker is then cleaved to release the 
subunits of the heterodimer. Proricin has no N-glycosidase 
activity but is still functional as a lectin (Richardson et 
al., 1989). The linker region must significantly disrupt the
active site of the A-chain, or prevent access by the substrate 
to the cleft within the A-chain, but not interfere with the 
galactose binding sites of the B-chain.
Unexpectedly the linker in the cloned abrin-related gene 
has a potential glycosylation site. The ricin toxins and RCA do 
not have a glycosylated linker. The glycosylation of the linker 
may stabilise the polypeptide in some way during transport to 
the protein storage bodies or the increased bulk of the linker 
domain may contribute to the folding of the polypeptide. A 
glycosylated linker is found in concanavalin A (Con A) , a 
lectin which constitutes up to 15% of the protein in the 
cotyledons of Canavalia ensiformis (Carrington et al., 1985).
Con A also undergoes post-translational cleavage of a 
glycosylated linker.
The linker in the gene described here is also unusual in 
that it does not end with an Asn residue. In the ricin toxins.
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in RCA and in Con A all the points which must be cleaved to 
produce the mature protein have an Asn residue to the N- 
terminal side of the point of cleavage indicating the 
specificity of the enzyme involved.
3 . 7 . ?  M m ly p j s  9 t  t h t  B - Cha iB
Overview
The B-chain of the preproprotein is 263 amino acids long. 
The serine was selected as the N-terminus based on comparison 
with ricin and RCA to conserve the positioning of cysteine 
residues and serine versus alanine (in ricin and RCA) is a 
relatively conservative change. Sequencing of the N-tenninus of 
the B-chain of abrin toxins has been unsuccessful to date 
(personal communication. Dr E.J. Wawrzynczak, Institute of 
Cancer research, Surrey, UK) . This has been due to blocking 
either in nature or as a consequence of the sequencing 
procedure. The glutamate residue is more likely to be blocked 
in nature but without protein sequence information the first 
residue of the B-chain cannot be confirmed.
The sequence for the B-chain reported here is only the 
second to be reported apart from those from R. communis. The 
structure of the B-chain of ricin has been determined (Montford 
et a l ., 1987) and from this, the residues critical to correct
folding and activity have been indicated.
Ricin B-chain contains 4 intrachain disulphide bonds. The 
cysteine residues in the abrin-related B-chain sequence are 
conserved with ricin and are at positions 4, 20, 39, 63, 80, 
151, 164, 190 and 207. The cysteine residue at position 4 in 
the B-chain is likely to form the interchain bond with the A- 
chain. The N-terminus of ricin B-chain has been shown to be 
flexible and mobile from NMR spectra studies (Bushuev and 
Tonevitsky, 1989) and the X-ray crystallographic studies of 
crystals of ricin (Montford et al., 1987) shows the N-terminus
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of the B-chain lies outside the globular part of the protein. 
It has been suggested that the high mobility of the N-terminus 
of the B-chain may promote both the formation and destruction 
of the interchain disulphide bond. The remaining 8 cysteine 
residues, being in the identical positions to ricin can 
potentially form 4 intrachain disulphide bonds with the 
pairings of 20/39, 63/80, 151/164 and 190/207.
Glvcosvlation sites
The B-chain sequence reported here contains 2 potential 
glycosylation sites. The ricin toxins also contain 2 
glycosylation sites in the B-chain which are at the same 
position as in the B-chain of the abrin-related preproprotein. 
The glycosylation of the B-chain has been shown to be important 
in the stability of the B-chain. When ricin B-chain is 
expressed in E. coli, and is therefore unglycosylated, it is 
unstable and aggregates rapidly (Hussain et al., 1989) although 
initially it is soluble and active. Glycosylation has been 
shown to be significant for expression of B-chain in oocytes. 
When pre-ricin B-chain is expressed in oocytes the product is 
soluble, stable and functionally active (Richardson et al., 
1988a). However, if tunicamycin is used to inhibit 
glycosylation (Richardson et al., 1989) or the glycosylation 
sites are mutated (Wales et al., 1991) the product is unstable, 
rapidly aggregates and is devoid of lectin activity. The 
glycosylation of the B-chains of the type II ribosome­
inactivating proteins is therefore of significance to the 
stability and activity of the isolated B-chain. The importance 
of N-linked oligosaccharides in maintaining native and 
recombinant glycoproteins in active conformations has been 
demonstrated for several different protein types (Fischer et 
al., 1990 and Kretz et al., 1990)
The structure of the sugar chains of the B-chain of abrin 
C has been determined (Kimura et al., 1988b). Kimura postulated 
that the glycosylation sites within the abrin B-chain 
correspond to Asn97 and Asnl36 of ricin B-chain based on the
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sequence of the glycopeptides generated from pronase digestion 
of the B-chain. The estimated structures of sugar chains 
obtained from abrin C B-chain are shown in Figure 24. The two 
oligomannose-type sugars M7A and M6B were linked to the site 
corresponding to Asn 97 in ricin B-chain, and the two 
oligomannose-type sugars M6B and M5A and the xylomannose-type 
sugar M4X were linked to the site corresponding to Asn 136 in 
ricin B-chain.
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Figure 24 The structure of the sugar chains of abrin C B-chain 
The structure of the oligosaccharide side chains determined by 
Kimura et al., 1988, are shown below. Abbreviations are Man, 
mannose; Xyl, D-xylose; GlcNAc, N-acetylglucosamine
M4X
,MiMl
*Mm £I -  4CtcNAc*l -  4C«eNAc 
M i h I Xyl*l
M5A
Mum I
\
* Manat
M a w /  S ‘ M a a il-4 C »c N A c il  -  ACtcNAc
,*
Manat — XManal
Manat -  ZManal
Manat ‘ Man*l -  ACtcNAcJI -  4CtcNAc *Maa*l -  ACtcNAc^t -  ACtcNAc
Manat —  IManal
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Evolution of the B-chain
Ricin B-chain is postulated to be a product of gene 
duplication. Structural homology within the ricin B-chain show 
that the two halves exhibit a relationship in the pattern of 
disulphide bridges, loop size and sequence homologies 
(Villafranca and Robertus, 1980). Rutenber et al. (1987) have 
analysed structural homology within the B-chain to a more 
extensive degree and postulate that the B-chain of ricin is a 
product of a series of gene duplications of an ancient 
galactose-binding peptide of approximately 40 residues. 
Analysis of primary and tertiary structure has revealed that 
the the two halves of ricin B-chain can be divided into four 
peptides called the X , cx , B and "7$ subdomains. The lambda 
domains are homologous to each other but not to the other 
domains. The cx, fi and domains are all homologous with each 
other - despite considerable divergence the similarities are 
statistically significant.
Amino acid sequence analysis of the subdomain units of the 
abrin-related B-chain (Figure 25A) show that the subdomains o<, 
B and 7$ are homologous and show similarity to the subdomains of 
ricin B-chain. As with ricin B-chain there are invariant Trp 
residues and strongly conserved lie residues. Dr M.P. Ready 
(University of Texas at Austin, Texas, USA) determined the 
similarity matrix between ricin B-chain and the cloned abrin B- 
chain using the method of Robertus and Ready (1984). Briefly, 
the aligned sequences are scrambled several hundred times; an 
average number of identities and standard deviations are 
determined for random sequences of the same composition as the 
test sequences; a variable gap penalty is then applied which 
gives large penalties for gaps which produce few new identities 
and small penalties for gaps which produce many; a similarity 
index is then determined for the aligned sequences, based on 
the gap-corrected number of identities between them, in 
standard deviations above the mean for randomised sequences. As 
shown in Figure 25B the similarity between the subdomains of 
ricin B-chain and the cloned abrin B-chain is strong.
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Figure 25 Alignment of the subdomains of ricin B-chain and the 
abrin-related B-chain based on amino acid sequence similarity 
(A) Amino acid sequence alignment of the subdomains of ricin B- 
chain (RTB) with the subdomains of the B-chain of the 
preproabrin (ATBKW). The subdomains correspond to residues as 
follows: 1« residues 17-60 (RTB), 18-61 (ATBKW); IB, 61-101,62- 
102 (ATBKW); lK, 104-136 (RTB), 105-137 (ATBKW); IX, 1-16 
(RTB), 1-15 (ATBKW); 2«, 151-183 (RTB), 152-184 (ATBKW); 2B, 
187-226 (RTB), 188-227 (ATBKW); 21, 228-262 (RTB), 229-263 
(ATBKW); 2 X, 136-150 (RTB), 137-151 (ATBKW). (B) Similarity 
indices for all possible comparisons, calculated as described 
(Robertus and Ready, 1984), measured in standard deviations 
above the mean for random matches and including gap penalties
A) A lig n m e n t  Based  on  Amino A c id  Sequence S im i l a r i t y
ATBKW la
2a
RTB la
2a
ATBKW 1 *
20
RTB 10
20
ATBKW I t
2t
RTB I t
2t
ATBKW n
21
RTB 11
21
DGMCVDVYDDCYHNGNRIIAW— KCKDRLEENQLWTLKSDKTIRS
SDLCMQA------------ QGSNVWLADC-DNNKKEQQWALYTDGS IR S
NGLCVDVRDGRFHNCNAIQLW— PCKSNTDANQLWTLKRDNTIRS 
YGLCLQA------------ NSGQVWIEDC-SS EKAEQQWALYADCSIRP
NGKCLTT EGYAPGNYV-MIYDCTSAVAEATYWEIWDNGT11N
TNNCLTS---- KDHKQCSPI-VLMAC-SNGWASQRWLFKNDCSIYN
NGKCLTT YGYS PG VYV-MIYDCNTAATDATRWQI WDNGT 11N
RDNCLTS---- DSN IRETW-KILSC-GPASSGQRW MFKNDGTILN
SALVLSAESSSMCGTLTVQTNEYLM--------- RQGW-RTGN
DDMVMDVKR— S D P SL K -E IILH P Y — HGKPNQIU-LTLF
SSLVLAATSGNSGTTLTVQTNIYAV--------- SQCW-LPTN
SGLVLDVRA— S DAS LK-Q 11LYPL—  HGDPNQIW-LPLF
SK ICSSRYEPTVRIGGR
NTSPFVTSISGY
ADVCM-DPEPIVRIVGR
NTQPFVTTIVGL
B)
RTB vs. ATB Alpha Beta Gamma
Subdomain 1 15.49 16.86 10.30
Subdomain 2 13.12 8.00 14.81
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Galactose binding sites
Ricin B-chain has been shown to bind two galactose 
molecules in a non-cooperative manner (Hooston and Dooley, 
1982) and the molecular interactions at the binding sites has 
been determined from X-ray crystallographic data (Montford et 
al., 1987). The galactose binding sites are found in non- 
homologous domains within ricin B-chain, namely the 1£* and the 
2ti domains. Montford and co-workers postulate that the ancestor 
of the modern B-chain was a peptide resembling the lex domain. 
The primordial molecule probably existed as a trimer linked by 
a Trp-Ile interaction. Gene duplication and fusion then formed 
the odJ#-molecule which allowed specialisation of the B subunit 
for a structural role, and the molecule could bind sugars 
at both the ex and domains. The molecule was stabilised by the 
addition of the X  peptide and a further gene duplication 
generated the current (¿txBTf) 2 motif. This duplication blocked 
access of galactose to the IK domain and although there is 
still solvent access to the 2 <x binding domain this has lost 
binding ability. It is suggested that selection for the two- 
domain structure involved the spacing of the binding sites for 
cell surface binding (Rutenber et al., 1987).
From the similarity indices determined for the abrin B- 
chain and ricin B-chain (Figure 25B) the 2B domain is the least 
constrained. Reduced similarity is consistent with the location 
of 2B in the protein, where it is exposed to the solvent and 
appears to play no crucial role other than contribution to 
overall folding.
The structure of the two functional binding domains in 
ricin B-chain is similar. The sugar molecule lies in a pocket 
formed on one side by an aromatic residue (Trp37 in loc and 
Tyr248 in 2X) and the other by a kink consisting of Asp-Val- 
Arg. The aromatic side chains provide a flat binding surface 
for galactose but the interaction does not involve specific 
binding. The galactose is hydrogen bonded by the homologous 
amides Asn46 and Asn255, which are in turn stabilised by 
hydrogen bonding to Asp22 and Asp234 (Montford et a l ., 1987).
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The sequence Gln-X-Trp is common to five of the ricin B-chain 
subdomains and the Trp is invariant. The Trp residues stabilise 
the carboxy-terminal loop of each subdomain and stabilises the 
subdomain contacts within each domain by Trp-Ile van der Waals' 
contacts with the highly conserved downstream lie residue 
(Robertus, 1991).
Recently, Rutenber and Robertus (1991) published a refined 
model for the structure of ricin B-chain at 2 . 5 A .  This 
structure differed from that previously published (Montford et 
al., 1987). An alignment between the cloned abrin B-chain 
sequence and ricin B-chain, based on the structural position of 
residues from the refined model of ricin B-chain, is shown in 
Figure 26A. The abrin B-chain molecule retains the vital 
folding core residues and the residues involved in the 
hydrophobic core are conserved apart from a Leu to Ala change 
in the la domain. The residues which make specific contact with 
the sugars are also retained except for the His to Tyr change 
in the 26 domain and Glu for lie in the ltx domain. The presence 
of lie in the 1 domain is unlikely to be important since the 
functional domain of ricin B-chain has an lie at this position.
The similarity indices of the alignment shown in Figure 
26A were determined by Dr M.P. Ready (University of Texas at 
Austin, Texas, USA) and are shown in Figure 26B. The similarity 
indices for the subdomains of the abrin B-chain are 
consistently less similar amongst themselves than the 
subdomains of ricin B-chain. Determining the subdomain 
structure of the abrin B-chain would have been difficult 
without comparison with ricin B-chain
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The motif for a functional binding site is evident at the 
loc domain of the cloned abrin B-chain. In ricin this domain is 
termed the low affinity site because it can bind to 
galactopyranosides but not N-acetylgalactosamines (Hatakeyama 
et al., 1989). From the sequence comparison the B-chain of the 
abrin clone was expected to have a low affinity binding site.
In the 2TS subdomain of the abrin B-chain there is only one 
significant difference in the residues considered important to 
galactose binding and this is a histidine as opposed to 
tyrosine in ricin B-chain. In ricin D the 2TS domain is a high 
affinity site, binding to both galactopyranosides and N- 
acetylgalactosamines (Hatakeyama et al., 1989). A histidine 
residue is found at the equivalent position in ricin E and in 
RCA. The significance of the histidine is not determined. 
Histidine also has an aromatic side chain but it is unlikely 
that histidine can substitute for tyrosine or tryptophan as a 
'sugar platform' (personal communication, Dr J.D. Robertus, 
University of Texas at Austin, Texas, USA) .
RCA can bind to only one molecule of lactose per B-chain 
(Podder et a l ., 1974). RCA has a similar motif to ricin D in 
the loc subdomain therefore it may be a consequence of the 
histidine in the 2~f domain that has led to loss of binding at 
this site. The interaction within the tetramer of RCA is 
unknown, therefore in the native RCA, solvent access to the 
second binding site on each B-chain may be prevented or the 
interactions involved in the quaternary arrangement of the 
protein disrupts one of the sites. The B-chains of APA have 
been isolated and shown to have very low cytoagglutinating 
activity of approximately 0.9% compared to intact APA (Islam 
and Funatsu, 1988) suggesting monovalency.
Based on the alignments described above the cloned abrin 
B-chain is expected to have a low affinity site in the la 
domain. The site in the 2* domain is expected to be equivalent 
to the binding site in the 2tf domain of ricin E B-chain.
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3,7.6 Comparison with ricin and RCA
Overview
An alignment between the preproprotein sequence, the ricin 
toxins and RCA is shown in Figure 27. The A-chain of the 
preproprotein exhibits 83% identity with the A-chain of abrin 
C, 42% identity with the ricin toxin A-chains and 36% identity 
with RCA A-chain. The abrin-related A-chain is one residue 
longer than abrin C A-chain due to an additional glycine 
residue at position 204.
The B-chain of the preproprotein exhibits 60.8% identity 
with ricin D B-chain and 60.2% identity with RCA B-chain. The 
preproprotein leader shows no significant similarity to the 
leaders of the ricin toxins or RCA apart from the Asn residue 
at -1. There is some similarity to the linkers of the ricin 
toxins and RCA.
Taxing yersug agglutinins
Ricin toxins are closely related to RCA and therefore an 
abrin toxin would be expected to be closely related to an APA. 
Despite the close similarity between these two types of protein 
some residues must be responsible for determining the enzymatic 
and structural differences exhibited by the toxins versus 
agglutinins. Previous comparisons have shown that ricin D 
differs from RCA at only 57 positions (Roberts et al., 1985). 
At the positions where these differences occur a comparison was 
made between the sequence described here and with the A-chain 
of abrin C, the ricin toxins and RCA.
Within the A-chain sequences there are 16 positions where 
■the ricin toxins and RCA differ. Of these 16 positions, 
residues are conserved between the preproprotein and abrin C 
alone at 4 positions. At 9 positions the residue is conserved 
between the preproprotein and all the toxins but at only one 
position is the residue conserved between the preproprotein, 
abrin C and RCA. At 2 positions the residues are not conserved 
between the five sequences.
-163-
Figure 27 Alignment of the preproabrin with abrin C, ricin 
toxins and RCA An alignment between the preproabrin (A) , abrin 
C (AC) , ricin D (RD), ricin E (RE) and RCA is shown using the 
single amino acid code; each sequence is numbered for reference 
according to the published sequences. The leader, A-chain, 
linker and B-chain sequences are marked. Residues conserved 
with the preproabrin are indicated by shaded boxes. N- 
glycosylation sites are underlined
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Within the B-chain sequences, differences occur at 41 
positions. At these positions the preproprotein matches a ricin 
toxin at 20 positions but at no position does the preproprotein 
match only RCA. At 20 positions the residues are not conserved 
between all four sequences.
N-terminal sequencing of an APA B-chain of Korean origin 
(Wood et al., 1991) generated the sequence:
This is similar to the N-terminal sequence determined for an 
APA B-chain of Bangladeshi origin (Islam and Funatsu, 1988).
Protein sequencing of a carboxy-terminal CNBr fragment 
from an abrin toxin A-chain of Korean origin (personal 
communication, Dr E. Wawrzynczak, Institute of Cancer Research, 
Surrey, UK) generated the sequence:
D—V—K—G-8-D-P-8—L—K-Q—I—X—L—H-P-Y-H—G-K-P-N-Q—I—
This is similar to the carboxy terminus of the B-chain sequence 
of the preproprotein reported here and has a His residue at the 
position postulated to be involved in potential galactose 
binding at the 2g domain of the cloned abrin sequence (*) .
Based on the closer similarity of the preproprotein to the 
ricin toxins than to RCA and the dissimilarity between the N- 
terminal sequence data available on APA, the preproprotein is 
abrin-like as opposed to APA-like.
interchain interactions
The A-chain and B-chain of ricin are linked by a single 
disulphide bond. Youle et a l . (1983) have shown that this 
disulphide bond is not required for cytotoxicity except at low 
concentrations when the disulphide bond maintains the subunits 
in close juxtaposition. The association between the subunits of 
ricin has been shown to be via hydrophobic interactions. The
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and thedissociation constant was determined as 1.72 x 10”6 , 
entropy and enthalpy values were positive.
In ricin the interchain interactions between the A-chain 
and B-chain are shown in Table 4. The residues in the A-chain 
which are conserved with the sequence reported here are 
equivalent to Tyrl83, Leu207, and Pro250. Within the B-chain 
the residues which are conserved are eqivalent to Phe262 and 
Phel40. The high percentage identity between abrin C A-chain 
and the similarity in the tertiary structure of abrin C A-chain 
to ricin A-chain therefore suggests a similar hydrophobic 
interaction between the A-chain and B-chain of the protein 
desribed here. The 3-dimensional structure of ricin has shown 
that in addition to the driving hydrophobic interactions there 
are also some polar interactions which occur over a small 
contact area. In the A-chain of the abrin-related gene there is 
conservation of polar residues in the domains involved in the 
contact area. The tertiary structure of abrin C A-chain is 
similar to ricin in these domains therefore it seems likely 
that these polar interactions extend over a relatively small 
area in the abr in-related protein. It is postulated that the 
interaction between the subunits relies on both hydrophobic and 
polar interactions so that the two chains can be separated. The 
subunits could not be separated if the interaction consisted of 
entirely hydrophobic bonding (Robertus, 1991).
3.7.7 Summary of gequgflgg analysis
Sequence analysis has shown that the preproprotein is 
closely related to the ricin toxins. Based on the closer 
similarity to the toxin sequences than to the RCA sequence, at 
the few residues where differences are seen, the preproprotein 
most closely resembles a toxin and not an APA. The protein will 
be termed as an abrin in future discussion.
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Table 4 I nterchain int e r a c t i o n s  in ricin
P o l a r I n t e r a c t i o n s
A - c h a i n B - c h a i n A - c h a i n B - c h a i n
T y r l 8 3 P h e 2  62 A r g 2 5 8 A l a l
P r o 2 6 0 A l a 2  60 A s p 2
H i s 4  0 A s p 9  4
L e u 2 0 7 P h e 2 6 2 A r g 2  3 4 V a l l 4 1
G l u 4 1 L y s 2 19
P h e 2 4 0 P b e l 4 0 G l n l 8 2 A s n 2  2 0
P h e 2 62 I l e 2 4 9 A s n 2  2 0
1 1 0 2 5 2 A s n 2 2 0
I l e 2 4 7 P h e l 4 0 A r g 2 3 5 P h e 2  62
P r o 2 5 0  P h e 2 18
P r o 2 6 0
I l « 2 5 1  P r o 2 6 0
P h e 2 6 2
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3.8 A-CHAIN EXPRESSION IN E. COLI
3.8.1 PTiplagmic •xpressjoB
Periplasmic expression construe
The signal sequence used to direct the nascent A-chain 
polypeptide to the periplasmic space of E. coli was the OmpA 
signal peptide. Omp A is the major outer membrane protein of E. 
coli, present at a concentration of 105 per cell (Beck and 
Bremer, 1980) . The signal peptide of Omp A has been used to 
export a wide variety of eukaryotic proteins to the periplasmic 
space (Takagi et al., 1988). These secretion cloning vectors
can have benefits over a cytoplasmic expression system: the 
mature secreted protein can have the correct native amino- 
terminal amino acid residue, protease activity in the periplasm 
is considerably less than in the cytoplasm and disulphide bond 
formation has been shown to occur simultaneously with secretion 
(Marston, 1986).
A double stranded oligonucleotide encoding the OmpA signal 
was synthesised and is illustrated in Figure 28B. An additional 
codon encoding alanine was included at the 3' end: the first 
residue of the mature A-chain sequence is glutamine which is 
rarely found at the +1 position after prokaryotic signal 
sequences (Watson, 1984) . The inclusion of the alanine residue 
should improve the efficiency of cleavage of the signal in 
vivo. The oligonucleotides were designed such that, when 
annealed, an Ncol overhang was generated at the 5' end and the 
3' end was blunt.
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Figure 28 Oligonucleotide primer design for the OmpA signal 
sequence and for recover of the A-chain sequence by PCR (A) The 
primary sequence of the Omp A signal sequence is shown with the 
nucleotide sequence of the synthesised primers below. 
Restriction sites are marked and the cleavage site is indicated 
(T ) *  (B) The sequence of the oligonucleotide primers used in
PCR on pQK9 DNA template to recover the mature A-chain 
sequence. The sequence of the A-chain from which the primers 
were designed is numbered according to Figure 27. The 
orientation of the primers is indicated with the primer 9-AR 
representing complementary DNA. The linker regions, to generate 
restriction endonuclease recognition sites are underlined
(A).
MetLysLysThrAlaXlaAlallaAlaValAlaLeuAlaQlyFheAlaThrValAlaainAlaAla
SeoI (ovarhang) TspI
(B) Primer 9-AF
1 8
Gin Asp Gin Vel lie Lye Phe Thr 
5' - CACOGATCCCTCQAOCT CAO GAC CAO GTC ATT AAA TTT ACT AC -3' 
BamHI SacI
Primer 9-AR
24« 2S1
▼ml Cye Ann Pro Pro Ann TER TER 
3'- CAO ACO TTA GOC GOT TTA ATT ATT CQAAQQACGTCCAC -5'
HindiII PstI
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Figure 29 Summary of the cloning strategy for periplasmic A- 
chain expression construct pKK-9A3
9A-F
_ Leader ^  A  -chain
* * \
9 A -R  
PCR
OmpA
signal
M  1
Hindi 11 ^
a) Sacl digest/overhang blunt
b) Hindi 11 digest
E H TAA j——i
Omp A signal
QCT ECT CAQ-
PKK-9A3
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The mature A-chain sequence was recovered by PCR using 
linker-extended primers 9A-F and 9A-R, on pQK9 DNA template. 
The design of the primers is shown in Figure 28B. The PCR 
product therefore consisted of the A-chain sequence flanked by 
a 5' SacI site, and a 3' Hindi 11 site. The final construct 
termed pKK-9A3 was generated by a tripartite ligation of the 
double stranded oligonucleotide, the A-chain which had been 
sequentially blunted at the SacI site then digested with 
Hindlll, and the vector pKK233-2 which had been digested with 
Ncol and HindiII. The cloning strategy is summarised in Figure 
29.
Periplasmic expression in E. coli
The results from periplasmic expression in E. coli are 
shown in Figure 30. Analysis by SDS-PAGE and Coomassie blue 
staining (Figure 30A) reveal a very faint band is present in 
the periplasmic fraction (lane 6) which migrates the same 
distance as native abrin C A-chain (lane 7). Careful 
examination of the total cell fraction (lane 4) and shocked 
cell fractions (lane 5) suggest an increase in the intensity of 
a band of approximately 28kDa compared to the non-recombinant 
vector control.
Western blot analysis (Figure 30B) clearly shows the 
presence of an immunoreactive band of 28kDa present in total 
(lane 4), shocked cell (lane 5) and periplasmic fractions (lane 
6). There are also however two immunoreactive bands present in 
the non-recombinant vector cell fractions (lanes 1 and 2) 
indicating cross-reactivity between the anti-sera and an E . 
coli extract. This was despite preincubation of the anti-sera 
with E. coli extract. As one of these cross-immunoreactive 
proteins was of a similar size to the recombinant A-chain some 
affinity purified anti-abrin A-chain was obtained (kindly 
provided by Dr E. Wawrzynczak) for the majority of future 
Western blot analysis.
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F i g u r e  3 0  Periplasmic expression of recombinant abrin A-chain 
J A 2 2 1  t r a n s f o r m e d  w i t h  p K K -9 A 3  w as c u l t u r e d  t o  OD6 0 0  o f  0 . 8 ,  
in d u c e d  w i t h  O .lm M  IP T G  a n d  t h e n  c u l t u r e d  f o r  a  f u r t h e r  3 
h o u r s .  T h e  c e l l s  w e re  h a r v e s t e d  an d  t h e  p r o t e i n  f r a c t i o n s  w e re  
p r e p a r e d  a s  d e s c r i b e d  ( s e c t i o n  2 . 1 6 . 2 ) .  T h e  t o t a l ,  s h o c k e d  c e l l  
an d  p e r i p l a s m i c  f r a c t i o n s  w e re  a n a ly s e d  b y  (A ) S D S -P A G E  a n d  
C o o m a s s ie  b lu e  s t a i n i n g  a n d  b y  (B ) W e s te rn  b l o t  u s i n g  t h e  a n t i -  
b a b b i t  I g G ) - a l k a l i n e - p h o s p h a t a s e  c o n j u g a t e  a s  d e s c r i b e d  
( s e c t i o n  2 . 1 8 . 2 ) .  L a n e s  1 - 3 ,  t o t a l ,  s h o c k e d  c e l l  f r a c t i o n  a n d  
p e r i p l a s m i c  f r a c t i o n  r e s p e c t i v e l y  f ro m  n o n - r e c o m b in a n t  v e c t o r  
c o n t r o l ;  l a n e s  4 - 6 ,  t o t a l ,  s h o c k e d  c e l l  f r a c t i o n  a n d  
p e r i p l a s m i c  f r a c t i o n  r e s p e c t i v e l y  fro m  J A 2 2 1 / p K K -9 A 3 ; l a n e  7 , 
n a t i v e  a b r i n  C ;  l a n e  8 ,  p r e s t a in e d  low  m o l e c u l a r  w e ig h t  m a r k e r s
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It is clear from the Western blot that recombinant A-chain 
is being translated and some is being exported to the 
periplasm. The size estimate of 28kDa for this exported A-chain 
suggests that the signal peptide has been cleaved. If the 
signal peptide had not been cleaved a protein of approximately 
30kDa would be expected. Lehnhardt et a l. (1987) and Emr and 
Bassford (1982) have shown that the unprocessed fraction of 
pro-OmpA-B-lactamase is clearly distinguishable from the 
processed form by 12% and 15% SDS-PAGE. There is no evidence of 
a doublet in either the total or shocked cell fractions which 
suggests that the majority of the expressed A-chain has lost 
the signal peptide and the A-chain seen in the shocked cell 
fraction is due to inefficient periplasmic shock.
Summary o f Barlttiaam ifi exp ressio n
Periplasmic expression was initially chosen for expression 
because purification from the periplasmic fraction was expected 
to be relatively simple due to the low number of contaminants.
The secreted recombinant A-chain contains an additional 
alanine at the amino-terminus. The amino-terminus of ricin has 
prevously been shown to be mobile and flexible (Bushuev and 
Tor.evitsky, 1989) and mutations within the first 18 residues 
(Bradley et a l ., 1989) or a deletion of the first 9 residues of 
ricin A-chain (May et al., 1989) do not alter activity or 
solubility. Based on the close structural relationship between 
ricin and abrin C an additional alanine residue at the amino 
terminus would not be expected to alter the properties of the 
protein significantly.
Periplasmic expression was successful, however because of 
the relatively low yield of A-chain obtained in the periplasmic 
fraction and the problems associated with scaling up the 
procedure for purification, cytoplasmic expression was pursued 
for purification of recombinant abrin A-chain.
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3.8.2 Cytoplasmic expression
Cytoplasmic expression construct for native sequence 
The first construct prepared for cytoplasmic expression 
consisted of the mature A-chain sequence cloned into pKK-233-2, 
utilising the ATG codon provided within the Ncol site of the 
vector. The mature A-chain sequence was recovered by PCR using 
the primers 9A-F and 9A-R (shown in Figure 28B) . The PCR 
product was blunted at the 5' SacI site prior to digestion with 
Hindlll. The A-chain fragment was then subcloned into the 
pKK233-2 vector which had been sequentially digested with Ncol, 
followed by filling in of the 5' overhang, and then Hindlll. 
The final construct was designated as pKK-9Al. The cloning 
strategy is summarised in Figure 31.
Cytoplasmic expression in E . coli 
The results from cytoplasmic expression of the mature A- 
chain at 37°C using the construct pKK-9Al are shown in Figure 
32. On analysis by SDS-PAGE and Coomassie blue staining (Figure 
32A) there is no evidence of an expressed protein of the 
expected size in the total cell fraction (lane 3) compared to 
the non-recombinant vector control (lane 2). Western blot 
analysis using [125I]-protein A as the development system 
(Figure 32B) shows that there is an immunoreactive band of 
28kDa present in the total cell sonicate (lane 3) which is not 
present in the control (lane 2). Recombinant A-chain is 
therefore being expressed but levels are exceedingly low at 
less than 0.1% of total protein. The product is also insoluble 
as the A-chain is found exclusively in the pelleted fraction 
(lane 4) .
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Figure 31 Summary of the cloning strategy for cytoplasmic A- 
chain expression construct pKK-9Al
9A-F
Leader A-chain '¡nks;______ B-chain
A
9A-R 
1 PCR
A-chain
Sacl i . Hindlll ^  
a) Sacl digest/overhang blunt 
1 b) Hindlll digest
A-chain
{5a G ~ w i — i
____________  P KK 233-2
a) Ncol/overhang filled
b) Hindlll digest
t r c - ^ -
rbs
PK K -9A 1
pQK9
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Figure 32 Cytoplasmic expression of native A-chain sequence in 
E.coli JM 1 0 9  h a r b o u r i n g  p K K -9 A l  w a s c u l t u r e d  t o  a n  O D6 0 0  o f  
0 . 8 ,  i n d u c e d  w i t h  ImM IP T G  an d  c u l t u r e d  f o r  a  f u r t h e r  3 h o u r s .  
T h e  c e l l s  w e re  h a r v e s t e d  an d  p r o t e i n  f r a c t i o n s  w e re  p r e p a r e d  a s  
d e s c r i b e d  ( s e c t i o n  2 . 1 6 . 1 ) .  T h e  p r o t e i n  f r a c t i o n s  w e re  a n a l y s e d  
b y  (A )  S D S -P A G E  a n d  C o o m a s s ie  b lu e  s t a i n i n g  a n d  b y  (B )  W e s t e r n  
b l o t  u s i n g  t h e  [ 1 2 5 I ] - p r o t e i n  A  d e v e lo p m e n t  s y s t e m  a s  d e s c r i b e d  
( s e c t i o n  2 . 1 8 . 2 ) .  L a n e  1 , p r e s t a in e d  lo w  m o l e c u l a r  w e ig h t  
m a r k e r s ;  la n e  2 , n o n - r e c o m b in a n t  v e c t o r  c o n t r o l ;  l a n e s  3 - 5 ,  
t o t a l ,  i n s o l u b l e  a n d  s o l u b l e  f r a c t i o n s  r e s p e c t i v e l y  fro m  
J M 1 0 9 / p K K - 9 A l ; l a n e  6 ,  n a t i v e  a b r i n  C . T h e  a r r o w  i n d i c a t e s  
a b r i n  C  A - c h a i n
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Cytoplasmic expression of altered A-chain sequence
A potential reason for the low level of expression 
achieved with the construct pKK-9Al may have been a consequence 
of secondary structure formation within the mRNA which might 
interfere with translation. On analysis of the mRNA that would 
be transcribed from the construct pKK-9Al, a hairpin loop 
structure, close to the start codon, which could form in the 
mRNA was noted. In an effort to improve levels of expression a 
second cytoplasmic expression construct was generated in which 
the codons at the 5' end of the mature A-chain sequence were 
altered to contain maximal A+T content and to reduce any 
potential secondary structure formation within the mRNA without 
altering the protein sequence.
A double stranded oligonucleotide encoding the 5' end of 
the A-chain sequence to a Haell site at nucleotide position 68 
was designed and is illustrated in Figure 33A. The 
oligonucleotides were designed so that, when annealed, the 5' 
end would consist of an Ncol overhang and the 3' end would 
consist of an Haell overhang. The final construct designated 
pKK-9A2 was generated in a tripartite ligation containing the 
double-stranded oligonucleotide, the A-chain sequence isolated 
from pKK9Al on a Haell to Hindlll fragment and the vector 
pKK233-2 digested with Ncol and Hindlll. The cloning strategy 
is illustrated in Figure 33B.
The results from expression of the A-chain in E. coli at 
37°C using the construct pKK-9A2 is shown in Figure 34. 
Analysis by SDS-PAGE and Coomassie blue staining (Figure 34A) 
shows the presence of a band of 28kDa in the total cell 
fraction (lane 3) not visible in the non-recombinant vector 
control (lane 2). However the recombinant A-chain is found in 
the insoluble pellet fraction (lane 4) . Insolubility of the 
expressed A-chain is confirmed by Western blot analysis using 
the [125I]-protein A development system (Figure 34B) showing 
that the immunoreactive product of 28kDa is found exclusively 
within the insoluble fraction (lane 4).
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Figure 34 Cytoplasmic expression of altered A-chain sequence in 
E. coli JM 109  h a r b o u r i n g  p K K -9 A 2  w a s  c u l t u r e d  t o  a n  0 D 6 0 0  o f  
0 . 8 ,  in d u c e d  w i t h  ImM IP T G  an d  c u l t u r e d  f o r  a f u r t h e r  3 h o u r s  
a t  3 7 ° C .  T h e  c e l l s  w e re  h a r v e s t e d  a n d  p r o t e i n  f r a c t i o n s  w e re  
p r e p a r e d  a s  d e s c r i b e d  ( s e c t i o n  2 . 1 6 . 1 ) .  T h e  p r o t e i n  f r a c t i o n s  
w e re  a n a ly s e d  b y  (A )  S D S -P A G E  an d  C o o m a s s ie  b lu e  s t a i n i n g  a n d  
b y  (B )  W e s t e r n  b l o t  u s i n g  t h e  [ 1 2 5 I  ] - p r o t e i n  A  d e v e lo p m e n t  
s y s t e m  a s  d e s c r i b e d  ( s e c t i o n  2 . 1 8 . 2 ) .  L a n e  1 , p r e s t a i n e d  lo w  
m o l e c u l a r  w e ig h t  m a r k e r s ;  la n e  2 ,  n o n - r e c o m b in a n t  v e c t o r  
c o n t r o l ;  l a n e s  3 - 5 ,  t o t a l ,  i n s o l u b l e  a n d  s o l u b l e  f r a c t i o n s  
r e s p e c t i v e l y  f ro m  J M 1 0 9 / p K K -9 A 2 ; l a n e  6 ,  n a t i v e  a b r i n  C. T h e  
a r r o w  i n d i c a t e s  a b r i n  C A - c h a i n
0) 2 3 4 5 o
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on A-chain solubility
A comparison was made of the effect of temperature on A- 
chain expression: three cultures of JM109 harbouring the 
expression plasmid pKK-9A2 were grown at 37°C to an OD600 of 
0.7, then two cultures were shifted to either 30°C or 18°C for 
30 minutes, and at an OD60o of 0.8 a11 cultures were induced 
with IPTG.
The results of analysis by SDS-PAGE and Western blot are 
shown in Figure 35. On a Coomassie blue stained gel (Figure 
35A) it is clear that at 30°C (lanes 6-8) the majority of the 
A-chain in the total cell fraction (lane 6) is found in the 
soluble fraction (lane 8). At 18°C there is an additional band 
in the total cell fraction (lane 9), which is also present in 
the soluble fraction (lane 11), compared to the control (lane 
2) . The Western blot (Figure 3 5B) confirms that the A-chain is 
soluble when expressed at 30°C. However the band of 
approximately 28kDa seen in the soluble fraction from 
expression at 18°C is not immunoreactive. It seems probable 
that these additional bands are E. coll host proteins which 
have been induced by the shift to the lower temperature.
Schein and Noteborn (1988) have shown that the formation 
of soluble recombinant proteins in E . coli is favoured by lower 
temperatures. Three different recombinant proteins (interferon- 
c*-2, interferon-if and murine protein Mx) with different 
physical properties undergo temperature dependent 
insolubilisation during growth in E . coli and the addition of 
soluble interferon- to E . coli lysates rendered the protein 
insoluble. It was postulated that the higher temperatures allow 
crossing of thermodynamic barriers to generate intermolecular 
reactions which involve E. coli host proteins. The rate of 
protein synthesis may also contribute to solubility since it is 
generally the overexpression of proteins that leads to 
insoluble aggregate formation (Kane and Hartley, 1988) .
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Figure 3 5 Effect of temperature on solubility of expressed A- 
chain C u l t u r e s  o f  ¿H 1 0 9  h a r b o u r in g  p K K -9 A 2  w e re  in d u c e d  a t
OD6 0 0  o f  0 , 8  w i t h  lmM IP T G  an d  t h 6 n  c u l t u r e d  t o  a n  OD6 0 0  o f  1 , 2  
a t  e i t h e r  3 7 ° C , 3 0 ° C  o r  1 8° C . P r o t e i n  f r a c t i o n s  w e re  p r e p a r e d  
a n d  a n a l y s e d  b y  (A ) S D S -P A G E  an d  C o o m a s s ie  b l u e  s t a i n i n g  a n d  b y  
(B )  W e s t e r n  b l o t  u s i n g  t h e  a n t i - ( r a b b i t  I g G ) - a l k a l i n e -  
p h o p h a t a s e  c o n j u g a t e  a s  d e s c r ib e d  ( s e c t i o n  2 . 1 8 . 2 ) .  L a n e  1 , 
p r e s t a i n e d  lo w  m o le c u la r  w e ig h t  m a r k e r s ;  l a n e  2 ,  n o n ­
r e c o m b in a n t  v e c t o r  c o n t r o l ;  l a n e  3 - 5 ,  t o t a l ,  i n s o l u b l e  a n d  
s o l u b l e  f r a c t i o n  r e s p e c t i v e l y  a t  3 7 ° C ; l a n e s  6 - 8 ,  t o t a l ,  
i n s o l u b l e  a n d  s o l u b l e  f r a c t i o n s  r e s p e c t i v e l y  a t  3 0 ° C ;  l a n e s  9 -  
1 1 , t o t a l ,  i n s o l u b l e  and  s o l u b l e  f r a c t i o n s  r e s p e c t i v e l y  a t  
1 8 ° C ; l a n e  12 ,  n a t i v e  a b r i n  C . The  a r r o w  i n d i c a t e s  t h e  a b r i n  
A - c h a i n
A) 1 2 3 4 5 6 7 8 910 1 112
kOo
110
B) 2 3 4 5 6 7 8 9 10 1112
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The expression of ricin A-chain in E. coli is found to be 
temperature dependent. Piatak et al., (1988) showed that ricin
A-chain was insoluble and inactive when expressed at 42°C and 
O'Hare et al. (1987) showed that ricin A-chain formed insoluble 
aggregates with reduced activity when expressed at 37°C 
compared to fully soluble, biologically active ricin A-chain 
expressed at 30°C. Trichosanthin, a type I ribosome- 
inactivating protein, undergoes a conformational change at 35°C 
(personal communication, Dr. J. Wang, Institute of Biophysics, 
Beijing, China). In nature, the ribosome-inactivating proteins 
would be expressed at temperatures considerably lower than 37°C 
and therefore the most energetically stable conformation of the 
protein i.e. a stable, soluble and active conformation, may be 
altered by the higher temperature leading to an insoluble 
protein of reduced or no activity
Analysis of the gel in Figure 35A, and others, using a 
densitometer shows that soluble A-chain is expressed at levels 
exceeding 6% of total cellular protein when expressed at 30°C.
The samples analysed by Western blot and shown in Figure 
35B were 24 hours post-sonication and had been stored at 4°C. 
It is clear from the Western blot that there is breakdown of 
the A-chain into specific polypeptides on storage of the cell 
sonicates. Inclusion of leupeptin in sonication buffer did not 
improve on this degree of breakdown over a 24 hour storage 
time. Protease action on cytoplasmically-expressed heterologous 
proteins is a common problem (Marston, 1986).
3.8.4 In vitro activity in cell extracts containing A-
chain
To determine activity of the expressed A-chain in the 
crude cell extracts, the in vitro assay was used (section 
2.20.2). However the RNA was severely degraded due to RNases. 
To overcome this the crude cell extracts were preincubated with 
20mM vanadyl ribonucleoside complex at 37°C for 1 hour prior to 
incubation with the ribosomes.
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Figure 36 N-glycosidase activity in crude extracts of E. coli 
expressing A-chain The crude cell fractions were preincubated 
with 20mM vanadyl ribonucleoside complex for 1 hour at 30°C. A 
30/il volume of rabbit reticulocyte lysate was incubated with 
l/il of the crude cell extract for 30 minutes at 30°C; the RNA 
was extracted and treated with aniline for 2 minutes at 65°C 
and analysed as described (section 2.20.2). Lane 1, total 
extract from non-recombinant vector control; lanes 2-4, total, 
insoluble and soluble fractions respectively from JM109/pKK-9A2 
cultured at 37°C; lanes 5-7, total, insoluble and soluble 
fractions respectively from JM109/pKK-9A2 cultured at 30°C; 
lanes 8-10, total, insoluble and soluble fractions respectively 
from JM109/pKK-9A2 cultured at 18°C; lane 11, total extract 
from JM109/pKK-9A2 cultured at 30°C, no aniline treatment; 
lanes 11 and 12, O.lnq ricin A-chain plus and minus aniline 
treatment respectively. The diagnostic 400b fragment released 
from 28S rRNA by ricin is indicated
1 2 3 4 5 6 7 8 9 10 11 12 13
28S 
18S
400b
5.8S
5S
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The results of the in vitro assay are shown in Figure 36. 
Lane 12 illustrates the diagnostic 400b fragment released from 
28S rRNA by aniline after incubation with O.lug ricin. This 
400b fragment is absent when treatment of aniline is omitted 
(lane 13) or incubation with ricin is omitted (lane 11). Lane 1 
shows that there is no N-glycosidase activity associated with a 
non-recombinant vector control. Lanes 2 to 10 inclusive show 
that activity as a consequence of A-chain expression is found 
at all expression temperatures and activity can be detected in 
both soluble and insoluble fractions.
3,8.5 Effect of IPTO OP A-Chain expression levels
To determine if the amount of IPTG could alter or improve 
the amount of A-chain expressed several different IPTG 
concentrations were used for induction of A-chain expression at 
30°C. The result is shown in Figure 37. The amount of soluble 
A-chain produced is not significantly altered by the IPTG 
concentration but ImM IPTG was the optimum of the 
concentrations tested here (lane 1).
Previously very low concentrations of IPTG (5/iM) for 
induction have been shown to improve the production of 
heterologous genes expressed in E. coli (Takagi et al., 1988). 
Generally however the low inducer concentrations improve 
expression levels when higher IPTG concentrations lead to a 
massive induction of the heterologous protein which forms 
aggregates. By slowing down the rate of expression and 
preventing aggregate formation, the amount of soluble product 
is increased. In the system used here the product is not 
forming aggregates and a slower rate of production of the A- 
chain does not improve the yield.
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Figure 37 Effect of IPTG concentration, at induction, on A- 
chain expression Cultures of JM109 harbouring pKK-9A2 were 
induced at OD600 of 0.8 and at 30°C with either ImM, lOO^M or 
lOOnM IPTG. Total cell sonicates were analysed by SDS-PAGE and 
Coomassie blue staining. Lanes 1 and 6, prestained low 
molecular weight markers; lane 2, ImM IPTG; lane 3, 100/iM IPTG; 
lane 4, lOOnM IPTG; lane 5, native abrin C. The arrow indicates 
the A-chain
-185-
3.8.6 Growth r»t«8 and plasmid stability
E. coli ribosomes have been shown to be resistant to the 
action of ricin and abrin C therefore toxicity of the 
recombinant protein to the cells was not expected. However, 
during the construction of the vectors pKK-9Al and pKK-9A2, no 
transformants could be obtained when the host strain used to 
prepare competent cells was JM109 which had lost the F' 
episome. The episome carries the gene for the repressor of the 
tac promoter such that there is no transcription in the absence 
of inducer. The problem of low transformation efficiency in 
JM109/F'” suggested that expression of the recombinant A-chain 
was leading to negative selection pressure.
Habuka et al., (1990) have shown that a type I ribosome­
inactivating protein, Mirabilis antiviral protein (MAP), 
inhibited the growth of E. coli when (MAP) was expressed 
cytoplasmically. MAP was found to have an IC50 of 200nM in an 
E. coli in vitro translation system. Habuka et al. (1989) could 
not obtain transformants containing the MAP expression plasmid 
in strains lacking laclq such as HB101 and DH1. Trichosanthin 
has been expressed cytoplasmically in E. coli, (Chow et al., 
1S90), and constitutive expression during growth of the host 
strain gave optimal levels of the recombinant trichosanthin 
(personal communication. Dr M. Piatak, Genelabs, California, 
USA). Chow et al. did not analyse the E . coli ribosomes, from a 
culture expressing trichosanthin, for modification but based on 
the good growth of the cultures and the ability of the host to 
support constitutive expression of trichosanthin it is highly 
improbable that trichosanthin modifies E. coli ribosomes.
Faced with the possibility that the recombinant abrin was 
toxic to E. coli, transformations were carried out using 
minimal media to prepare competent cells and to plate out 
transformants. This was to ensure maintenance of the F' episome 
to prevent expression of the recombinant abrin in positive 
transformants. Percent positive transformants in JM109 carrying 
the episome was high using this method. It should be noted that
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in generating the periplasmic constructs no problems with 
obtaining positive transformants occurred. In the case of 
periplasmic expression the protein is expected to be exported 
to the periplasmic space, and therefore the recombinant abrin 
will be sequestered in a compartment without access to the host 
ribosomes. In addition, although ricin A-chain retains activity 
with an amino-terminal extension, in the form of a fusion 
protein (Frankel et al., 1989 and O'Hare et al. , 1987), the Omp 
A signal peptide may alter the conformation of the protein 
sufficiently to alter activity.
Growth curves of various cultures of JM109 harbouring pKK- 
9A2 under different conditions of induction and in either 
minimal media or LB media are shown in Figure 38A and Figure 
38B respectively. The optical density of the control 
(JM109/non-recombinant vector control) was always higher after 
extended periods of growth than a recombinant vector. This 
suggested that the promoter in the expression constructs is 
leaky and even low levels of expression slowed growth. 
Recombinant A-chain could be detected in cultures grown in LB 
and minimal media, in the absence of added IPTG although in 
minimal media the level of expressed A-chain was at the lower 
limit of detection. Growth is slowed by constitutive expression 
of recombinant A-chain in both LB and minimal media and the 
yield of A-chain was less than from cultures induced during 
late exponential growth.
The degree of inhibition of growth due to expression of 
the recombinant abrin A-chain was significantly less than that 
seen for MAP where growth of the E. coll host stopped within 1 
hour of expression. It therefore seemed most likely that it was 
the burden on the host cell of producing the additional 
recombinant protein and of replicating the larger plasmid that 
was slowing growth rather than any toxicity of the protein per 
se.
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Figure 38 Growth curves of JM109 harbouring pKK-9A2 Overnight 
cultures of JM109 harbouring pKK9A2 or pKK233-2 in minimal 
media supplemented with ampicillin were diluted 1 in 100 into 
either (A) LB media, or (B) minimal media and were cultured at 
30°C. The cultures were induced at either t=0 (c) or when the 
OD6oo reached 0.8 (i).
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Minimal media was selected for expression of recombinant 
A-chain for purification, and the cultures were induced at the 
end of exponential growth when the cells would be able to 
support the rapid burst of protein synthesis. A supplement of 
caseamino acids provided an exogenous source of amino acids at 
this stage.
Harris and Emtage (1986) reported the instability of a 
plasmid encoding prochymosin during culture. To check the 
stability of the plasmid and the F' episome in the system 
described here aliquots of a culture of JM109/pKK-9A2 grown in 
minimal media to OD60o of 0.8, then induced with ImM IPTG and 
cultured for a further 3 hours, were serially diluted and 
plated out on several different selection plates in triplicate: 
LB plates (for total counts), LB plates supplemented with 
ampicillin (for cells retaining the plasmid), minimal media 
plates (for cells retaining the episome) and minimal media 
plates supplemented with ampicillin (for cells retaining both 
plasmid and episome). The results (Table 5) showed that the 
difference in number of cells on each of the four selection 
plates was not statistically significant with the range being 
from 95% to 102% of the control. This showed that under the 
conditions of expression used the plasmid and the episome were 
stable.
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Table 5 Stability of pKK-9A2 and the F' episome in JM109 A 
culture of JM109 harbouring pKK-9A2 was cultured in minimal 
media to an OD600 of 0.8, induced with ImM IPTG and 
supplemented with 2% caseamino acids then cultured for a 
further 3 hours. The culture was serially diluted and plated 
out in triplicate onto selective media plates. The experiment 
was carried out in triplicate
Selective media Number of colonies as % of control
1 2 2 Average
LB 100 100 100 100
LB + ampicillin 96 108 102 102
Minimal media 88 84 113 95
Minimal media + ampicillin 102 101 94 99
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off A-chain expression
To obtain satisfactory amounts of recombinant A-chain for 
purification it was necessary to alter the nucleotide sequence 
of the A-chain to reduce secondary structure within the 
transcribed RNA. Cytoplasmic expression of soluble active A- 
chain at levels exceeding 6% of total protein were achieved by 
reducing the temperature of the cultures at induction, with ImM 
IPTG, to 30°C. Constitutive expression of the A-chain did not 
improve yield. Minimal media, supplemented with 2% caseamino 
acids at induction, gave the optimum yield of A-chain and under 
the selected conditions for large scale culture the plasmid and 
F' episome are stable.
A problem encountered with cytoplasmic expression was that 
of protease action on the recombinant abrin A-chain. The degree 
of breakdown increased with storage time. The amount of intact 
A-chain even after 24 hours of storage was significantly higher 
than for the other constructs and with prompt purification the 
degree of breakdown could be minimised.
3.9 PURIFICATION OF_ABCOMBIMAMT A-CHAIN
Ammonium sulphate precipitation
Initially a 50% ammonium sulphate precipitation was used 
to reduce the volume of crude cell extract for ease of 
handling. At 50% all the A-chain precipitated. However when a 
range of ammonium sulphate concentrations were used 
sequentially to precipitate proteins it was found that intact 
A-chain precipitated at lower ammonium sulphate concentrations 
than the degraded A-chain fragments. The result is shown in 
Figure 39. This procedure allowed removal of the smaller A- 
chain products and also allowed analysis of the breakdown 
polypeptides in isolation. For the final scheme devised for 
large scale purification of A-chain a 20-30% ammonium sulphate 
cut was used to concentrate and enrich for the A-chain.
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F i g u r e  39  Ammonium sulphate precipitation of cell sonicates 
S o l i d  am m onium  s u l p h a t e  w a s  a d d e d  t o  c r u d e  c e l l  s o n i c a t e  an d  
t h e  p r e c i p i t a t e d  p r o t e i n s  w e re  r e c o v e r e d  b y  c e n t r i f u g a t i o n  and  
r e s u s p e n d e d  i n  1 t im e s  S D S -P A G E  l o a d i n g  b u f f e r .  S e q u e n t i a l  
am m onium  s u l p h a t e  p r e c i p i t a t i o n s  o f  i n c r e a s i n g  c o n c e n t r a t i o n s  
w e re  p e r f o r m e d  o n  t h e  s u p e r n a t a n t .  T h e  s a m p le s  w e re  a n a l y s e d  b y  
(A ) S D S -P A G E  a n d  C o o m a s s ie  b lu e  s t a i n i n g  an d  b y  ( B )  W e s t e r n  
b l o t  u s i n g  t h e  a n t i - ( r a b b i t  I g G ) - a l k a l i n e - p h o s p h a t a s e  c o n j u g a t e  
a s  d e s c r i b e d  ( s e c t i o n  2 . 1 8 . 2 ) .  L a n e  1 ,  p r e s t a in e d  lo w  m o l e c u l a r  
w e i g h t  m a r k e r s ;  l a n e  2 ,  t o t a l  c e l l  s o n i c a t e ;  l a n e s  3 - 8 ,  0 - 2 0 % ,  
> 2 0 % —3 0 % ,  > 3 0 % - 4 0 % , > 4 0 % - 5 0 % , > 5 0 % -6 0 %  a n d  > 6 0 % -7 0 %  ammonium  
s u l p h a t e  p r e c i p i t a t i o n s  r e s p e c t i v e l y ;  l a n e  9 ,  n a t i v e  a b r i n  C. 
T h e  a r r o w  i n d i c a t e s  t h e  A - c h a i n .
(C ) N-glycosidase activity in precipitated fractions E a c h  
sa m p le  w a s  a s s a y e d  f o r  in vitro a c t i v i t y  a s  d e s c r i b e d  i n  th e  
l e g e n d  t o  F i g u r e  3 6 .  L a n e s  1 a n d  2 ,  Ipq r i c i n  A - c h a i n  m in u s  and  
p l u s  a n i l i n e  t r e a t m e n t  r e s p e c t i v e l y ;  l a n e s  4 a n d  5 ,  t o t a l  c e l l  
s o n i c a t e  m in u s  a n d  p l u s  a n i l i n e  t r e a t m e n t  r e s p e c t i v e l y ;  l a n e s  
5 - 1 0 ,  a s  f o r  l a n e s  3 - 8  a b o v e  r e s p e c t i v e l y
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3.9.2 Gel filtration on Sephadex G75
To reduce the amounts of contaminating E. coli proteins 
from the ammonium sulphate precipitation, gel filtration on G75 
was used. The result is shown in Figure 40. Gel filtration gave 
a reasonable enrichment of A-chain when a small volume column 
was used (1cm x 30cm) and analytical ammounts were loaded. 
However when the procedure was scaled up to a lm x 2.5cm column 
the results were less satisfactory and the A-chain eluted 
within a large volume which would therefore require 
concentration before application to the next step in 
purification. Gel filtration was therefore not used in 
purification of A-chain from a 1 litre culture.
Figure 40 Gel filtration on Sephadex G-75 A 20%-30% ammonium 
sulphate precipitate was resuspended in 1/10 growth volume of 
10mM phosphate buffer, pH 7.5, 250mM NaCl and then dialysed 
against this buffer overnight at 4°C. A 0.5ml volume was loaded 
onto a 1 x 30cm Sephadex G-75 column pre-equilibrated with lOmM 
phoshate buffer, pH 7.5, 250mM NaCl. The column was washed with 
lOmM phosphate buffer, pH 7.5, 250mM NaCl at a flow rate of 
0.25ml per minute and 1ml fractions were collected. The 
fractions were analysed by SDS-PAGE and Coomassie blue 
staining. M, prestained molecular weight markers; AC, native 
abrin C. The fraction numbers analysed are indicated and the 
arrow indicates the A-chain
M 10 15 20 25  30  35 40  4 5  AC
kDa
110
84
47
33
24
-194-
3.9.3 HPLC on DEAE-Sephadex
Because of the problem of breakdown of the intact A-chain 
by E. coli proteases a purification step which gave a high 
degree of enrichment of the A-chain and removal of the 
contaminating proteases was required. In addition the 
conditions must be non-denaturing. Sephadex was the matrix of 
choice because it is bead-formed and therefore has good flow 
properties and packs easily. Sephadex is hydrophilic and 
therefore has low non-specific absorbance for proteins and does 
not denature biological molecules. To select the functional 
group, small 1ml columns of several ion exchangers were 
prepared in 1ml disposable syringes to analyse for A-chain 
binding. DEAE-Sephadex was shown to be suitable and was 
selected for large scale purification of the recombinant abrin 
A-chain.
The elution profile from HPLC using the DEAE-Sephadex 
column is shown in Figure 41. The A-chain eluted at 
approximately 250mM NaCl and was readily detected on stained 
SDS—PAGE gel (Figure 41A) in a single peak which was generally 
found in two sequential 6ml fractions. This was confirmed by 
Western blot analysis (Figure 41B). Once the elution profile of 
the A-chain had been determined, 1ml fractions were collected 
during the portion of the gradient when the A-chain eluted and 
Figure 42A shows a stained gel of sequential fractions 
containing the A-chain eluted at 250mM HaCl from a DEAE- 
Sephadex column. A high degree of enrichment was obtained and 
the majority of contaminating proteins were removed in this 
single stage of purification. A range of pH conditions was 
analysed but no improvement on the degree of purification was 
obtained. At pH9 or above, the capacity of the column was 
reduced significantly and at pH 7 the A-chain eluted at a lower 
NaCl concentration with an increase in the amounts of 
contaminating protein.
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F i g u r e  41  Enrichment of the A-chain by HPLC on DEAE-Sephadex A 
2 0 % —30% ammonium  s u lp h a t e  p r e c i p i t a t i o n  o f  c e l l  s o n i c a t e  w as 
r e s u s p e n d e d  i n  1 / 1 0  g r o w t h  vo lu m e  lOmM p h o s p h a te  b u f f e r ,  pH 
7 . 5 ,  25mM N a C l  ( s t a r t  b u f f e r ) .  T h e  s a m p le  w a s  d i a l y s e d  a g a i n s t  
t h e  s t a r t  b u f f e r  o v e r n i g h t  a t  4°C . A  D E A E - S e p h a d e x  c o lu m n  w as 
e q u i l i b r a t e d  w i t h  s t a r t  b u f f e r  a t  a  f l o w  r a t e  o f  3m l p e r  m in u te  
a n d  t h e  OD2 8 0  b a s e l i n e  w as e s t a b l i s h e d .  A  5m l sa m p le  w a s  lo a d e d  
a n d  t h e  c o lu m n  w as w ash e d  w i t h  s t a r t  b u f f e r  u n t i l  t h e  b a s e l i n e  
v a l u e  w as r e a c h e d .  Boun d  p r o t e i n s  w e re  e l u t e d  w i t h  a  g r a d i e n t  
o f  N a C l f ro m  25mM t o  500mM i n  lOmM p h o s p h a t e  b u f f e r ,  pH  7 . 5  a t  
a  f l o w  r a t e  o f  3m l p e r  m in u te  a n d  6m l f r a c t i o n s  w e re  c o l l e c t e d .  
T h e  e l u t e d  f r a c t i o n s  w e re  a n a ly s e d  b y  (A) S D S -P A G E  an d  
C o o m a s s ie  b l u e  s t a i n i n g  a n d  b y  (B )  W e s t e r n  b l o t  u s i n g  t h e  a n t i -  
( r a b b i t  I g G ) - a l k a l i n e - p h o s p h a t a s e  c o n j u g a t e  a s  d e s c r i b e d  
( s e c t i o n  2 . 1 8 . 2 ) .  M, p r e s t a in e d  m o l e c u l a r  w e ig h t  m a r k e r s ;  AC , 
n a t i v e  a b r i n  C ;  S ,  lo a d e d  sa m p le .  T h e  f r a c t i o n  n u m b e rs  a n a ly s e d  
a r e  i n d i c a t e d  a n d  t h e  a r ro w  i n d i c a t e s  t h e  A - c h a i n
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F i g u r e  42  Activity of the A-chain-containing fractions eluted 
from DEAE-Sephadex H PLC  o n  D E A E -S e p h a d e x  w a s  p e r fo r m e d  a s  
d e s c r i b e d  i n  t h e  l e g e n d  t o  F i g u r e  41  e x c e p t  t h a t  1m l f r a c t i o n s  
w e re  c o l l e c t e d .  T h e  f r a c t i o n s  c o n t a i n i n g  t h e  A - c h a i n  a r e  sh o w n  
b y  (A ) S D S -P A G E  an d  C o o m a s s ie  b lu e  s t a i n i n g  w h e re  t h e  f r a c t i o n  
n u m b e rs  a n a l y s e d  a r e  i n d i c a t e d .  M, p r e s t a in e d  m o le c u la r  w e i g h t  
m a r k e r s ;  A C , n a t i v e  a b r i n  C . T h e  a r r o w  i n d i c a t e s  t h e  A - c h a i n .  
T h e  f r a c t i o n  n u m b e rs  3 9 - 4 5  sh ow n  i n  (A ) w e re  p o o le d  a n d  a  l u l  
a l i q u o t  w a s  u s e d  t o  (B )  d e t e r m in e  t h e  a c t i v i t y  a g a i n s t  r a b b i t  
r e t i c u l o c y t e  l y s a t e  a s  d e s c r i b e d  ( s e c t i o n  2 . 2 0 . 2 ) .  L a n e s  1 a n d  
2 ,  t r e a t m e n t  w i t h  O . l u g  r i c i n  A - c h a i n  m in u s  a n d  p l u s  a n i l i n e  
r e s p e c t i v e l y ;  l a n e s  3 a n d  4 , l u l  p a r t i a l l y  p u r i f i e d  a b r i n  A -  
c h a i n  m in u s  a n d  p l u s  a n i l i n e  t r e a t m e n t  r e s p e c t i v e l y
-facing 197-

The fractions containing A-chain were pooled and a 1/il 
aliquot was used to determine if in vitro activity could be 
detected against rabbit reticulocyte lysate (section 2.20.2). 
The result is shown in Figure 42B. The diagnostic 400b fragment 
is clearly visible when the ribosomes were incubated with the 
pertially purified A-chain followed by aniline treatment of the 
rRNA (lane 4).
The intact A-chain was contained in a total of less than 
10ml eluent, which allowed direct application to the Blue- 
Sepharose CL-6B column, after dialysis, without concentration.
3.9.4 Purification on Blua-Sapharoftft C L - «
For the final step in purification affinity chromatography 
was chosen to select the recombinant abrin A-chain on the basis 
of its biological function. Blue Sepharose CL-6B contains the 
dye, Cibacron Blue F3G-A, which has affinity for a variety of 
enzymes and proteins. The partial structure of Blue Sepharose
1979) as does gelonin and it has been postulated that the 
interaction of the ribosome-inactivating proteins with the dye 
is via the active site of these proteins. The dye resembles 
dinucleotides in 3-dimensional structures (Knowles and Thorpe, 
1987) and it can be envisaged that the ribosome-inactivating 
proteins can interact with the ligand in a similar manner to 
the way they would interact with the RNA in the ribosome. Blue- 
Sepharose has been used to purify immunotoxins containing ricin 
A-chain, abrin A-chain and gelonin from unconjugated antibody 
(Lambert et a l ., 1985, Cumber et a l ., 1990 and Ghetie et a l . ,  
1990).
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Figure 43 Purification of A-chain on Blue-Sepharose CL-6B The 
partially purified A-chain was dialysed against lOmM phosphate 
buffer, pH 7.5, 25mM NaCl overnight at 4°C. A 1 x 30cm column 
of Blue-Sepharose CL-6B was eqilibrated with lOmM phosphate 
buffer, pH 7.5, 25mM NaCl at a flow rate of 0.2ml per minute 
and the OD280 baseline was established. The sample was loaded 
and the column was washed with lOmM phosphate buffer, pH 7.5, 
2 5mM NaCl at a flow rate of 0.125ml per minute until the 
baseline value was reached. Bound protein was eluted with a 
gradient of NaCl from 25mM-1000mM in lOmM phosphate buffer, pH 
7.5, at a flow rate of 0.125ml per minute and 1ml fractions 
were collected. The fractions were analysed by (A) SDS-PAGE and 
silver staining and by (B) Western blot using the anti-(rabbit 
IgG)-alkaline-phosphatase conjugate as described (section 
2.18.2). M, prestained molecular weight markers; AC, native 
abrin C. The fraction numbers analysed are indicated and the 
arrow indicates the A-chain
M 38  39 4 0  41 4 2  43  44 45  M
kDo
66.2
\
45
31
B ) S  40  41 4 2  4 3  44  45 AC
The elution profile obtained from Blue-Sepharose CL-6B is 
shown in Figure 43. The A-chain eluted as a single peak in 
approximately 5ml of eluent at 3 00mM NaCl.
The pooled A-chain fractions were analysed by SDS-PAGE and 
by HPLC on DEAE-Sephadex and the results are shown in Figure 
44. The A-chain is estimated to be greater than 99% pure. Using 
the extinction coefficient of abrin C A-chain of 7.87 the yield 
of pure A-chain was approximately lmg/ litre of culture.
3.9.5 Storage of purified A-chain
Ricin A-chain and the type I ribosome-inactivating 
proteins are generally stored at 4°C without significant loss 
of activity. The purified abrin-related A-chain was initially 
stored at 4°C but was found to lose all activity within 14 
days. The protein also insolubilised during this time. The 
isoform abrin-b was also noted to be relatively unstable (Lin 
et al., 1982). The A-chain was therefore stored at -20°C in the 
presence of 15% (v/v) glycerol. The A-chain was stable under 
these conditions as determined from the in vitro assay for 
activity (section 2 .2 0 .2 ).
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F i g u r e  4 4 Analysis o f  the purity of the A-chain The f r a c t i o n s  
c o n t a i n i n g  A - c h a in  t h a t  were e lu te d  from  B lu e -S e p h a ro s e  C L -6 B  
w ere  p o o le d  and  d i a l y s e d  a g a in s t  PBS o v e r n ig h t  a t  4°C . The 
p u r i f i e d  A - c h a in  w as a n a ly s e d  by (A) SDS -PAG E and  C o o m a s s ie  
b lu e  s t a i n i n g ;  la n e s  1 and 4. m o le c u la r  w e ig h t  m a rk e r s ;  la n e  2, 
0 . 0 1  OD28 0  u n i t s  c e l l  s o n i c a t e ;  la n e  3, 0 .0 1  OD280 u n i t s
p u r i f i e d  A - c h a in ;  and by (B ) HPLC on  D EAE -Sephadex a s  d e s c r ib e d  
( s e c t i o n  2 . 1 9 . 3 ) .  The peak c o r re s p o n d in g  t o  th e  A - c h a in  i s  
i n d i c a t e dA) 1 2  3  4
kOo
9.10 IlUilXBQ. ACTIVITY Of  PPRiriBP M BMUIMMB M U M
3.10.1 8»Bsi^lyltY_Qi.-£ibogOBtg %<? ft-chajn
To determine the sensitivity of ribosomes to the activity 
of the purified recombinant A-chain, ribosomes from a variety 
of sources were used as the substrate in the in vitro assay 
(section 2.20.2). The positive control used was incubation of 
the ribosomes with 0.1/ig PAP which has been shown to be active 
on all the ribosome species analysed here (personal 
communication. Dr M.R. Hartley, University of Warwick).
The result is shown in Figure 45. The diagnostic fragment 
is absent when aniline treatment is omitted (lanes 1 and 3) or 
without treatment of the ribosomes with a ribosome-inactivating 
protein (lane 1). The A-chain has activity against yeast 
ribosomes (Y, lane 3), rabbit reticulocyte lysate ribosomes (R, 
lane 3) and tobacco ribosomes (T, lane 3) but no activity was 
detected against chloroplast ribosomes (C, lane 3) or E. coli 
ribosomes (E, lane 3). The concentration of the recombinant A- 
chain in this assay is approximately 6 x 10-6M.
The type II ribosome-inactivating proteins abrin C and 
ricin share a similar profile of activity: eukaryotic ribosomes 
are sensitive whereas prokaryotic ribosomes are insensitive.
Plant ribosomes tend to be less sensitive to the action of 
ribosome-inactivating proteins. Stirpe and Hughes (1989) 
determined the IC50 values of 6 different ribosome-inactivating 
proteins against a variety of plant and protazoan species using 
poly(U)-directed phenylalanine polymerisation. The results 
showed that ribosome-inactivating proteins were inactive 
against ribosomes from their own plant species but ribosomes 
from any one plant showed a large range of sensitivities to 
different ribosome-inactivating proteins. Ribosome-inactivating 
proteins from taxonomically related plants were more similar, 
in their activity, to each other than to ribosome-inactivating 
proteins from distantly-related species.
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Figura 45 Sensitivity of ribosomes to the A-chain Approximately 
10ng of ribosomes, isolated from S.cerevisiae (Y) , rabbit liver 
(R) , tobacco leaves (T), spinach chloroplasts (C) or E. coli 
(E) , were incubated with either O.lnq PAP or lug purified 
recombinant abrin A-chain for 1 hour at 30°C. The rRNA was 
extracted and incubated with aniline and analysed as described 
(section 2.20.2). Lanes 1, no treatment; lane 2, incubation 
with PAP; lane 3, incubation with the abrin A-chain; lane 4, 
incubation with the abrin A-chain minus aniline treatment The 
diagnostic fragment released by PAP is indicated
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Unfortunately, Stirpe does not indicate how the plant 
ribosomes were isolated and therefore the ribosome preparations 
may have been heavily contaminated with chloroplast ribosomes. 
Chloroplast ribosomes were shown here to be resistant to the 
action of the recombinant abrin A-chain and chloroplast 
ribosomes are insensitive to ricin A-chain (personal 
communication. Dr M.R. Hartley, University of Warwick). The 
detection method used of poly(U)-directed phenylalanine 
polymerisation is a relatively poor method for determining 
activity therefore the results of Stirpe and co-workers must be 
viewed with caution.
It is clear that there is extensive variability in the 
sensitivity of ribosomes to the action of ribosome-inactivating 
proteins. Amongst the protozoa, Tetrahymena pyriformis and 
Acanthamoeba castellanii ribosomes show differing degrees of 
sensitivities to dianthin, abrin and ricin (Cenini et a l . , 
1987). Brigotti et al. (1989) has shown that this variability 
extends to the metazoa. Artemia salina ribosomes are sensitive 
to PAP, ricin and momordin but are remarkably resistant to 
gelonin. The ribosomes of the Trypanosoma and of the Leishmania 
exibit different sensitivities to abrin but are resistant to 
ricin (Cenini et al., 1988).
Generally, ribosomes are resistant to the action of the 
ribosome-inactivating protein(s) from the parent plant but this 
is not absolute. Clearly, if the plant is susceptible to the 
action of its own ribosome-inactivating protein the protein 
must be sequestered within a compartment of the plant cell or 
maintained in an inactive conformation. The spacial 
distribution of most ribosome-inactivating proteins is not 
known. PAP has been shown to be localised within the cell wall 
matrix of mesodermal cells of P. americana and is therefore 
extracellular (Ready et al., 1986). Taylor and Irvin (1990) 
have shown that ribosomes from P. americana are depurinated 
during extraction. Ricin and abrin are sequestered within the 
protein storage bodies and until sequestration are in an 
inactive conformation due to the presence of the linker
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sequence. Ricin A-chain has recently been shown to be active 
against R. communis ribosomes but the ribosomal RNA in the 
seed remains unmodified (Dr. M.R. Hartley, unpublished data).
The popular theory for the function of these ribosome­
inactivating proteins as anti-viral agents relies on the host 
plant being susceptible to the action of its own ribosome­
inactivating protein: on damage to the host cell by e.g. an 
aphid, or grazing of the leaf by herbivores, the ribosome­
inactivating protein is released from its storage compartment 
and kills the cell. Once the cell wall has been compromised the 
cell is open to attack by virus and the ribosome-inactivating 
proteins may act as a host suicide agent preventing viral 
spread from the primary site of infection.
Recently, three proteins isolated from barley seeds were 
found to act synergistically in inhibiting the growth of fungi. 
The three proteins were a chitinase, a (1-3)-6-glucanase and a 
30kDa ribosome-inactivating protein. The action of the 
ribosome-inactivating protein was enhanced by permeabilisation 
of the hyphal walls by the action of the chitinase and 
glucanase. There may therefore be other proteins present in the 
tissue containing the ribosome-inactivating protein which act 
synergistically in inhibiting the growth of fungi.
Q m n t i f U v »  » «U ly a ja  9t ft- gha ip  a c t i v i t y
The activity of the recombinant A-chain against yeast and 
rabbit reticulocyte lysate ribosomes was quantitated by using 
ten-fold serial dilutions of the A-chain in the assay. The 
results are shown in Figure 46. The lowest concentration of A- 
chain which modified rabbit reticulocyte lysate ribosomes was 6 
x 10”14M (Figure 46A) and the lowest concentration of A-chain 
which modified yeast ribosomes was 6 x 10“12M (Figure 46B) . 
The values obtained are 10-100 fold higher than those obtained 
for recombinant ricin A-chain assayed under the same conditions 
(Osborn, 1991). A direct comparison was not performed because 
the recombinant ricin A-chain available for assay had been
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stored for several months and activity was therefore lower than 
freshly purified recombinant A-chain.
The assay used here to determine the activity of the 
recombinant abrin A-chain is not ideal but provides an end 
point below which activity is not detected. The degree of 
modification prior to the end point can be determined by 
scanning densitometry analysis of the gels following 
electrophoresis of the modified rRNA.
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Figure 46 Quantitative analysis of the activity of the A-chain 
S e r i a l  d i l u t i o n s  o f  t h e  p u r i f i e d  r e c o m b in a n t  A - c h a i n  w e re  
i n c u b a t e d  w i t h  10/tg s a l t  w a sh e d  r ib o s o m e s  f o r  1 h o u r  a t  3 0 ° C .  
T h e  r R N A  w a s  e x t r a c t e d  a n d  t r e a t e d  w i t h  a n i l i n e  a n d  a n a ly s e d  a s  
d e s c r i b e d  ( s e c t i o n  2 . 2 0 . 2 ) .  (A ) R a b b i t  r e t i c u l o c y t e  l y s a t e  
r i b o s o m e  in c u b a t e d  w i t h :  la n e  1, P B S / a n i l i n e ;  l a n e s  2 a n d  3 ;
0 .  1/ig r i c i n  A - c h a i n ,  m in u s  an d  p l u s  a n i l i n e  t r e a t m e n t  
r e p e c t i v e l y ;  l a n e s  4 a n d  5 , 0 .1/ ig  a b r i n  A - c h a in ,  m in u s  an d  p l u s  
a n i l i n e  r e s p e c t i v e l y ;  l a n e s  6 - 1 2 ,  lO p g ,  l p g ,  O . l p g ,  O .O lp g ,  
l f g ,  O . l f g  a n d  O . O l f g  A b r i n  A - c h a i n ,  p l u s  a n i l i n e ,  
r e s p e c t i v e l y .  (B )  S. cerevisiae r ib o s o m e s  t r e a t e d  w i t h  : l a n e
1, P B S / a n i l i n e ;  l a n e s  2 an d  3 ,  0 .1/ ig  r i c i n  A - c h a i n  m in u s  a n d  
p l u s  a n i l i n e  r e s p e c t i v e l y ;  l a n e s  4 - 9 ,  0 . 1  /ig, l o n g ,  l n g ,  lO O p g , 
lO p g  a n d  l p g  a b r i n  A - c h a i n ,  p l u s  a n i l i n e ,  r e s p e c t i v e l y
-facing 207-

The other assays commonly used include inhibition of 
protein synthesis in cell free systems (Olsnes and Pihl, 1982) 
and the translation of a second message in the presence of a 
ribosome-inactivating protein mRNA (May et al. , 1989). Neither 
of these methods allow true quantitation of the activity of 
ribosome-inactivating proteins.
A new method was developed by Zamboni et al. (1989) to 
measure the amount of adenine released from ribosomes on 
treatment with a ribosome-inactivating protein and is based on 
the conversion of adenine to l,N6-ethano derivatives and 
quantitative detection using HPLC. Using [14C]-labelled 
adenine, no exchange or reverse reactions were detected and the 
product did not inhibit depurination.
The method of Zamboni et al. allowed the effect of ricin 
on ribosomes which had been pretreated with a-sarcin to be 
determined. It had been shown previously that ricin sensitises 
ribosomes to the activity of a-sarcin (Terao et al., 1988). 
Pretreatment of ribosomes with a-sarcin significantly reduced 
the N-glycosidase action of ricin (Sperti et al., 1989), and 
the conformational changes induced in the L3-L4 domain by a- 
sarcin were postulated to be responsible. From the results of 
Sperti et al. it was evident that the amount of adenine 
released did not correlate with the inhibition of protein 
synthesis. The maximum amount of adenine released was 0.8 mole 
per mole of ribosomes. At 2/3 of the maximum amount of adenine 
released protein synthesis was inhibited by 90%, at 1/3 maximum 
adenine release protein synthesis was inhibited by 66%. A 
possible conclusion which might be drawn from these results is 
that only a proportion of ribosomes are sensitive to the action 
of ricin, equivalent to about 20% of the total population. In 
addition only a proportion of the ribosome population may be 
involved in active protein synthesis. Nygard and Nillson (1988) 
demonstrated that about 80% of the ribosome population formed a 
stable high-affinity complex with EF-2 in the presence of GTP, 
the remainder formed a low-affinity complex. Treatment with 
ricin A-chain generated a homogeneous population with the low-
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affinity binding properties. The results of Zamboni et al. 
(1989) support the notion that modification of a ribosome bound 
to mRNA inactivates the polysome, the majority of the ribosomes 
being protected from the action of ricin A-chain by bound EF-2.
The development of a truly quantitative and rapid assay 
will be complex, requiring consideration of a potentially 
resistant ribosome population, of inactivation of polysomes by 
the modification of only one or a few molecules of 28S rRNA 
within the polysome and of the protective effect of EF-2
The specific depurination reaction carried out by the 
ribosome-inactivating proteins is now well understood but the 
gross effects on the protein synthesising machinery continues 
to be investigated. It now seems clear that initiation is 
inhibited by these proteins in addition to elongation. Osborn 
and Hartley (1990) followed the appearance of [35S]-methionine 
from initiator (35S]-Met tRNA into 40S subunits, 80S monosomes 
and 80S polysomes in the presence and absence of ricin A-chain. 
Accumulation of [35S]-methionine in monosomes which did not 
enter polysomes was noted. The formation of the 80S complex was 
reduced 6-fold with ricin A-chain compared to diphtheria toxin. 
Inhibition of translocation was implicated by the predominance 
of Met-Val when the system was programmed with globin mRNA. 
Puramycin had no effect on this system indicating that the 
acceptor site was occupied.
Together, the experiments on the effect of the ribosome­
inactivating proteins, suggest that the modification to the 28S 
rRNA leads to a conformational change in the structural 
integrity of the ribosome (Endo et al., 1988). This alteration 
slows the formation of 80S monosomes, and therefore of 
polysomes (Osborn and Hartley, 1990) . The binding of EF-2 is 
prevented by the modification (Nilsson and Nygard, 1986) and 
the GTPase activity complemented by both EF-1 and EF-2 is 
inhibited (Benson et al., 1975 and Sperti et al., 1975) 
although the direct binding of EF-1 or the EF-l-dependent 
binding of amino-acyl tRNAs is unaltered (Montanaro et al., 
1973, Nilsson and Nygard, 1986 and Nilsson et al., 1986).
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Figure 47 Binding of the A-chain breakdown products to DEAE- 
Sephadex A 50% ammonium sulphate precipitation of a total cell 
sonicate was analysed by HPLC on DEAE-Sephadex as described 
(section 2.19.3). Sequential fractions were analysed by (A) 
SDS-PAGE and silver staining and by (B) Western blot using the 
anti-(rabbit IgG)-alkaline-phosphatase conjugate as described 
(2.18.2). M, prestained protein standards; AC native abrin C; 
S, sample analysed. The fraction numbers analysed are indicated 
and the intact A-chain and the major breakdown products are
M S  3 5 3 6  3 7  38 3 9 4 0  4 1 42  4 3 4 4 AC
/
28kDa
27kDa
24kDa
AC3638404244
28kDa
27kDa
M -----24kDa
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3.10.1Q Properties of the breakdown product» of_tfa» .. A=
chain
Figure 47A shows that the breakdown products elute from 
DEAE-Sephadex with a very similar profile to the intact A-chain 
when a 50% ammonium sulphate precipitation was used to 
concentrate the cell sonicate. The two major breakdown products 
are approximately 27kDa and 24kDa and may consist of the A- 
chain minus the amino-terminus and/or the carboxy-terminus. The 
reduction in size is not sufficient to alter the charge on the 
proteins at pH 8.5. The Western blot shown in Figure 4 7B 
illustrates the breakdown products more clearly.
Ammonium sulphate precipitation, to separate the breakdown 
products from the intact A-chain, provided the opportunity to 
study these proteins in isolation. A 35-50% ammonium sulphate 
precipitation was used to isolate the breakdown products from 
intact A-chain prior to application to DEAE-sephadex. The 
immunoreactive A-chain-derived polypeptides eluted from DEAE- 
Sephadex are shown in Figure 48A. Lane 3 of Figure 4 8A shows 
the pooled fractions containing the A-chain breakdown products. 
Intact A-chain in this fraction was below the limit of 
detection by Western blot. The fraction illustrated in lane 3, 
Figure 48A, was analysed for activity, and as shown in Figure 
48B, modification to rRNA was detected and therefore at least 
one of the breakdown products visualised in Figure 48A, lane 3, 
retains N-glycosidase activity.
The properties of the two major breakdown products was 
different on Blue-Sepharose CL-6B. The larger of the two 
proteins bound to the column and eluted at 300mM NaCl and 
therefore behaved as the intact A-chain under the conditions 
used. The smaller of the two proteins did not bind to the 
column and was eluted in the void volume. This indicated that 
there had been a significant change in the properties of this 
peptide compared to the intact A-chain.
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Figure 48 The properties of the 27kDa breakdown product A 35- 
50% ammonium sulphate precipitation of total cell sonicate was 
analysed by HPLC on DEAE-sephadex as described (section 
2.19.3). The fractions containing breakdown products of the 
intact A-chain were pooled and the activity was determined 
using the in vitro assay as described (section 2.20.2). The 
pooled fraction was analysed on Blue-sepharose CL-6B as 
described (section 2.19.4). The fractions containing breakdown 
products of A-chain were pooled and serial dilutions were 
analysed for activity as described (section 2.20.2).
(A) Western blot using the anti-(rabbit IgG)-alkaline- 
phosphatase conjugate as described (section 2.18.2). Lanes 1 
and 2, recombinant abrin A-chain; lane 3, breakdown products of 
A-chain eluted from DEAE-sephadex; lane 4, breakdown products 
of A-chain eluted from Blue-sepharose CL-6B; lane 5, native 
abrin C.
(B) Assay for activity associated with the fraction shown in 
lane 3 of (A) above. Lanes 1 and 2, O.l^g ricin A-chain minus 
and plus aniline treatment respectively; lane 3 and 4, Ipl of 
fraction shown in lane 3 of (A) above minus and plus aniline 
treatment respectively.
(C) Assay for activity associated with the 27kDa breakdown 
product of A-chain shown in lane 4 of (A) above. Lanes 1 and 2, 
0.1/ig ricin A-chain minus and plus aniline treatment 
respectively, lanes 3 and 4, lOOng, lOOpg and lOOfg 
respectively of 27kDa breakdown product of A-chain plus aniline 
treatment.
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Figure 48B, lane 4, shows the pooled fractions containing 
the 27kDa protein eluted from Blue-Sepharose CL-6B analysed by 
Western blot. The amount of the protein was too low to detect 
on stained gels. The fraction in lane 4 was concentrated by 
lyophilisation and dilutions were analysed for activity using 
the aniline assay (section 2.18.2). Figure 48C shows that the 
27kDa peptide retains activity and could modify rabbit 
reticulolysate ribosomes at concentrations as low as 10-10M.
A reduction in size of lkDa will correspond to the loss of 
approximately 10 amino acids. It is known that ricin A-chain 
retains activity when the first 9 residues at the amino 
terminus are deleted (May et al., 1989). This may therefore 
suggest that in the 27kDa peptide it is the N-terminus that has 
been removed. A breakdown product of native abrin C A-chain of 
about 27kDa, which did not bind to Blue-Sepharose, was 
partially sequenced and the N-terminus was intact (Dr E.J. 
Wawrzynczak, personal communication). The activity of this 
peptide in vitro was not determined but the lack of binding to 
Blue-Sepharose CL-6B suggests a severe disruption in the 
conformation of the active site. Funatsu et a l . (1989) showed 
that ricin A-chain lacking the residues from position 238 
retained only 1.8% of the activity of native A-chain, and 
binding to cibacron blue F3GA was severely reduced. These 
results therefore suggest that the 27kDa peptide derived from 
the recombinant abrin A-chain has lost the N-terminus and the 
C-terminus remains essentially intact. It would be necessary to 
sequence the 27kDa peptide to confirm this hypothesis.
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F i g u r e  49  Properties and activity of the 24kDa breakdown 
product of A-chain T h e  p o o le d  f r a c t i o n  c o n t a i n i n g  t h e  b re a k d o w n  
p r o d u c t s  o f  t h e  A - c h a in ,  e l u t e d  fro m  D E A E - s e p h a d e x , w e re  
a n a l y s e d  o n  B lu e - s e p h a r o s e  C L - 6 B .  T h e  v o i d  v o lu m e  f ro m  t h e  
c o lu m n  w a s a n a l y s e d  b y  (A )  S D S -P A G E  an d  C o o m a s s ie  b lu e  
s t a i n i n g ,  l a n e s  1 a n d  4 , lo w  r a n g e  p r o t e i n  s t a n d a r d s ;  l a n e  2 , 
t o t a l  c e l l  s o n i c a t e ;  la n e  3 , v o i d  v o lu m e , a n d  f o r  (B )  i n  vitro 
a c t i v i t y  a g a i n s t  r a b b i t  r e t i c u l o c y t e  l y s a t e  a s  d e s c r i b e d  
( 2 . 2 0 . 2 ) ,  l a n e s  1 a n d  2 , i n c u b a t i o n  w i t h  0 .1 / ig  r i c i n  A - c h a i n ,  
m in u s  an d  p l u s  a n i l i n e  t r e a t m e n t  r e s p e c t i v e l y ;  l a n e s  3 a n d  4 , 
i n c u b a t i o n  w i t h  5m 1 v o i d  v o lu m e ,  m in u s  an d  p l u s  a n i l i n e  
t r e a t m e n t  r e s p e c t i v e l y
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Figure 49A shows the void volume, containing the 24kDa 
protein, from Blue Sepharose CL-6B. An aliquot of this fraction 
(lane 3) was used in the aniline assay to determine if there 
was any activity associated with the 24kDa peptide. Figure 49B 
shows that no activity was detected in a sample containing an 
estimated lug of the 24kDa peptide. This suggests that loss of 
binding to Cibacron Blue is associated with loss of enzymatic 
activity. A loss of about 4kDa worth of protein sequence is 
considerable and at least one residue postulated to be involved 
in the active site is removed when 4kDa of peptide is removed 
from either the N-terminus, C-terminus or a combination of 
both. It was not unexpected that the 24kDa protein was 
inactive.
3.11 RBCOKBIWAWT B-CHAIW gl?Rg8gI0H IM HgTEBQLOQOP8 SYSTEMS
3.11.1 B-chain expression construct
The mature B-chain sequence was recovered from pQK9 by PCR 
using the linker extended primers illustrated in Figure 50A. 
These primers when used in PCR generate the B-chain sequence on 
a fragment flanked by a Haell site at the 5' end and a Bglll 
site at the 3' end.
The preproprotein leader sequence was also isolated from 
the sequence of pQK9 using linker extended primers (Figure 
50B) . These primers, when used in PCR, generate the leader 
sequence on a fragment flanked by a 5' Bglll site and by a 3' 
SspI site.
The B-chain expression plasmid designated as pSP-B was 
generated by a tripartite ligation containing the B-chain 
fragment sequentially blunted at the Haell site then digested 
with Bglll, the leader fragment digested with Bglll and SspI, 
and the vector pSP64T digested with Bglll and dephosphorylated. 
The cloning strategy is summarised in Figure 51.
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Figure 50 Primer design for recovery of the leader and B-chain 
sequences from pQK9 (A) The primers 9L-F and 9L-R and (B) 9B-F 
and 9B-R were used in PCR on pQK9 template to recover the 
leader and B-chain sequences. The corresponding coding sequence 
is shown above the DNA sequence, and is numbered according to 
Figure 27 for reference. The orientation of the primers is 
indicated with primers 9L-R and 9B-R representing complementary 
DNA. The linker regions, to generate restriction endonuclease 
sites are underlined
(X) Primer 9L-F
-34 -31Net Asp Lya Thr Leu Lys 
5 * — GCTGCAGATCT ATG GAC AAA ACT TTG AAG C -3'
PstI------
Bglll
Primer 9L-R
-5 “IPro Val Ale Thr Asn 3'— CCG OTA GCA ACA AAT ATTGAGCTCC -5'
SspI ------
SacI
(B) Primer 9B-F
246 270
8er Lys lie Cys Ser
5'- QGCTGCAGGCQC TCA AAG ATT TGC AGC -3'
PstI-------
Haell
Primer 9B-R
525 528
Leu Thr Leu Phe TER TER 3 G CTT ACT TTG TTT TAA TAA OATCTGAQCTCC
Bglll ----------
SacI
-5 '
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Figure 51 Cloning strategy for the B-chain expression construct
\  Leader
IjnKi _____ _^aLpQK9
I ^
IP C R
i i
Bglll Sspl
Bglll and Sspl 
digest
Hael I/overhang 
filled
Bglll digest
leader
M
B-chain
H i
p S P 6 4 -T (  B g ll I )
'«■asi__ L.
pSP-B
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3.11.2 Mutagenesis of putative galactose-binding »!*«■
The potential galactose binding sites
The feature of the B-chain on which research was centred 
was potential lactose binding ability. The majority of research 
to date has involved the study of the binding sites of ricin D 
B-chain. As discussed in section 3.7.5, the sequence of the 
cloned abrin B-chain has the features of the low affinity site 
of ricin D (1 domain) and of the 27f domain of ricin E.
There has been relatively little work done addressing the 
galactose binding of the B-chain of ricin E which has the 
histidine residue in the galactose binding domain of the 22f 
subunit. Ricin E has cytoagglutinating ability and is as toxic 
to mice as ricin D, however binding affinities to Sepharose 4B 
differ and ricin E is less toxic to cultured cells (Yamasaki et 
ai. 1989b). Hatakeyama et al. (1989) reported that ricin E has 
two binding sites, a high affinity site and a low affinity 
site. The low affinity site was similar to that in ricin D but 
the high affinity site had only half the affinity for galactose 
as the high affinity site of ricin D. The involvement of a 
tryptophan residue in galactose binding at both the low and 
high affinity binding site was postulated from oxidation of 
tryptophan residues by N-bromosuccinimide in the presence and 
absence of lactose (Yamasaki et al., 1989b and Hatakeyama et 
al., 1990a) . N-acetyl galactosamine did not protect the 
tryptophan in the low affinity site. Similar experiments using 
diethylpyrocarbonate to modify histidine residues in the 
presence and absence of lactose indicated that a histidine 
residue was involved in the high affinity site (Hatakeyama et 
al.,1990b) whereas modification of histidine residues had no 
effect on the binding at the low affinity site (Yamasaki et 
al.,1989). The histidine residue involved at the high affinity 
site was postulated to be either His248 or His251 and both 
galactopyranosides and N-galactosamines could protect the 
histidine residue from modification (Yamasaki et al. , 1989c). 
Taken together these results suggest that ricin E contains two
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binding sites, one involving Trp37 is a low affinity site, the 
other involving His248 is a high affinity site binding both N- 
actylgalactosamines and galactopyranosides. The experimental 
evidence on the binding of ricin E to various sugars must be 
viewed with caution however. The chemical modification of a 
residue may alter the native conformation of the protein 
leading to spurious binding activity. The use of acetylated 
sugars to analyse binding activity of chemically modified B- 
chain is of limited value since the more bulky sugar may be 
hindered in access to the binding sites.
Yamasaki et al. (1989a) studied the binding of APA to 
specific sugars. Using fluorescence spectroscopy four 
tryptophan residues were determined to be involved in binding 
to sugars. It was assumed that APA had a single binding site 
per B-chain and it was concluded from the association constants 
for lactose that each binding site had a subsite which could 
bind to the saccharide linked to galactopyranoside at the non­
reducing end in addition to binding to the galactopyranosyl 
residue. It may be possible that APA has two binding sites per 
B-chain which could explain the results obtained by Yamasaki et 
al. (1989a). Equilibrium dialysis was used by Ohba et al . 
(1990) to study the binding sites of abrin C B-chain. The data 
suggested that abrin C has two saccharide binding sites with 
different affinities for galactopyranosides. Spectroscopic 
studies indicated that the binding of galactosamines differed 
from the binding to galactopyranosides and suggested that a 
high affinity site bound to both galactopyranasides and 
galactosamines whereas a low affinity site bound only 
galactosamines. At both sites, galactosamines induced a change 
in the environment of tryptophan residues.
Site-directed mutagenisis of binding sites
It has previously been shown that mutation of Asn255 in 
ricin D B-chain to Gly abolished binding at the high affinity 
binding site (Wales et a l ., 1991). Vitetta and Yen (1990) 
showed that mutation of Asn255 to Ala in ricin B-chain
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abrogated binding by 99%. Similarly, simultaneous mutation of 
Lys40 and Asn46 to Gly and Met respectively abolished binding 
at the low affinity site (Wales et al., 1991). Wales and co­
workers demonstrated that loss of binding at the low affinity 
site abrogated binding hardly at all. Site-directed mutagenesis 
was carried out on the B-chain sequence of the abrin clone to 
determine the contribution specific residue changes made to 
galactose binding. The potential binding site in the 1«. domain 
was expected to be a low affinity site and the site in the 2~6 
domain was expected to have little or no binding activity. 
Rutenber and Robertus (1991) report that a histidine at 
position 248 in the B-chain can make hydrophobic contacts with 
the non-polar face of the sugar molecule but as the histidine 
residue is likely to be charged for most of the time this would 
interfere with the interaction.
The mutations carried out on the B-chain of the 
recombinant abrin are listed in Table 6. Mutation Al is 
expected to abrogate any binding associated with the low 
affinity site, mutation A2 is expected to abrogate any binding 
associated with the high affinity site and mutation Y2 is 
expected to generate a high affinity binding site with similar 
affinity for saccharides to ricin D. The double mutant A1A2 is 
expected to be a non-binding mutant, and the double mutant A1A2 
will allow analysis of the effect of His versus Tyr at the high 
affinity site independent of any binding at the low affinity 
site.
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Table 6 M u t a t i o n s  of the recombinant B-ch a i n
KStlT'lCt Position wna typg Mutant
AI 41 Lys Ala
47 Asn Ala
A2 256 Asn Ala
Y2 249 Bis Tyr
A1A2 41 Lys Ala
47 Asn Ala
256 Asn Ala
A1Y2 41 Lys Ala
47 Asn Ala
249 His Tyr
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3.11.3 In vitro t ra n s c r ip tio n  and tra n s la tio n
To allow comparison of the mutant B-chain with the wild 
type, batch solutions for the transcription and translation 
reactions were prepared and aliquoted out to reduce error in 
the final concentration of components of the systems and in 
pipetting.
The result from in vitro transcription and translation of 
the wild type and the five mutant B-chains is shown in Figure 
52. The band of 32kDa is immunoprecipitated from the 
translation mix only when B-chain RNA was translated (lanes 2- 
7) and not in the absence of any exogenous RNA (lane 9) or on 
translation of TMV RNA. There is also a band of approximately 
27kDa present in all lanes containing B-chain. It is unclear 
what this 27kDa band corresponds to.
It should be noted that the amount of B-chain produced was 
always lower than that for ricin B-chain. Wheat germ lysate was 
also used for translation of the abrin-related B-chain mRNA but 
a product of the correct size was barely detectable. Ricin B- 
chain mRNA translates well in both rabbit reticulocyte and 
wheat germ lysate.
3.11.4 Translation of B-chain mRNA la Xenopus oocytes 
Oocvte injections
For direct comparison of the wild type B-chain with the 
mutant forms, the in vitro transcribed mRNAs were injected into 
oocytes from the same ovary. The oocyte injections were 
performed by Professor H. Woodland (University of Warwick) . 
Oocytes isolated from different ovaries, or from the oocytes of 
different animals show a wide variability in translational 
efficiency (personal communication, Professor H. Woodland, 
University of Warwick) .
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Figure 52 In vitro translation of pre-B-chain mRNA The wild 
type and mutant pre-B-chain constructs were transcribed in 
vitro as described (section 2.21.1). The RNA was extracted and 
resuspended at ling/ml. The transcribed RNA (ljxg) was translated 
in vitro using nuclease treated rabbit reticulocyte lysate as 
described (section 2.20.2). The products of translation were 
immunoprecipitated as described (section 2.22.3) using anti- 
abrin sera, and analysed by SDS-PAGE and autoradiography. Lanes 
1 and 10, [14C]-labelled protein standards; lanes 2-8, 
translation of transcribed RNA of pre-B-chain, mutant Al, 
mutant A2, mutant Y2, mutant A1A2, mutant A1Y2 and Brome Mosaic 
Virus respectively and lane 9, no RNA
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Expression of B-chain and solubility
Figure 53A shows the result of immunoprécipitation from 
oocyte homogenates expressing the B-chain constructs. Each B- 
chain mRNA was successfully translated in oocytes producing 
immunoreactive products of approximately 38kDa. The size of 
the translated B-chains indicates that the proteins had been 
segregated to the ER and undergone core-glycosylation with 
removal of the signal sequence. The presence of two bands 
indicates differences in the degree of glycosylation. The wild 
type B-chain and each of the mutants were soluble and no 
immunoreactive B-chain was detected in the pelleted fraction.
When the oocyte homogenates were analysed 7 days after 
homogenisation it was found that the wild type B-chain and the 
mutant B-chains were insoluble. The results are shown in Figure 
53B. The majority of the B-chain in each sample was found in 
the pelleted fraction. This is in contrast to ricin B-chain 
which remains essentially soluble for several weeks. Mutations 
in the galactose binding sites of ricin B-chain do not 
significantly alter the stability of this protein.
The poor stability of the recombinant abrin B-chain 
indicates that the protein is undergoing a conformational 
change on storage, leading to insolubilisation. This may be a 
reflection of the in vivo protein structure. In the plant the 
B-chain is associated with A-chain by a covalent bond and the 
B-chain may be naturally unstable once released from the A- 
chain. Instability may also be as a consequence of expression 
in the heterologous system used: disulphide bond pairings may 
be altered for example. The wild type B-chain sequence and the 
mutant sequences were initially soluble however, which 
indicates that at extraction the proteins are in a relatively 
native form and would be expected to be soluble
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F i g u r e  5 3  Expression of pre-B-chain and pre-B-chain m u t a n t s  i n  
Xenopus oocytes lO O n g  o f  RNA t r a n s c r i b e d  in vitro w a s  i n j e c t e d  
i n t o  Xenopus o o c y t e s .  T h e  o o c y t e s  w e re  in c u b a t e d  o v e r n i g h t  i n  
t h e  p r e s e n c e  o f  [ 3 5 S ] - m e t h i o n i n e .  T h e  o o c y t e s  w e re  h o m o g e n is e d  
a n d  (A )  p r o d u c t  s o l u b i l i t y  w as d e t e r m in e d  b y  c e n t r i f u g a t i o n  a t  
100 , 000g  f o r  1 h o u r  a n d  b y  a n a l y s i s  o f  t h e  p e l l e t e d  a n d  s o l u b l e  
f r a c t i o n s  a n d  (B )  s t a b i l i t y  o f  t h e  p r o d u c t s  w a s d e t e r m in e d  by 
a n a l y s i n g  s o l u b i l i t y  o f  t h e  p r o t e i n s  a f t e r  7 d a y s  s t o r a g e  a t  
4 ° C .  T h e  s a m p le s  w e re  im m u n o p r e c ip i t a t e d  u s i n g  a n t i - a b r i n  s e r a  
a n d  a n a l y s e d  b y  S D S -P A G E  an d  a u t o r a d i o g r a p h y .  L a n e  M, [ C ] -  
l a b e l l e d  p r o t e i n  s t a n d a r d s ;  l a n e s  1 , 2 ,  a n d  3 , t o t a l ,  s o l u b l e  
a n d  i n s o l u b l e  f r a c t i o n s  r e s p e c t i v e l y ;  l a n e  C , t o t a l  f r a c t i o n  
f r o m  m ock  i n j e c t e d  o o c y te
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U ç*p m  tn< ijalof etuin
Binding to immobilised lactose 
The ability of the abrin-related B-chain to bind to 
immobilised lactose was determined using the oocyte homogenates 
immediately after homogenisation. The results are shown in 
Figure 54. It is clear that both the wild type B-chain and the 
mutant forms do not bind to the selectin column. There was no 
evidence of any B-chain in the eluted fractions. The mutant Y2 
may have been retarded slightly by the column since there is a 
very faint band present in the second wash, indicating that 
more than one column volume of buffer was required to remove 
all the B-chain. This is similar to abrin-b and abrin-c as 
described by Lin et al. (1981) which are retarded by 4B
Sepharose but elute in the absence of galactose. However, ricin 
B-chain which has had both binding sites mutated and does not 
bind to saccharides exibits a similar profile on immobilised 
lactose. The degree of retention, if any, on the column is 
therefore not significant to specific binding. To check that 
the column was functioning, native APA was used as a control 
and was found to bind satisfactorily and was eluted with 50mM
lactose. As an assay for saccharide binding the use of a
selectin column was relatively crude. B-chain may have been
binding to the column but at levels below the limit of
detection of the system.
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immobilised lactose by B-chainFigure 54 Analysis of binding to 
A sample of oocyte homogenate was made up to 1ml with oocyte 
homogenate buffer. The sample was passed down a column of 
Immobilised lactose several times to allow for binding. The 
column was washed three times with 1ml oocyte homogenisation 
buffer and the fractions were saved. Bound protein was eluted 
with 2ml 50mM lactose In oocyte homogenisation buffer end 1ml 
fractions were collected. Half of each fraction was 
immunoprecipitoted and analysed by SDS-PAGE and 
autoradiography, bane l, starting fraction, lanes 2, unbound 
fraction; lanes 3 and «, sequential wash fractions; lane 5, 
eluted fractions (pooled)
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Binding to asialofetuin
The asialofetuin plate assay is both sensitive and 
quantitative. The wild type B-chain and the mutant B-chains 
were each assayed for binding to asialofetuin as described. It 
had been previously shown that the anti-ricin B-chain 
antibodies used in the assay could immunoprecipitate the 
abrin-related B-chain. The results of the assay are shown in 
Table 7. It is clear that in the presence of abrin-related B- 
chain the detected radiolabel was as low as the background 
counts indicating that if any binding had occured it was below 
the limit of detection. Using ricin B-chain as a positive 
control, this assay could detect long of bound B-chain. Based 
on this value less than long of the abrin-related B-chain was 
binding to the asialofetuin. The value of lOng will be a slight 
over-estimation however since the antibodies used are expected 
to have a stronger affinity for ricin B-chain than for the 
abrin-related B-chain.
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Tabi* 7 Binding of B-chain to asialofetuin Binding to 
asialofetuin was determined using the asialofetuin plate assay 
as described (section 2.22.2). The table lists the average cpm 
determined from triplicate experiments
Sample cpm
with asialofetuin no asialofetuin
lOOng ricin B-chain 12,932 162
song ricin B-chain 7,351 154
long ricin B-chain 1,464 136
5ng ricin B-chain 672 171
abrin B-chain 151 163
mutant Al 173 170
mutant A2 166 159
mutant Y2 179 190
mutant A1A2 154 127
mutant A1Y2 121 189
mock injected oocyte homogenate 154 169
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3.11.6 Keaggoglation Of p-çh»in with A-ÇfaftiB
Based on the sequence of the wild type B-chain the B-chain 
is postulated to have at least one functional binding site but 
of low affinity. Lack of binding of the wild type might 
therefore suggest that this protein is devoid of lectin 
activity. The mutants Y2 and A1Y2 were expected to generate a 
high affinity binding site however so this suggested that the 
protein may be incorrectly folded and the altered conformation 
may be leading to the increased instability of the abrin- 
related B-chain compared to ricin B-chain produced in oocytes.
The isolation of the B-chain away from the A-chain does 
not occur in nature except perhaps at the final stage of 
intoxication of a cell when the A-chain is translocated to the 
cytosol. It is possible that the B-chain remains associated 
with the A-chain throughout the intoxication process and is 
translocated with the A-chain into the cytosol. In the case of 
the abrin-related protein the B-chain may be stabilised by the 
A-chain and association between the two polypeptides is 
required to maintain the functional activity of the B-chain. To 
determine if the B-chain required A-chain for conformational 
activity, B-chain was mixed with the abrin-related recombinant 
A-chain or recombinant ricin A-chain to allow reassociation 
(section 2.22.3). The asialofetuin plate assay was repeated and 
the results are given in Table 8. There was no evidence of 
binding to asialofetuin when A-chain was also present in the 
extract.
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Table 8 Binding to asialofetuin by B-chain in the presence of 
A-chain The asialofetuin plate assay was carried out as 
described (section 2.22.2). The table lists the average cpm 
determined from triplicate experiments
lOOng ricin B-chain 
50ng ricin B-chain 
long ricin B-chain 
5ng ricin B-chain
abrin B-chain + A-chain 
autant Al + A-chain 
mutant A2 + A-chain 
Mutant Y2 + A-chain 
Mutant A1A2 + A-chain 
Mutant A1Y2 + A-chain
Mock injected oocyte 
+ A-chain
13,056 157
6,971 129
1,576 163
714 165
134 122
111 108
117 154
135 136
177 179
151 162
134 156
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It was necessary to determine if the translated B-chain 
did reassociate with A-chain. Following mixing of the A-chain 
and B-chain, samples were immunoprecipitated with anti A-chain 
antibodies and analysed on reducing and non-reducing gels 
followed by autoradiography. Only labelled B-chain which has 
been immunoprecipitated because of association with A-chain 
will produce a signal. Therefore on a non-reducing gel a 
protein of about 68kDa would be expected consisting of 
associated A-chain with B-chain, whereas on a reducing gel any 
A-chain-associated B-chain will appear as a band of about 
38kDa. The results (not shown) indicated that there was no 
association of labelled B-chain with either the recombinant 
abrin A-chain or with ricin A-chain.
Summary of B-chain expression
Several conclusions may be drawn from the results. The 
wild type B-chain of the preproprotein may essentially lack any 
lectin activity, or the degree of binding is below the limits 
of detection of the assays and is therefore virtually 
negligable. This indicates that in the wild type B-chain both 
the lot and the 216 domain binding sites are non-functional. 
Mutation of the 216 binding site to replace the histidine at the 
26 domain with a tyrosine (mutants Y2 and A1Y2) did not 
generate a functional binding site as determined from passage 
down a column of immobilised lactose or the asialofetuin plate 
assay. The His to Tyr mutation was expected to generate a high 
affinity binding site therefore the lack of binding at the 216 
domain would suggest that the conformation of the protein has 
been disrupted, resulting in loss of binding activity in the 26 
domains of mutant Y2. This conclusion is supported by the poor 
stability of the B-chain compared to ricin.
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3.11.7 Expression of ths prtproprof la Ip Xenepus oecytes
It has been shown that preproricin retains functional 
galactose binding domains but lacks N-glycosidase activity 
(Richardson et al. , 1989b). Expression of the preproabrin mRNA 
in oocytes would be expected to produce a more stable protein 
than B-chain alone: in the plant the protein is expressed as a 
preproprotein, the co-translational folding of the A-chain and 
linker sequence are likely to contribute to the subsequent 
folding of the B-chain, the linker is expected to stabilise the 
proprotein, and the B-chain remains associated with A-chain. 
The glycosylated linker may be important for stability or 
folding of the B-chain.
The primers 9L-F and 9B-R (Figure 50) were used in PCR to 
isolate the preproprotein sequence and this was subcloned into 
pSP64-T. The cloning strategy is summarised in Figure 55. The 
mRNA was transcribed in vitro as described (section 2.22.1) and 
translated in vitro in rabbit reticulocyte lysate. The result 
from the translation is shown in Figure 56.
The in vitro transcribed mRNA was injected into oocytes 
and the products of translation were analysed for solubility, 
stability and binding to immobilised lactose and asialofetuin. 
The results for solubility and stability are shown in Figure 
57. The protein is essentially soluble immediately following 
oocyte homogenation (Figure 57A, lane 3). The trace of protein 
detected in the pelleted fraction (lane 4) is probably due to 
the trapping of some proprotein in the membranes, since after 
14 days of storage the preprotein was found entirely in the 
soluble fraction (Figure 57B, lane 3).
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Figure 55 Cloning strategy to generate preproprotein expression 
construct pSP-PPA
9L-F
\  Leader
| p c r
^PQK9
9B-R
4 Bglll
Bglii digest
ligate
p S P 6 4 -T (B g 1 ll)
egli I i
preproabnr
pSP-PPA
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Figure 56 Expression of preproprotein in vitro The construct 
shown in Figure 55 was transcribed in vitro as described 
(section 2.21.1). The transcribed RNA was extracted and 
resuspended at ling/ml. The preproprotein mRNA was translated 
using nuclease treated rabbit reticulocyte lysate as described 
(section 2.21.2) in the presence of [ 35S]-methionine. The 
products of translation were iramunoprecipitated with anti-abrin 
sera and analysed by SDS-PAGE and autoradiography. Lane 1, 
translation without exogenous RNA; lane 2, translation of Brome 
Mosaic Virus RNA; lane 3, translation of preproabrin RNA; lane 
4, [14C]-labelled protein standards
1 2  3 4
kDo
200
97.4
69
46
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Figure 57 Expression of the proprotein in Xenopus oocytes RNA 
encoding the preproprotein was injected into Xenopus oocytes as 
described (section 2 .2 2 .1 ) and the oocytes were incubated 
overnight in the presence of [35S]-methionine. The oocytes were 
homogenised and the insoluble protein fraction was recovered by 
centrifugation at 100,000g for 1 hour. The homogenates were 
stored for 14 days at 4°C and analysis of solubility was 
repeated. The fractions were immunoprecipitated and analysed by 
SDS-PAGE and autoradiography. (A) Solubility at extraction and 
(B) solubility after 14 days of storage. Lane 1, [14C]-labelled 
protein standards; lane 2, total homogenate; lane 3, soluble 
fraction; lane 4, insoluble fraction
The increase in stability of the proprotein compared to 
the B-chain expressed in oocytes indicates that the A-chain and 
linker are contributing to the conformational stability of the 
B-chain. The glycosylation of the linker may be important for 
correct folding. The amount of abrin-related proprotein 
produced is significantly lower than that obtained from 
translation of preproricin. Of a variety of mRNAs translated in 
oocytes, preproricin or pre-ricin B-chain mRNAs are translated 
at some of the highest levels, suggesting that oocytes contain 
all the components involved for efficient translation of ricin- 
derived mRNAs. It is probable that other mRNA species, which 
include the abrin-related mRNAs described here, are not 
optimally transcribed due to the lack of certain components of 
the protein synthesis machinery. Recently the role of 
chaperones has become increasingly evident (Ellis, 1990). It 
can readily be appreciated that the efficiency of folding of 
heterologous proteins into the native form in oocytes will 
depend on the presence of components which can substitute for 
those found in the homologous system.
The binding of the proprotein form of the abrin-related 
protein to immobilised lactose was determined and the results 
are shown in Figure 58. The proprotein was eluted from the 
column in the absence of lactose indicating that the protien 
was devoid of lectin activity.
The asialofetuin plate assay was carried out and the 
results shown in Table 9 confirm that the proprotein had no 
lectin activity. Again, the limit of detection for ricin B- 
chain was in the range of long.
-237-
Figure 58 Binding of proabrin to immobilised lactose A sample 
of oocyte homogenate was made up to 1ml with oocyte homogenate 
buffer. The sample was passed down a column of immobilised 
lactose several times to allow for binding. The column was 
washed three times with oocyte homogenisation buffer and the 
fractions were saved. Bound protein was eluted with 2ml 50mM 
lactose in oocyte homogenisation buffer and 1ml fractions were 
collected. Half of each fraction was immunoprecipitated and 
analysed by SDS-PAGE and autoradiography. Lane 1, [14C]- 
labelled protein standards; lane 2, starting fraction; lanes 3- 
5, sequential wash fractions; lanes 6 and 7, sequential eluted 
fractions
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Table 9 Binding of proabrin to asialofetuin The asialofetuin 
plate assay was carried out as described (section 2.22.2). The 
average cpm determined from triplicate experiments are shown
Sample ÇJ2®
with asialofetuin ]
lOOng ricin B-chain 13,816 174
50ng ricin B-chain 8,084 182
long ricin B-chain 1,690 201
5ng ricin B-chain 707 170
proprotein 226 195
mock injected oocyte homogenate 157 172
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M l . d  gypumry
The close similarity between ricin and the abrin-related 
clone suggested that the properties of the two proteins would 
be similar and that the systems used for analysis of ricin B- 
chain would be applicable. Based on the knowledge about ricin 
B-chain and the results obtained from experiments on the 
galactose binding sites of ricin B-chain, a hypothesis for 
binding of the abrin-related B-chain was made: the abrin clone 
contains a low affinity site in the lo< domain of the B-chain 
and the putative binding site in the domain is disrupted by 
the histidine residue.
The results obtained indicate that the B-chain of the 
abrin-related protein lacks specific lectin activity. However 
the lack of binding of the mutant B-chains Y2 and A1Y2 indicate 
that there is a significant difference between ricin B-chain 
and the B-chain studied here. The poor stability of the 
expressed B-chains is indicative of conformational change and 
this conclusion is supported by lack of reasociation between 
the B-chain and exogenously added recombinant A-chain. The 
abrin B-chain may be more stable when expressed in other 
heterologous systems. Ricin B-chain has been expressed in yeast 
(Richardson et al., 1988b) and glycosylated functionally active 
ricin B-chain has been expressed in monkey kidney cells (Chang 
et al., 1987).
In an attempt to overcome the problem of conformational 
stability, the preproprotein sequence was expressed in oocytes. 
The preproprotein form is expected to retain the activity 
associated with the B-chain, but lacks the activity of the A- 
chain. The improved sability of the abrin-related proprotein 
over the B-chain supports the hypothesis that the abrin-related 
protein is dependent on quaternary structure for solubility and 
therefore activity. The lack of binding activity of the 
proprotein indicates that the cloned abrin-related gene does 
not encode a lectin despite retention of the key residues 
involved in tertiary structure and hydrogen bonding.
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The 1 domain is non-functional therefore there must be 
structural changes in this domain. There are certain changes 
around a crucial Trp residue compared to ricin, shown below:
the abrin B-chain n r i i a w k c  
ricin B-chain N A I Q L W P C
The Arg to Ala, the lie to Gin and the Lys to Pro changes 
are chemically pronounced and as these changes concentrate in 
the putative binding site and interact with each other, the 
binding site may be seriously disturbed despite retention of 
the key hydrogen-bonding residues.
The lack of binding at the 2 domain supports the 
conclusion of Rutenber and Robertus (1991) that the charge on 
the histidine residue disrupts the hydrophobic interaction with 
a saccharide. There may be other less obvious changes in the 2$ 
domain which may alter structure and render the 216 domain non­
functional. It would be necessary to mutate the histidine to a 
tyrosine and express the B-chain in the preproprotein form to 
confirm if a histidine residue alone is resposible for non­
functionality.
Lack of lectin activity is supported by the increased 
internal divergence of the abrin B-chain compared to ricin 
(refer to Figure 26B). The constraints of natural selection 
will be lessened and the abrin B-chain may therefore have 
accumulated amino acid substitutions at a faster rate than 
ricin B-chain.
The abrin-related protein is devoid of lectin activity and 
therefore is not expected to be a cytotoxin. The B-chain is 
responsible for cell entry and it is now evident that the B- 
chain plays an important role in the intracellular trafficking 
of the A-chain.
Binding to the cell surface has been extensively 
investigated. As discussed in the introduction, the bound 
holotoxin is endocytosed through clathrin coated pits. The non- 
clathrin coated pits are almost certainly another endocytic
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route for ricin and Sandvig and van Deurs (1990) have clearly 
demonstrated the uptake of ricin when the clathrin coated pit 
pathway is blocked. Anti-tumour activity of ricin, against a 
neoplastic hepatic cell line, was shown to be related to the 
binding of the B-chain to high affinity receptors which led to 
endocytosis via neutral vesicles as opposed to acidic vesicles 
(Decastel et al., 1989). A holotoxin which lacks lectin 
activity cannot gain entry to cells by the usual endocytic 
pathways. The abrin clone is glycosylated in both the A-chain 
and the B-chain and it is highly likely that the 
oligosaccharide side chains will contain mannose. The holotoxin 
would be recognised by the mannose receptors on 
reticuloendothelial cells and therefore could gain entry to 
certain cells.
Bellilli et al. (1990) have used ricin labelled with 
fluorescein to follow the internal pathway of ricin in living 
cells and ricin was shown to reach late endosomal vesicles 
distinct from the lysosomal vesicles. Hansen et al. (1989) have 
used immunogold cytochemistry to demonstrate the colocalisation 
of internalised ricin with the high-molecular weight membrane 
glycoprotein MAM-6 of human breast epithelial cells in the 
trans-Golgi network. The Golgi-network has been shown to be 
important for ricin toxicity in Golgi-defective mutants of 
Chinese hamster ovary cells which exhibit increased sensitivity 
to ricin. The increased cytotoxicity of ricin was not due to 
different mechanisms of processing of the ricin in the mutant 
cells.
Recently, experiments using brefeldin A have confirmed 
that ricin must reach the trans-Golgi network for cytotoxicity 
(Yoshida et al., 1991). Brefeldin A is a fungal metabolite 
which dramatically alters the structure of the Golgi-network 
causing the Golgi contents and membranes to distribute to the 
ER. The Golgi stacks disassemble but markers for the trans- 
Golgi network are unaffected (Lippincott-Schwartz et al., 
1990). Brefeldin A blocks the transport of glycoproteins from 
the ER to the Golgi (Takatsuku and Tamara, 1985) and blocks the
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transport of VSV protein G to the plasma membrane (Vance et 
al., 1991). Brefeldin A protects cells from the action of ricin 
and abolishes the enhancement of toxicity seen by tunicamycin 
and ammonium chloride. It is postulated that ricin must move 
through the trans-Golgi network into cis/medial and/or trans- 
Golgi regions before release into the cytosol suggesting that 
ricin requires uninterrupted membrane transport between 
endosomes and the Golgi-complex for cytotoxicity.
Manske et al. (1989) studied the trafficking of an anti- 
CD5 antibody linked to ricin A-chain or to intact ricin. The A- 
chain-containing immunotoxin was less toxic than the ricin- 
containing immunotoxin. It was determined that the B-chain 
slowed trafficking to lysosomes and that the rate-limiting step 
in the differences in toxicity was due to the rate of transfer 
to the lysosomes. A bispecific antibody recognising ricin A- 
chain and a carcinoembryonic antigen was potentiated by ricin 
B-chain in the presence of galactose indicating an 
intracellular role for the B-chain.
It is possible that there may be modification or 
processing of the toxin by enzymes in the trans-Golgi network. 
The B-chain may therefore determine the intracellular routing 
of the A-chain to a translocation-competent compartment and be 
involved in the translocation step itself. The abrin described 
here may function as a component in the translocation process 
in cells to which it has gained entry through mannose 
recognition. Most recently however, ricin lacking galactose­
binding activity has been shown to be non-cytotoxic to 
macrophages (personal communication, Dr R. Youle, National 
Institutes of Health, Bethesda, Maryland, USA). The B-chain 
cannot bind to cell-surface receptors and is recognised by 
mannose receptors. Wawrzynczak et al. (1991) have shown that 
blocked ricin immunotoxins were more efficient than ricin A- 
chain containing immunotoxins potentiated with B-chain. It was 
postulated that the blocked ricin becomes unblocked after 
binding to the target antigen, the galactose binding sites are 
exposed and contribute to cell killing. These results indicate
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that the galactose binding activity associated with the B-chain 
plays an intracellular role in addition to cell surface 
binding. The B-chain may recognise glycoproteins or glycolipids 
intracellularly and thereby determine trafficking of the A- 
chain or translocation. It would be of interest to determine 
the cytotoxicity of the abrin-related protein in this system. 
Lack of cytotoxicity will confirm the results of Youle. If the 
abrin-related protein was toxic to intact macrophages however 
this would indicate a role for the B-chain independent of 
galactose binding.
The presence of a non-lectin toxin in seeds is therefore 
unexpected. There are no other detailed reports of a non-lectin 
type II ribosome-inactivating protein. The isolation method 
used by most laboratories of passage down Sepharose-4B column 
depends upon lectin activity therefore it is possible that the 
non-lectin forms have not been detected as they pass directly 
through the column. Roy et al. (1976) described an Abrus lectin 
which had no cytohaemagglutinating activity and did not bind 
galactose.
The clone isolated may not be translated in the plant. 
From the nucleotide sequence of the untranslated regions, the 
gene has all the expected features of a transcribed gene and 
the long open reading frame which shows extensive homology to 
the other type II ribosome-inactivating proteins suggests that 
this is not the case.
There is clearly some evolutionary selection to maintain 
galactose binding domains in the ricin toxins. Ricin retains 
two binding sites of potentially six ancestral galactose 
binding domains, RCA has retained perhaps only one functional 
binding site per B-chain. It is possible that the abrin-related 
gene has lost all six.
The function of the type II ribosome-inactivating proteins 
in nature remains speculative. They are clearly storage 
proteins which are hydrolysed to provide a source of amino 
acids in the germinating seed. Evolutionary selection for 
galactose binding cannot be related to a role in protein
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storage. The interchain disulphide bond must be broken for A- 
chain activity therefore after removal of the linker region the 
presence of the B-chain maintains the protein in an inactive 
form. This may be sufficient to maintain selection for the B- 
chain in evolutionary terms, independent of galactose binding.
-245-
4. SUMMARY AMD OVERALL CONCLUSIONS
An abrin-related sequence was isolated which encodes a 
preproprotein. Analysis of the sequence revealed that the 
leader peptide encodes a 19 amino acid N-terminal signal 
sequence. The A-chain sequence is homologous at the amino acid 
level with abrin C A-chain and ricin A-chain. The residues 
known to be important for N-glycosidase activity of ricin A- 
chain, determined from the 3-dimensional structure and from 
mutational analysis, are all retained in the A-chain sequence 
reported here. The B-chain sequence is 60% similar to ricin B- 
chain at the amino acid level and exhibits the same pattern of 
subdomain duplication postulated for ricin B-chain i.e. 
[X (ocfltf) ] j • The residues which are critical for folding of the 
subdomains and for the interactions between the subdomains of 
the B-chain are retained.
The A-chain of the abrin-related preproprotein was 
expressed in E. coli. The yield of soluble A-chain was 
increased to greater than 6% of the total protein by 
cytoplasmic expression of the A-chain sequence which had been 
maximised for A+T content at the 5' end of the coding sequence 
and by growth of the host E. coli at 30°C. The recombinant A- 
chain was purified to greater than 99% purity from crude cell 
sonicates. The purified A-chain is at least as active as ricin 
A-chain against rabbit reticulocyte lysate and yeast ribosomes. 
Chloroplast and E. coli ribosomes were shown to be resistant to 
the abrin A-chain.
The B-chain of the preproprotein has been expressed in 
Xenopus oocytes. The isolated B-chain is unstable and devoid of 
lectin activity. Lack of lectin activity was confirmed by 
expression of the preproprotein sequence in Xenopus oocytes 
which lacked ability to bind lactose or asialofetuin. It is 
surmised from the results that the environment of the 
tryptophan residue in the lot binding domain is crucial for 
function and that a histidine in the 2t domain prevents binding 
to saccharides. Lack of lectin activity of the abrin-related
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protein is supported by the increase in the internal divergence 
of the subdomains compared to ricin B-chain.
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